<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66397</article-id><article-id pub-id-type="doi">10.7554/eLife.66397</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Regulation of Nodal signaling propagation by receptor interactions and positive feedback</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-222004"><name><surname>Preiß</surname><given-names>Hannes</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6873-9440</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-289385"><name><surname>Kögler</surname><given-names>Anna C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2794-3589</contrib-id><email>anna.koegler@uni-konstanz.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-222005"><name><surname>Mörsdorf</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8982-2155</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-289387"><name><surname>Čapek</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5199-9940</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289388"><name><surname>Soh</surname><given-names>Gary H</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0755-6805</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-282134"><name><surname>Rogers</surname><given-names>Katherine W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5700-2662</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-289386"><name><surname>Morales-Navarrete</surname><given-names>Hernán</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9578-2556</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244182"><name><surname>Almuedo-Castillo</surname><given-names>María</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6759-5879</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa3">#</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-221395"><name><surname>Müller</surname><given-names>Patrick</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0702-6209</contrib-id><email>patrick.mueller@uni-konstanz.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Friedrich Miescher Laboratory of the Max Planck Society</institution><addr-line><named-content content-type="city">Tübingen</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0546hnb39</institution-id><institution>University of Konstanz</institution></institution-wrap><addr-line><named-content content-type="city">Konstanz</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Solnica-Krezel</surname><given-names>Lilianna</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Neurosciences and Developmental Biology, University of Vienna, Vienna, Austria</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, United States</p></fn><fn fn-type="present-address" id="pa3"><label>#</label><p>Centro Andaluz de Biología de Desarrollo, Seville, Spain</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>09</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e66397</elocation-id><history><date date-type="received" iso-8601-date="2021-01-09"><day>09</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-09-19"><day>19</day><month>09</month><year>2022</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66397-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-66397-figures-v3.pdf"/><abstract><p>During vertebrate embryogenesis, the germ layers are patterned by secreted Nodal signals. In the classical model, Nodals elicit signaling by binding to a complex comprising Type I/II Activin receptors (Acvr) and the co-receptor Tdgf1. However, it is currently unclear whether receptor binding can also affect the distribution of Nodals themselves through the embryo, and it is unknown which of the putative Acvr paralogs mediate Nodal signaling in zebrafish. Here, we characterize three Type I (Acvr1) and four Type II (Acvr2) homologs and show that – except for Acvr1c – all receptor-encoding transcripts are maternally deposited and present during zebrafish embryogenesis. We generated mutants and used them together with combinatorial morpholino knockdown and CRISPR F0 knockout (KO) approaches to assess compound loss-of-function phenotypes. We discovered that the Acvr2 homologs function partly redundantly and partially independently of Nodal to pattern the early zebrafish embryo, whereas the Type I receptors Acvr1b-a and Acvr1b-b redundantly act as major mediators of Nodal signaling. By combining quantitative analyses with expression manipulations, we found that feedback-regulated Type I receptors and co-receptors can directly influence the diffusion and distribution of Nodals, providing a mechanism for the spatial restriction of Nodal signaling during germ layer patterning.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Building a body is complicated. Cells must organise themselves head-to-tail, belly-to-back, and inside-to-outside. They do this by laying down a chemical map, which is made up of gradients of molecular signals, high in some places and lower in others. The amount of signal each cell receives helps to decide which part of the body it will become.</p><p>One of the essential signals in developing vertebrates is Nodal. It helps cells to tell inside from outside and left from right. Cells detect Nodal using an activin receptor and co-receptor complex, which catch hold of passing Nodal proteins and transmit developmental signals into cells. An important model to study Nodal signals is the zebrafish embryo, but the identity of the activin receptors and their exact role in this organism has been unclear.</p><p>To find out more, Preiß, Kögler, Mörsdorf et al. studied the activin receptors Acvr1 and Acvr2 in zebrafish embryos. The experiments revealed that two putative Acvr1 and four Acvr2 receptors were present during early development. To better understand their roles, Preiß et al. eliminated them one at a time, and in combination. Losing single activin receptors had no effect. But losing both Acvr1 receptors together stopped Nodal signalling and changed the distribution of the Nodal gradient. Loss of all Acvr2 receptors also caused developmental problems, but they were partly independent of Nodal. This suggests that Acvr1s seem to be able to transmit signals and to shape the Nodal gradient, and that Acvr2s might have another, so far unknown, role.</p><p>Nodal signals guide the development of all vertebrates. Understanding how they work in a model species like zebrafish could shed light on their role in other species, including humans. A clearer picture could help to uncover what happens at a molecular level when development goes wrong.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Nodal signaling</kwd><kwd>Receptors</kwd><kwd>Germ layer patterning</kwd><kwd>Gradient formation</kwd><kwd>Diffusion</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>International Max Planck Research School &quot;From Molecules to Organisms&quot;</institution></institution-wrap></funding-source><award-id>Graduate Student Fellowship</award-id><principal-award-recipient><name><surname>Preiß</surname><given-names>Hannes</given-names></name><name><surname>Mörsdorf</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Max Planck Society</institution></institution-wrap></funding-source><award-id>Max Planck Research Group</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Patrick</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>Grant agreement No 637840 (QUANTPATTERN)</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Patrick</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>Grant agreement No 863952 (ACE-OF-SPACE)</award-id><principal-award-recipient><name><surname>Müller</surname><given-names>Patrick</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A subset of the zebrafish Nodal receptor complex is regulated by positive feedback and controls the diffusion and distribution of Nodal signals during germ layer formation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The formation of the body plan during early embryogenesis depends on the interplay between evolutionarily conserved signaling pathways. The TGF-β superfamily member Nodal is one of the key regulators of vertebrate development and is required to specify mesoderm and endoderm (collectively termed mesendoderm) during germ layer formation (<xref ref-type="bibr" rid="bib79">Schier, 2009</xref>). In the classical model, Nodal ligands signal through a receptor complex comprising Type I and Type II single-transmembrane serine/threonine kinase receptors (<xref ref-type="bibr" rid="bib3">Attisano and Wrana, 2002</xref>; <xref ref-type="bibr" rid="bib82">Shi and Massagué, 2003</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Unlike other members of the TGF-β superfamily, Nodal signaling additionally requires the presence of an EGF-CFC co-receptor to activate signaling. Our current understanding of Nodal signaling is that Nodal directly binds to Type II receptors and the EGF-CFC co-receptor Tdgf1, which in turn mediates the recruitment of the Type I receptors. Upon oligomerization of the receptor complex, Type II receptors phosphorylate the Type I receptors in their GS domains, leading to the recruitment and phosphorylation of the C-terminal SSXS motif of the receptor-regulated Smad (R-Smad) proteins Smad2 and Smad3 by the Type I receptor. The activated pSmad2/pSmad3 proteins associate with the co-factor Smad4 and translocate into the nucleus, where they activate target gene expression (<xref ref-type="bibr" rid="bib31">Hill, 2018</xref>; <xref ref-type="bibr" rid="bib46">Macías-Silva et al., 1996</xref>; <xref ref-type="bibr" rid="bib82">Shi and Massagué, 2003</xref>; <xref ref-type="bibr" rid="bib99">Yeo and Whitman, 2001</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Multiple Nodal receptor candidates are expressed during early zebrafish development.</title><p>(<bold>A</bold>) In the classical model, Nodal signaling requires the recruitment of a receptor complex comprising the co-receptor Oep (Tdgf1 homolog) as well as Type I and Type II Activin receptors (Acvr) to induce phosphorylation and nuclear translocation of the signal transducer pSmad2/3 for the induction of Nodal target genes. (<bold>B</bold>) Phylogenetic neighbor-joining alignment tree of Type I and Type II receptor protein sequences from human, mouse, and zebrafish. Bootstrap values are listed at the nodes and indicate evolutionary distances. (<bold>C</bold>) Temporal expression analysis of putative Nodal receptors at different developmental stages. TPM: Transcripts per million. dpf: day(s) post-fertilization. Data adapted from <xref ref-type="bibr" rid="bib97">White et al., 2017</xref>. (<bold>D</bold>) Spatial expression analysis of Type I and Type II receptors at 2 cell and shield stages revealed by in situ hybridization. Except for <italic>acvr1c</italic>, all receptor-encoding transcripts are maternally deposited. At shield stage, <italic>acvr1b-a</italic> is the only receptor that is not uniformly expressed but restricted to the embryonic margin. (<bold>E</bold>) Nodal signaling controls the expression of <italic>acvr1b-a</italic> and <italic>oep</italic>. Fold change of Nodal receptor expression calculated from qRT-PCR experiments comparing the overexpression of 30 pg <italic>squint-GFP</italic> mRNA, 30 pg <italic>cyclops-GFP</italic> mRNA, 30 pg <italic>lefty2-Dendra2</italic> mRNA and exposure to 50 μM SB-505124 Nodal inhibitor to untreated embryos at 6 hours post-fertilization (hpf). Each point is the mean fold change of an individual embryo compared to an untreated embryo. Error bars represent standard deviation. (<bold>F</bold>) In situ hybridization analysis of <italic>acvr1b-a</italic> with increased (<italic>+squint</italic> GFP) or decreased (+SB-505124) Nodal signaling. Scale bar represents 250 µm. See the <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref> file for source data and sample size.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Sequences and protein domains of putative Nodal receptors.</title><p>(<bold>A</bold>) DNA sequence of the start of the <italic>acvr2a-b</italic> transcript as identified experimentally using 5’RACE. The DNA sequence of the 5’ UTR and exon 1 mapping to chrUn_KN150226v1 are colored in orange, with the start codon colored in green. The remaining DNA sequence is colored black, with the previously predicted start codon boxed. The translation of exon 1, exon 2, and exon 3 are highlighted in green, cyan, and blue, respectively. (<bold>B–H</bold>) Amino acid sequences of the putative Nodal receptors Acvr1b-a, Acvr1b-b, Acvr1c, Acvr2a-a, Acvr2a-b, Acvr2b-a, and Acvr2b-b. The signal peptide is marked in bold, the activin receptor domain in red, the transmembrane domain is underlined, the GS domain is marked in blue, and the protein kinase domain is shown in italics.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig1-figsupp1-v3.tif"/></fig></fig-group><p>In zebrafish, mesendoderm patterning depends on the two secreted Nodal signals Squint (Sqt) and Cyclops (Cyc) (<xref ref-type="bibr" rid="bib19">Dougan et al., 2003</xref>; <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib79">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib81">Shen, 2007</xref>). Nodal expression begins in the yolk syncytial layer at the embryonic margin during the blastula stage and then spreads into the embryo, generating a Nodal signaling gradient. This gradient is translated into different mesendodermal cell fates depending on the signaling level and target gene induction kinetics (<xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>). Loss of Nodal signaling causes absence of endoderm as well as trunk and head mesoderm, which leads to cyclopia due to a failure to separate the eye fields, resulting in embryonic lethality (<xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>). Nodal signaling is antagonized by the secreted long-range feedback inhibitor Lefty, which is also produced at the margin (<xref ref-type="bibr" rid="bib51">Meno et al., 1999</xref>; <xref ref-type="bibr" rid="bib88">Thisse and Thisse, 1999</xref>). Establishment and maintenance of a correct signaling range is crucial for correct development, as also excess Nodal signaling – for example in <italic>lefty</italic> mutants – can cause severe patterning defects and embryonic lethality (<xref ref-type="bibr" rid="bib2">Almuedo-Castillo et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Rogers et al., 2017</xref>).</p><p>Measurements of active GFP-tagged fusions showed that Squint and Cyclops proteins have a lower effective diffusivity than their inhibitors Lefty1 (Lft1) and Lefty2 (Lft2) (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>). It has been proposed that this mobility difference is due to interactions between Nodal ligands and membrane-bound diffusion regulators, whereas Lefty proteins move more freely in the extracellular space (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>). Indeed, Nodal’s signaling range and distribution dramatically increase in the absence of the zebrafish Tdgf1 co-receptor homolog Oep (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>), and single-molecule imaging has recently shown that the fraction of molecules in the bound state is larger for Nodal than for Lefty (<xref ref-type="bibr" rid="bib39">Kuhn et al., 2022</xref>). Since Nodals strongly bind to the zebrafish Type II receptor Acvr2b-a in vivo (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>), the main Nodal receptors themselves might also act as diffusion regulators. However, it is unclear whether this strong ligand-receptor interaction indeed influences Nodal dispersal, whether receptor binding affects Nodal diffusion or stability in the embryo, and what role other putative Type I and Type II Acvr receptors play in the propagation of Nodal signaling through the embryo.</p><p>The two mouse, frog and human Type I receptors Acvr1b (also known as Alk4/TARAM-A) and Acvr1c (also known as Alk7) and the two Type II receptors Acvr2a and Acvr2b were identified using in vitro binding and target induction assays, and cause developmental defects when mutated (<xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>; <xref ref-type="bibr" rid="bib29">Gu et al., 1998</xref>; <xref ref-type="bibr" rid="bib36">Kosaki et al., 1999</xref>; <xref ref-type="bibr" rid="bib49">Matzuk et al., 1995</xref>; <xref ref-type="bibr" rid="bib60">Oh and Li, 1997</xref>; <xref ref-type="bibr" rid="bib67">Reissmann et al., 2001</xref>). Surprisingly, except for the zebrafish co-receptor Oep (<xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>), no zebrafish Nodal receptor mutants are known to recapitulate Nodal loss-of-function phenotypes; and although zebrafish are widely used to investigate Nodal signaling during development, it is unknown which of the receptor paralogs mediate endogenous Nodal signaling during germ layer formation.</p><p>To understand the role of the zebrafish receptor homologs in Nodal distribution and signaling, we generated several loss-of-function mutants and used them together with combinatorial morpholino knockdown and CRISPR F0 knockout (KO) approaches to assess compound loss-of-function phenotypes. Due to the severity of single receptor knock-outs in mice (<xref ref-type="bibr" rid="bib29">Gu et al., 1998</xref>; <xref ref-type="bibr" rid="bib36">Kosaki et al., 1999</xref>; <xref ref-type="bibr" rid="bib49">Matzuk et al., 1995</xref>; <xref ref-type="bibr" rid="bib60">Oh and Li, 1997</xref>; <xref ref-type="bibr" rid="bib67">Reissmann et al., 2001</xref>), we expected phenotypes similar to Nodal loss-of-function mutants in zebrafish. Strikingly, loss of individual receptor function did not cause obvious patterning defects. Severe patterning phenotypes and embryonic lethality were observed with combinatorial loss of putative Type II Acvr receptors, but the defects were at least partly independently of Nodal signaling. Instead, only the combined loss of the Type I receptors <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> phenocopied known Nodal loss-of-function phenotypes (<xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>), identifying these receptors as the main Type I receptors that mediate early Nodal signaling in zebrafish. Using quantitative imaging assays, we found that Type I receptor and co-receptor levels can modulate Nodal mobility and thereby directly influence the distribution of Nodal in the embryo, providing a mechanism for the spatial restriction of Nodal signaling during germ layer patterning.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Nodal Type I and Type II receptors have several putative paralogs in zebrafish</title><p>To systematically identify and characterize zebrafish Nodal receptors, we used the protein sequences of the human and mouse Type I receptors Acvr1b and Acvr1c as well as the Type II receptors Acvr2a and Acvr2b as queries for homology searches in the Uniprot database. In addition to the previously experimentally identified zebrafish Type I (<xref ref-type="bibr" rid="bib68">Renucci et al., 1996</xref>) and Type II (<xref ref-type="bibr" rid="bib26">Garg et al., 1999</xref>; <xref ref-type="bibr" rid="bib59">Nagaso et al., 1999</xref>) Nodal receptor orthologs Acvr1b-a, Acvr1c, Acvr2a-a, and Acvr2b-a, our analysis yielded further potential Nodal receptor paralogous sequences named Acvr1b-b, Acvr2a-b and Acvr2b-b (<xref ref-type="bibr" rid="bib24">Funkenstein et al., 2012</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2019</xref>), respectively, resulting in a total of three putative Type I and four putative Type II receptors. For Acvr2a-b, the start of the gene’s coding sequence and the full amino acid sequence of the receptor was not resolved, and corresponding predictions differed between genome assemblies. Therefore, we performed 5’RACE (Rapid Amplification of cDNA Ends) and thereby mapped the start of <italic>acvr2a-b</italic> to chrUn_KN150226v1 (see <italic>Materials and methods</italic> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref> for further details). Reconstruction of a putative phylogenetic tree shows a close clustering of the zebrafish receptors with their human and mouse paralogs, and the highest sequence similarity was found between the zebrafish Type I receptors Acvr1b-a and Acvr1b-b (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). All putative homologs have the typical features of Type I and Type II receptors, including a signal peptide, TGF-β receptor domain, transmembrane domain, cytosolic kinase domain and a GS domain in case of the Type I receptors (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B-H</xref>).</p></sec><sec id="s2-2"><title>Most Nodal receptor paralog transcripts are present during mesendoderm formation</title><p>To determine which of the putative Nodal receptor paralogs might have roles in germ layer patterning, we first assessed their expression during early embryogenesis, focusing on early blastula and gastrula stages during which germ layer patterning takes place (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Analysis of a published developmental transcriptome (<xref ref-type="bibr" rid="bib97">White et al., 2017</xref>) indicated that the transcripts of most receptor paralogs are present at these stages and before the maternal-zygotic transition, suggesting that they are maternally deposited (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Expression of the identified receptors persists throughout larval development up to 4 days post-fertilization (dpf). The only receptor-encoding gene that does not seem to be expressed during early development is the Type I receptor homolog <italic>acvr1c</italic>, which is first detected at 4 dpf (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Therefore, all putative receptors except for <italic>acvr1c</italic> are expressed at the developmental stages, during which Nodal signaling patterns the germ layers.</p><p>We next used in situ hybridization analysis to characterize the spatial expression patterns of the putative receptors, and in particular to determine whether they are expressed at the embryonic margin, where Nodal signaling induces mesendoderm (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In agreement with the temporal analysis (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), we found that transcripts of all putative Nodal Type I and II receptors – with the exception of <italic>acvr1c</italic> – are evenly distributed at the two-cell stage (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), consistent with maternal deposition. During early gastrulation (shield stage), most receptors are ubiquitously expressed throughout the embryo (<xref ref-type="bibr" rid="bib26">Garg et al., 1999</xref>; <xref ref-type="bibr" rid="bib59">Nagaso et al., 1999</xref>) – except for <italic>acvr1c</italic>, which is not expressed, and <italic>acvr1b-a</italic>, which is constrained to the embryonic margin (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), similar to the co-receptor <italic>oep</italic> (<xref ref-type="bibr" rid="bib68">Renucci et al., 1996</xref>; <xref ref-type="bibr" rid="bib94">Vopalensky et al., 2018</xref>). Together, our analyses show that, except for <italic>acvr1c</italic> all putative receptors are expressed at the right time and place to potentially act as mediators of endogenous Nodal signaling during zebrafish germ layer patterning.</p></sec><sec id="s2-3"><title>Nodal signaling upregulates <italic>acvr1b-a</italic> expression but does not affect other putative Nodal receptors</title><p>In zebrafish, Nodal signaling induces several of its own signaling pathway components, including <italic>squint</italic>, <italic>cyclops, lefty1, lefty2,</italic> and <italic>oep</italic> (<xref ref-type="bibr" rid="bib5">Bennett et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Feldman et al., 2002</xref>; <xref ref-type="bibr" rid="bib51">Meno et al., 1999</xref>). To systematically assess potential receptor induction by Nodal signaling, we used qRT-PCR to measure receptor expression levels in embryos with increased Nodal signaling (injection of <italic>squint-GFP</italic> or <italic>cyclops-GFP</italic> mRNA [<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>]) or decreased Nodal signaling (injection of <italic>lefty2-Dendra2</italic> mRNA [<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>] or treatment with the Nodal inhibitor SB-505124 [<xref ref-type="bibr" rid="bib17">DaCosta Byfield et al., 2004</xref>]). <italic>acvr1c</italic> was excluded from this analysis because its spatiotemporal expression suggests that it does not mediate endogenous Nodal signaling during germ layer patterning (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In agreement with previous studies (<xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>), <italic>oep</italic> and <italic>acvr1b-a</italic> were upregulated by increased Nodal signaling and downregulated by decreased signaling (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Upon Nodal overexpression, <italic>acvr1b-a</italic> expression expanded beyond its usual domain at the margin, whereas Nodal inhibition abolished its expression (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). In contrast, none of the other putative Nodal receptor-encoding genes exhibited a substantial change in expression upon Nodal overexpression or inhibition (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p></sec><sec id="s2-4"><title>The Acvr2 receptors act in part redundantly to pattern the early zebrafish embryo through a partially Nodal-independent mechanism</title><p>To elucidate the roles of the putative Nodal receptors in germ layer formation, we assessed the effect of their loss of function on embryonic morphologies, starting with the putative Type II receptors Acvr2a-a, Acvr2a-b, Acvr2b-a, and Acvr2b-b. These receptors are thought, and in the case of Acvr2b-a have been shown (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>), to be bound by Nodals directly. To achieve receptor loss of function, we used three different approaches: (1) mutants, (2) morpholino-mediated knockdown (<xref ref-type="bibr" rid="bib21">El-Brolosy et al., 2019</xref>; <xref ref-type="bibr" rid="bib76">Rossi et al., 2015</xref>), and (3) CRISPR-mediated F0 knockouts (KO) (<xref ref-type="bibr" rid="bib38">Kroll et al., 2021</xref>).</p><p>To study receptor loss of function in mutants, we obtained <italic>acvr2a-a<sup>SA34654</sup></italic> and <italic>acvr2a-b<sup>SA18285</sup></italic> mutants from the European Zebrafish Resource Center (EZRC) and generated a mutant allele for <italic>acvr2b-a</italic> using CRISPR/Cas9. In all three mutants, the signal peptide or receptor domain and all downstream domains were disrupted, likely causing a complete loss of gene function (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A-D</xref>). However, surprisingly, none of the maternal-zygotic homozygous receptor mutants displayed obvious patterning defects at 1 dpf (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A-D</xref>) and all were viable. This is in stark contrast to the mouse Type IIB receptor mutants that exhibit severe malformations during early embryonic development (<xref ref-type="bibr" rid="bib29">Gu et al., 1998</xref>; <xref ref-type="bibr" rid="bib60">Oh and Li, 1997</xref>).</p><p>Genetic compensation can mask potential patterning defects in mutants (<xref ref-type="bibr" rid="bib21">El-Brolosy et al., 2019</xref>; <xref ref-type="bibr" rid="bib76">Rossi et al., 2015</xref>) and may occur in some instances in the <italic>acvr2</italic> mutants (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E, F</xref>). Therefore, we also assessed the effect of acutely knocking down gene activity using antisense morpholino oligonucleotides targeting the ATG start codons or splice sites of the putative receptor mRNAs. We found that morpholinos targeting individual receptor-encoding mRNAs had no effects or caused non-specific head or tail defects similar to a standard control morpholino (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G-L</xref>). Some morpholino treatments at high doses increased lethality (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H-L</xref>), but none of the conditions led to the Nodal-specific patterning defects observed in loss-of-function mutants of other Nodal signaling pathway components (<xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>).</p><p>To complement our mutant and morpholino analyses, we acutely knocked down the putative Type II Nodal receptors using CRISPR-mediated F0 KO (<xref ref-type="bibr" rid="bib38">Kroll et al., 2021</xref>). In this approach, multiple exons of a single gene are targeted by Cas9/gRNA ribonucleoproteins (RNPs), thereby generating a biallelic zygotic KO directly in the injected embryos, the so-called F0 generation. Using this technique, we found that F0 KO of <italic>acvr2a-a</italic>, <italic>acvr2a-b</italic>, <italic>acvr2b-a,</italic> or <italic>acvr2b-b</italic> did not affect embryo morphology (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), confirming that the disruption of individual Acvr2 receptors has no substantial influence on embryonic patterning.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Combinatorial removal of putative Type II Nodal receptors causes dorsal-ventral patterning defects.</title><p>(<bold>A–B</bold>) Phenotypes of embryos upon single, double, triple, and quadruple CRISPR F0 KO of <italic>acvr2</italic> receptors. (<bold>A</bold>) Lateral view of embryos of the indicated condition approximately 28–31 hpf. Arrowheads indicate the extent of ventral fin loss. Boxes indicate the phenotype class according to the scheme presented in (<bold>B</bold>). Scale bar represents 250 µm. (<bold>B</bold>) Frequency of phenotypes observed in embryos of the indicated condition at 1 dpf. n indicates the number of analyzed embryos. (<bold>C</bold>) Nodal and BMP signaling visualized by pSmad2/3 and pSmad1/5/9 immunostaining, respectively, in wild-type and quadruple <italic>acvr2</italic> F0 KO embryos at 50% and 80–90% epiboly. Maximum intensity projections show lateral views with dorsal to the right. The number of embryos with the presented phenotype is indicated. Scale bar represents 200 µm. See the <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref> file for source data.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Single <italic>acvr2</italic> receptor mutant or knockdown embryos have no obvious patterning defects.</title><p>(<bold>A–D</bold>) Phenotypes of single putative Type II Nodal receptor mutants. Left panels: Schematic diagram showing a typical full-length Type II protein (<bold>A</bold>) and predicted receptor protein truncations resulting from the <italic>acvr2a-a<sup>SA34654</sup></italic> (<bold>B</bold>), <italic>acvr2a-b<sup>SA18285</sup></italic> (<bold>C</bold>) and <italic>acvr2b-a<sup>t08pm</sup></italic> (<bold>D</bold>) mutant alleles. Mutated nucleic acid sequences and resulting protein lengths in amino acids (aa) are indicated. Also see <italic>Materials and methods</italic>. Right panels: Lateral views of embryos at approximately 27–31 hpf for wild-type and maternal-zygotic single receptor homozygous mutants. Scale bars represent 250 µm. aa: amino acids; SP: Signal peptide; RD: Receptor domain; TM: Transmembrane domain; Kinase: Kinase domain; Black: Predicted novel aa sequence between frameshift mutation and new stop site. (<bold>E,F</bold>) Change of <italic>acvr2a-b</italic> (<bold>E</bold>) and <italic>acvr2b-b</italic> (<bold>F</bold>) expression in <italic>acvr2a-a<sup>SA34654</sup></italic> and <italic>acvr2b-a<sup>t08pm</sup></italic> mutant compared to WT embryos. Fold change was calculated from qRT-PCR experiments. Error bars represent standard deviation. n = 3 in each case. (<bold>G–L</bold>) Phenotypes of embryos 1 day after morpholino-mediated knockdown of putative Type II Nodal receptors. (<bold>G</bold>) Phenotype classification categories with example images of lateral view embryos at 1 dpf (same as in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). (<bold>H–L</bold>) Frequency of phenotypes observed upon injection of <italic>acvr2a-a</italic> (<bold>H</bold>), <italic>acvr2a-b</italic> (<bold>I</bold>), <italic>acvr2b-a</italic> (<bold>J</bold>), <italic>acvr2b-b</italic> (<bold>K</bold>) and control (<bold>L</bold>) morpholinos into wild-type embryos at the indicated amounts in ng. n indicates the number of analyzed embryos. See the <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref> file for source data.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig2-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig2-figsupp1-v3.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Combinatorial removal of <italic>acvr2</italic> receptors using morpholinos, CRISPR F0 KO and mutants causes axis-patterning defects.</title><p>(<bold>A</bold>) Phenotype classification categories (same as in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). (<bold>B</bold>) Phenotype distributions after injection of a mix of all available <italic>acvr2a-a</italic>, <italic>acvr2a-b, acvr2b-a</italic> and <italic>acvr2b-b</italic> morpholinos (see <italic>Materials and methods</italic>) at the indicated total morpholino concentration into wild-type embryos. n indicates the number of embryos analyzed at 1 dpf. (<bold>C</bold>) Phenotypes observed upon <italic>acvr2b-b</italic> CRISPR F0 KO in progeny of an <italic>acvr2a-a</italic><sup>+/-</sup>;<italic>acvr2a-b</italic><sup>+/-</sup>;<italic>acvr2b-a</italic><sup>+/-</sup> incross at 1 dpf. Embryos with different phenotypes were selected, imaged and subsequently sacrificed for genotyping. The genotype of the presented embryos is indicated at the top with green, yellow and red marking homozygous wild-type, heterozygous and homozygous mutant alleles, respectively. Arrowheads indicate the extent of fin tissue loss. Boxes indicate the phenotype class according to the scheme presented in (<bold>A</bold>). (<bold>D</bold>) Phenotypes observed upon double <italic>acvr1b-a</italic>,<italic>acvr1b-b</italic> or quadruple <italic>acvr2a-a</italic>,<italic>acvr2a-b</italic>,<italic>acvr2b-a</italic>,<italic>acvr2b-b</italic> CRISPR F0 KO in MZ<italic>oep</italic> embryos at 1 dpf. Arrowheads point to a single cyclopic eye. Lateral views are presented in (<bold>C</bold>) and (<bold>D</bold>). Scale bars represent 250 µm. See the <xref ref-type="supplementary-material" rid="fig2s2sdata1">Figure 2—figure supplement 2—source data 1</xref> file for source data.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig2-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig2-figsupp2-v3.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Validation of gRNAs targeting putative Type II Nodal receptors for F0 KO.</title><p>(<bold>A–D</bold>) T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2a-a</italic> (<bold>A</bold>), <italic>acvr2a-b</italic> (<bold>B</bold>), <italic>acvr2b-a</italic> (<bold>C</bold>) and <italic>acvr2b-b</italic> (<bold>D</bold>). Genomic DNA was isolated from ten control embryos (uninjected) and ten embryos injected with a gene-specific gRNA/Cas9 ribonucleoprotein (RNP) and used in a T7E1 assay to estimate the cutting efficiency of individual RNPs. The size of the PCR product and its digestion products expected upon RNP injection and in the presence of the enzyme (T7E1) are indicated. See <xref ref-type="supplementary-material" rid="fig2s3sdata1">Figure 2—figure supplement 3—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig2s3sdata2">Figure 2—figure supplement 3—source data 2</xref> for uncropped, labeled and <xref ref-type="supplementary-material" rid="fig2s3sdata3">Figure 2—figure supplement 3—source data 3</xref>, <xref ref-type="supplementary-material" rid="fig2s3sdata4">Figure 2—figure supplement 3—source data 4</xref>, <xref ref-type="supplementary-material" rid="fig2s3sdata5">Figure 2—figure supplement 3—source data 5</xref> and <xref ref-type="supplementary-material" rid="fig2s3sdata6">Figure 2—figure supplement 3—source data 6</xref> for raw, unedited pictures of agarose gels.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><caption><title>Uncropped pictures of agarose gels showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2a-a</italic> (<bold>A</bold>) and <italic>acvr2a-b</italic> (<bold>B</bold>) presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A, B</xref>.</title><p>See <xref ref-type="supplementary-material" rid="fig2s3sdata3">Figure 2—figure supplement 3—source data 3</xref>, <xref ref-type="supplementary-material" rid="fig2s3sdata4">Figure 2—figure supplement 3—source data 4</xref> for raw and unedited pictures.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig2-figsupp3-data1-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig2s3sdata2"><label>Figure 2—figure supplement 3—source data 2.</label><caption><title>Uncropped pictures of agarose gels showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2b-a</italic> (<bold>A</bold>) and <italic>acvr2b-b</italic> (<bold>B</bold>) presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3C, D</xref>.</title><p>See <xref ref-type="supplementary-material" rid="fig2s3sdata5">Figure 2—figure supplement 3—source data 5</xref>, <xref ref-type="supplementary-material" rid="fig2s3sdata6">Figure 2—figure supplement 3—source data 6</xref> for raw and unedited pictures.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig2-figsupp3-data2-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig2s3sdata3"><label>Figure 2—figure supplement 3—source data 3.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2a-a</italic> presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig2-figsupp3-data3-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig2s3sdata4"><label>Figure 2—figure supplement 3—source data 4.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2a-b</italic> presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig2-figsupp3-data4-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig2s3sdata5"><label>Figure 2—figure supplement 3—source data 5.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2b-a</italic> presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig2-figsupp3-data5-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig2s3sdata6"><label>Figure 2—figure supplement 3—source data 6.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr2b-b</italic> presented in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig2-figsupp3-data6-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig2-figsupp3-v3.tif"/></fig></fig-group><p>Teleosts like zebrafish have undergone an additional genome duplication following the two vertebrate-specific rounds of whole-genome duplications (<xref ref-type="bibr" rid="bib52">Meyer and Van de Peer, 2005</xref>), and partial redundancy of paralogs can underlie the lack of abnormal phenotypes in single mutants (<xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib41">Leerberg et al., 2019</xref>). To test whether the putative Nodal Type II receptors function redundantly, we used the CRISPR F0 KO strategy to simultaneously disrupt multiple <italic>acvr2</italic> genes, thereby creating combinatorial KOs. Double, triple, and quadruple F0 KO embryos were analyzed for patterning defects. In contrast to the Nodal-specific loss-of-function phenotype, embryos of all KO combinations developed two properly spaced eyes (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, with an increasing number of <italic>acvr2</italic> genes disrupted, embryos displayed more severe dorsalization phenotypes (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>): <italic>acvr2b-a</italic>,<italic>acvr2b-b</italic> double KO embryos had mild dorsalization phenotypes with the ventral tail fin partly or completely missing, similar to class 1 (C1) BMP mutant phenotypes (<xref ref-type="bibr" rid="bib35">Kishimoto et al., 1997</xref>). Triple <italic>acvr2a-a</italic>,<italic>acvr2b-a</italic>,<italic>acvr2b-b</italic> F0 KO embryos additionally showed a bent or kinked tail and a thickened yolk extension (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). Embryos disrupted zygotically for <italic>acvr2a-b,acvr2b-a</italic>,<italic>acvr2b-b</italic> or all four <italic>acvr2</italic> genes showed the most severe patterning defects, including a kinked or curled tail, the absence of fin tissue, a larger yolk sac with shortened yolk extension, prominent hatching glands, smaller eyes and head structures, cuboidal instead of chevron-shaped somites, head necrosis (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>) and lethality at 2–3 dpf. These robust phenotypes were seen in the large majority (97%) of quadruple F0 KO embryos, and although they include typical features of dorsalization, like a curled tail seen upon loss of BMP signaling (<xref ref-type="bibr" rid="bib35">Kishimoto et al., 1997</xref>; <xref ref-type="bibr" rid="bib43">Little and Mullins, 2009</xref>), other aspects like the reduction in head and eye size do not fit the classical dorsalization phenotype.</p><p>To ensure that the observed phenotypes are specific to the loss of the Acvr2 receptors, we additionally combinatorially disrupted the <italic>acvr2</italic> genes by quadruple morpholino-mediated knockdown and zygotic F0 KO of <italic>acvr2b-b</italic> in the incross progeny of a triple-heterozygous <italic>acvr2a-a</italic><sup>+/-</sup>;<italic>acvr2a-b</italic><sup>+/-</sup>;<italic>acvr2b-a</italic><sup>+/-</sup> mutant line. The resulting embryos were analyzed for patterning defects at 1 dpf and, in the case of the mutant line, subsequently genotyped. Both approaches reliably recapitulated the phenotypes observed for the quadruple F0 <italic>acvr2</italic> KO (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A-C</xref>). Furthermore, the mutants confirmed the difference between the <italic>acvr2</italic> genes observed in the combinatorial F0 KO: While <italic>acvr2a-a</italic> and <italic>acvr2a-b,</italic> on their own, were not able to rescue the loss of the other three receptors, the most severe phenotypes were only observed in the absence of functional <italic>acvr2b-a</italic> or <italic>acvr2b-b</italic> alleles (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>).</p><p>To directly determine potential consequences of combinatorial <italic>acvr2</italic> loss on Nodal and BMP signaling, we performed immunostainings for the Nodal signal transducer phosphorylated Smad2/3 (pSmad2/3) and the BMP signal transducer phosphorylated Smad1/5/9 (pSmad1/5/9) in wild-type and quadruple F0 KO embryos at early and late gastrulation stages (50% and 80–90% epiboly, respectively). At 50% epiboly, the pSmad2/3 signal was elevated in quadruple F0 KO embryos, while the pSmad1/5/9 signal appeared unaffected (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Towards the end of gastrulation (80–90% epiboly), quadruple F0 KO embryos still showed an increased pSmad2/3 signal compared to wild-type embryos, but in addition a weaker pSmad1/5/9 signal (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This indicates that in the absence of the Acvr2 receptors Nodal signaling increases while, with some delay, BMP signaling decreases. To further test whether the Acvr2 receptors act within the same pathway as Nodal, we performed quadruple receptor F0 KO in MZ<italic>oep</italic> mutant embryos and observed their phenotypes at 1 dpf. In addition to MZ<italic>oep</italic>-specific defects, including cyclopia, these embryos also had a shortened body axis and curled tails (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>), indicating at least partially additive patterning defects.</p><p>Overall, our results show that the zebrafish receptors Acvr2a-a, Acvr2a-b, Acvr2b-a, and Acvr2b-b act partly redundantly and are essential for the formation of the embryonic body plan. However, they do not appear to fulfill the function of classical Type II Nodal receptors. It will be interesting in the future to determine the mechanism by which the Type II receptors mediate partially Nodal-independent patterning processes.</p></sec><sec id="s2-5"><title>The Type I receptors Acvr1b-a and Acvr1b-b redundantly mediate Nodal signaling during zebrafish germ layer patterning</title><p>We next investigated the role of the putative Type I Nodal receptors Acvr1b-a, Acvr1b-b, and Acvr1c in early zebrafish development. We first examined the morphological phenotypes of single receptor loss of function using mutants, morpholino-mediated knockdown and CRISPR F0 KO as described above. Similar to the Acvr2 receptors, loss of individual Acvr1 receptors did not cause severe phenotypes apart from the non-specific head or tail defects observed for some morpholino treatments (<xref ref-type="fig" rid="fig3">Figure 3A and C</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A-C and E-H</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Combinatorial removal of putative Type I Nodal receptors causes Nodal-specific patterning defects.</title><p>Phenotypes of wild-type, MZ<italic>oep</italic> and <italic>oep</italic> CRISPR F0 KO embryos compared to embryos depleted of either or both <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> using morpholino KDs, CRISPR F0 KOs and mutants. (<bold>A</bold>) Lateral view of embryos of the indicated condition approximately 28–31 hpf. Large arrowheads point to a single cyclopic eye, small arrowheads to fused or convergent eyes. Boxes indicate the phenotype class according to the scheme presented in (<bold>C</bold>). Scale bar represents 250 µm. (<bold>B</bold>) Nodal signaling visualized by pSmad2/3 immunostaining in embryos of the indicated condition (<bold>A</bold>) at 50% epiboly. Maximum intensity projections show lateral views. The number of embryos with the presented phenotype is indicated. Scale bar represents 200 µm. (<bold>C</bold>) Frequency of phenotypes observed in embryos of the indicated condition 1 dpf. n indicates the number of analyzed embryos. Note that one of the gRNAs used for <italic>acvr1b-b</italic> F0 KO has <italic>acvr1b-a</italic> as a predicted off-target, likely explaining the rare occurrences of the convergent eyes phenotype (see <italic>Materials and methods</italic>). See the <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref> file for source data.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Single Type I Nodal receptor mutants or knockdown embryos have no obvious patterning defects.</title><p>(<bold>A–C</bold>) Phenotypes of single Type I Nodal receptor mutants. Left panels: Schematic diagram showing a typical full-length Type I protein (<bold>A</bold>) and predicted receptor protein truncations resulting from the <italic>acvr1b-a<sup>t03pm</sup></italic> (<bold>B</bold>) and <italic>acvr1c<sup>t06pm</sup></italic> (<bold>C</bold>) mutant alleles. Mutated nucleic acid sequences and resulting protein lengths in amino acids (aa) are indicated. Right panels: Lateral views of embryos at approximately 27–31 hpf for wild-type and maternal-zygotic single receptor homozygous mutants. Scale bars represent 250 µm. aa: amino acids; SP: Signal peptide; RD: Receptor domain; TM: Transmembrane domain; GS: GS domain; Kinase: Kinase domain; Black: Predicted novel aa sequence between frameshift mutation and new stop site. (<bold>D</bold>) Change of <italic>acvr1b-b</italic> expression in <italic>acvr1b-a<sup>t03pm</sup></italic> mutant compared to wild-type embryos as calculated from qRT-PCR experiments. Error bars represent standard deviation. n = 3 in each case. (<bold>E–H</bold>) Phenotypes of embryos 1 day after morpholino-mediated knockdown of putative Type I Nodal receptors. (<bold>E</bold>) Phenotype classification categories with example images of lateral view embryos at 1 dpf (same as in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). (<bold>F–H</bold>) Frequency of phenotypes observed upon injection of <italic>acvr1b-a</italic> (<bold>F</bold>), <italic>acvr1b-b</italic> (<bold>G</bold>), and <italic>acvr1c</italic> (<bold>H</bold>) morpholinos into wild-type embryos at the indicated amounts in ng. Results for control morpholino injections are shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1L</xref>. n indicates the number of analyzed embryos. See the <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref> file for source data.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig3-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig3-figsupp1-v3.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Combinatorial removal of <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> using morpholinos and mutants mimic Nodal loss-of-function phenotypes.</title><p>(<bold>A</bold>) Phenotype classification categories (same as in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). (<bold>B</bold>) Phenotype distributions after injection of a mix of all available <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> morpholinos at the indicated total morpholino concentration into wild-type embryos. (<bold>C</bold>) Phenotype distributions after injection of <italic>acvr1b-b</italic> transcriptional start site (MO-1) and <italic>acvr1b-b</italic> splice site-targeting (MO-2) morpholinos into maternal-zygotic <italic>acvr1b-a<sup>t03pm/t03pm</sup></italic> embryos. n indicates the number of analyzed embryos in (<bold>B</bold>) and (<bold>C</bold>). (<bold>D</bold>) The effect of <italic>acvr1b-b</italic> splice site-targeting morpholino (MO-2) on the maternal and zygotic transcript. cDNA of 512 cell or shield stage control embryos and embryos injected with 0.4 ng or 2 ng <italic>acvr1b-b</italic> MO-2 was used to amplify the unspliced (1) and spliced (2) <italic>acvr1b-b</italic> transcript. Arrowheads indicate the unspliced transcript’s PCR product, which is not detected before the zygotic genome activation (i.e. at the 512 cell stage). For (<bold>B,C</bold>), see the <xref ref-type="supplementary-material" rid="fig3s2sdata1">Figure 3—figure supplement 2—source data 1</xref> table for source data. For (<bold>D</bold>), see <xref ref-type="supplementary-material" rid="fig3s2sdata2">Figure 3—figure supplement 2—source data 2</xref> for the uncropped, labeled and <xref ref-type="supplementary-material" rid="fig3s2sdata3">Figure 3—figure supplement 2—source data 3</xref> for the raw, unedited picture of the agarose gel.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Source data table for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B, C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp2-data1-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata2"><label>Figure 3—figure supplement 2—source data 2.</label><caption><title>Uncropped picture of the agarose gel showing the effect of <italic>acvr1b-b</italic> splice site-targeting morpholino (MO-2) on the maternal and zygotic transcript presented in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>.</title><p>See <xref ref-type="supplementary-material" rid="fig3s2sdata3">Figure 3—figure supplement 2—source data 3</xref> for the raw and unedited picture.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp2-data2-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s2sdata3"><label>Figure 3—figure supplement 2—source data 3.</label><caption><title>Raw, unedited picture of the agarose gel showing the effect of <italic>acvr1b-b</italic> splice site-targeting morpholino (MO-2) on the maternal and zygotic transcript presented in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp2-data3-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig3-figsupp2-v3.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Confirmation of gRNAs targeting putative Type I Nodal receptors and <italic>oep</italic> for F0 KO.</title><p>(<bold>A–C</bold>) T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr1b-a</italic> (<bold>A</bold>), <italic>acvr1b-b</italic> (<bold>B</bold>) and <italic>oep</italic> (<bold>C</bold>). Genomic DNA was isolated from ten control embryos (uninjected) and ten embryos injected with a gene-specific gRNA/Cas9 ribonucleoprotein (RNP) and used in a T7E1 assay to estimate the cutting efficiency of individual RNPs. The size of the PCR product and its digestion products expected upon RNP injection and in the presence of the enzyme (T7E1) are indicated. See <xref ref-type="supplementary-material" rid="fig3s3sdata1">Figure 3—figure supplement 3—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig3s3sdata2">Figure 3—figure supplement 3—source data 2</xref> for uncropped, labeled and <xref ref-type="supplementary-material" rid="fig3s3sdata3">Figure 3—figure supplement 3—source data 3</xref>, <xref ref-type="supplementary-material" rid="fig3s3sdata4">Figure 3—figure supplement 3—source data 4</xref>, <xref ref-type="supplementary-material" rid="fig3s3sdata5">Figure 3—figure supplement 3—source data 5</xref> for raw, unedited pictures of agarose gels.</p><p><supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Uncropped pictures of agarose gels showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr1b-a</italic> (<bold>A</bold>) and <italic>acvr1b-b</italic> (<bold>B</bold>) presented in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A, B</xref>.</title><p>See <xref ref-type="supplementary-material" rid="fig3s3sdata3">Figure 3—figure supplement 3—source data 3</xref>, <xref ref-type="supplementary-material" rid="fig3s3sdata4">Figure 3—figure supplement 3—source data 4</xref> for raw and unedited pictures.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp3-data1-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata2"><label>Figure 3—figure supplement 3—source data 2.</label><caption><title>Uncropped picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>oep</italic> presented in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>.</title><p>See <xref ref-type="supplementary-material" rid="fig3s3sdata5">Figure 3—figure supplement 3—source data 5for the raw and unedited</xref> picture.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp3-data2-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata3"><label>Figure 3—figure supplement 3—source data 3.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr1b-a</italic> presented in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp3-data3-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata4"><label>Figure 3—figure supplement 3—source data 4.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>acvr1b-b</italic> presented in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp3-data4-v3.zip"/></supplementary-material></p><p><supplementary-material id="fig3s3sdata5"><label>Figure 3—figure supplement 3—source data 5.</label><caption><title>Raw, unedited picture of the agarose gel showing the T7 Endonuclease I (T7E1) assay results for gRNAs targeting <italic>oep</italic> presented in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-66397-fig3-figsupp3-data5-v3.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig3-figsupp3-v3.tif"/></fig></fig-group><p>To test whether the putative Type I receptors may redundantly mediate Nodal signaling during germ layer patterning, we used combinatorial receptor loss-of-function approaches for <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic>. Morpholino-mediated double knockdown of <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> resulted in a clear loss of head mesoderm at 1 dpf, leading to the distinctive fused-eye phenotype and a curved body axis associated with loss-of-Nodal signaling (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A, B</xref>). However, somites still formed in the trunk region, suggesting an incomplete loss of Nodal signaling possibly due to maternal deposition of receptor proteins or incomplete mRNA knockdown. Similar but slightly milder phenotypes were obtained with the double <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> F0 KO: Most embryos developed two eyes but showed reduced spacing between them (convergent eyes) recapitulating the zygotic F0 KO of <italic>oep</italic> (<xref ref-type="fig" rid="fig3">Figure 3A and C</xref>), indicating a maternal contribution. Therefore, we injected <italic>acvr1b-b</italic>-targeting morpholinos into maternal-zygotic <italic>acvr1b-a<sup>-</sup></italic><sup>/<italic>-</italic></sup> mutant embryos. This combination reliably recapitulated the full Nodal loss-of-function phenotype at 1 dpf (<xref ref-type="fig" rid="fig3">Figure 3A and C</xref>). Interestingly, knockdown of <italic>acvr1b-b</italic> in <italic>acvr1b-a<sup>-</sup></italic><sup>/<italic>-</italic></sup> mutants only resulted in Nodal loss-of-function phenotypes when the ATG-targeting morpholino (‘MO-1’) was used, but not with the splice site-targeting morpholino (‘MO-2’) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). Since the splice site-targeting morpholino does not affect the maternally deposited <italic>acvr1b-b</italic> mRNA (i.e. the mRNA at 512-cell stage) (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>), this observation indicates that maternally deposited <italic>acvr1b-b</italic> mRNA contributes to proper germ layer formation.</p><p>The phenotypes observed in embryos lacking functional <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> suggest a loss of Nodal signaling. To test this hypothesis, we directly assessed Nodal signaling in these embryos by staining for pSmad2/3 during early gastrulation at 50% epiboly and shield stage (<xref ref-type="fig" rid="fig3">Figure 3B</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>). The range of Nodal signaling at shield stage was quantified as the number of pSmad2/3-positive nuclei tiers on the dorsal side (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) or the normalized intensity of nuclei from the dorsal or lateral side relative to their distance from the margin (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). We observed pSmad2/3-positive cells over a distance of about 12-cell tiers at the embryonic margin of wild-type embryos (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>) similar to previous reports (<xref ref-type="bibr" rid="bib2">Almuedo-Castillo et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>; <xref ref-type="bibr" rid="bib73">Rogers et al., 2017</xref>; <xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>). <italic>acvr1b-a<sup>-</sup></italic><sup>/<italic>-</italic></sup> mutants and embryos injected with <italic>acvr1b-b</italic>-targeting morpholinos had a Nodal signaling range similar to untreated wild-type embryos on the dorsal side. Laterally, <italic>acvr1b-a<sup>-</sup></italic><sup>/<italic>-</italic></sup> mutants showed a slight reduction in pSmad2/3 signal intensity at distances above 30 µm (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). In contrast, combined mutation/knockdown of both Type I receptors almost completely abolished the pSmad2/3 signal throughout the embryo (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Importantly, the range of pSmad2/3-positive nuclei could be restored to a near-normal extent by injection of 50 pg <italic>acvr1b-a</italic> or 25 pg <italic>acvr1b-b</italic> mRNA (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>), and up to 60% of injected embryos displayed normal or partially rescued phenotypes at 1 dpf (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). These results demonstrate that <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> redundantly mediate Nodal signaling during germ layer patterning.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The Type I receptors Acvr1b-a and Acvr1b-b redundantly mediate Nodal signaling.</title><p>(<bold>A,B</bold>) Influence of <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> on the Nodal signaling range at shield stage. The range of Nodal signaling in shield-stage wild-type, knockdown and rescued embryos was determined by counting the maximum number of nuclei tiers positive for pSmad2/3 immunostaining from the embryonic margin towards the animal pole (i.e. the number of pSmad2/3 positive nuclei tiers at the dorsal side). <italic>acvr1b-a<sup>t03pm/t03pm</sup></italic> mutants and 0.4 ng <italic>acvr1b-b</italic> transcriptional start site-targeting morpholino (MO-1) were used for receptor loss-of-function conditions. Receptor loss-of-function was rescued with 50 pg of <italic>acvr1b-a</italic> or 25 pg of <italic>acvr1b-b</italic> mRNA. Data was obtained from three independent replicate experiments. (<bold>A</bold>) Maximum intensity projections show dorsal views. Scale bar represents 200 µm. (<bold>B</bold>) n indicates the number of analyzed embryos. Averages are displayed in red, and error bars show standard deviation. (<bold>C</bold>) Rescue of Type I receptor function after combinatorial mutation/knockdown using <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> mRNA. To deplete the Type I receptors, the <italic>acvr1b-a<sup>t03pm/t03pm</sup></italic> mutant was used in combination with 0.4 ng <italic>acvr1b-b</italic> transcriptional start site-targeting morpholino (MO-1). mRNA amounts are given in pg. n indicates the number of analyzed embryos. Note that strong overexpression of Acvr1b-a receptor-encoding mRNA leads to high lethality or tissue aggregates that eventually disintegrate (termed ‘Nodal gain-of-function’). See the <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref> file for source data.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig4-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The Type I receptors Acvr1b-a and Acvr1b-b redundantly mediate Nodal signaling.</title><p>Quantification of the margin to animal pSmad2/3 immunofluorescence signal at shield stage from data presented in <xref ref-type="fig" rid="fig4">Figure 4</xref>. Only samples recorded on the same day were used to ensure comparability. The average background-subtracted intensity of nuclei relative to their distance from the margin (in µm) normalized to the intensity of the average wild-type signal at position x=0 µm is shown. Mutant (<italic>acvr1b-a<sup>-/-</sup></italic>) and wild-type embryos were used and either injected with 0.4 ng <italic>acvr1b-b</italic> morpholino 1 (MO-1), 50 pg <italic>acvr1b-a</italic> or 25 ng <italic>acvr1b–b</italic>-mRNA or a combination. Dorsal measurements were only performed if the dorsal side could be distinguished from the lateral side based on the microscopy data (therefore no plot for <italic>acvr1b-a</italic> mutants injected with <italic>acvr1b-b</italic> morpholino is shown). Sample sizes are indicated in parentheses. The error bars (shaded regions) show the standard error of the mean. See the <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref> file for source data.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig4-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig4-figsupp1-v3.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Nodal receptors affect Nodal dispersal in zebrafish embryos</title><p>During gastrulation, the establishment of the correct range of Nodal signaling is thought to be crucial for normal germ layer patterning (reviewed in <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>). It has previously been hypothesized that the interaction of Nodal with its receptors might control signal propagation (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>), and the strong affinity of Nodals for the receptor Acvr2b-a has been suggested to shape the Nodal gradient (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>). Furthermore, it has recently been shown that the co-receptor Oep can dramatically alter the Nodal signaling range and distribution (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>), but the effect of the receptors on the distribution of Nodal ligands has not been assessed. To test whether Nodal receptors can indeed affect Nodal distribution during germ layer patterning, we transplanted clones expressing Squint-GFP or Cyclops-GFP into the embryonic animal pole (<xref ref-type="bibr" rid="bib84">Soh et al., 2020</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>) or mimicked the secretion of endogenous Nodal from the marginal zone by injecting <italic>squint-GFP</italic> or <italic>cyclops-GFP</italic> mRNA (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>) into the yolk syncytial layer (YSL) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), similar to experiments previously executed for the co-receptor Oep (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>). We then measured the distribution of the tagged Nodal proteins in wild-type embryos and receptor knockout/knockdown conditions (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B-D</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Nodal receptors and co-receptors can shape the distribution of Nodal ligands in zebrafish embryos.</title><p>(<bold>A</bold>) Schematic of the transplantation assay to create ectopic Nodal signaling sources. Cells from the animal pole of sphere-stage wild-type embryos injected with <italic>squint-GFP</italic> or <italic>cyclops-GFP</italic> mRNA and Alexa Fluor 647 dextran (AF647 dex.) were transplanted to the animal pole of wild-type, MZ<italic>oep<sup>-</sup></italic><sup>/-</sup>, or acvr1b-a<sup>-/-</sup> + <italic>acvr1b-b</italic> MO-1 embryos (hosts). Host embryos were imaged 60 min post-transplantation to determine the dispersal of Nodal ligands secreted by the clone. (<bold>B</bold>) Animal-pole view of transplanted Squint-GFP or Cyclops-GFP clones in the indicated host embryo 60 min post-transplantation. Single z-slices show the ligand distribution (GFP signal) and the transplanted cells (AF647 dextran signal). Scale bar represents 100 µm. (<bold>C,D</bold>) Quantification of Squint-GFP (<bold>C</bold>) and Cyclops-GFP (<bold>D</bold>) signal distributions in wild-type, MZ<italic>oep<sup>-</sup></italic><sup>/-</sup> and acvr1b-a<sup>-/-</sup> + <italic>acvr1b-b</italic> MO-1 embryos. The mean normalized background-subtracted intensities are shown as a function of their distance from the transplantation site. The error bars (shaded regions) indicate SEM. The number of measured embryos is indicated in parentheses. See the <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref> file for source data.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig5-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Loss of Acvr1b-a/Acvr1b-b or Oep broadens the range of Squint-GFP and Cyclops-GFP secreted from the YSL.</title><p>(<bold>A</bold>) Schematic of the YSL-injection assay to create local Nodal sources in a native context. 100 pg of Squint-GFP- or Cyclops-GFP-encoding mRNA were injected into the YSL of sphere-stage embryos, which were subsequently imaged at 2 or 4 hours post-injection (hpi), respectively, to measure Nodal distributions. The amount of injected mRNA was chosen according to its tested physiological relevance (see (<bold>E</bold>)). (<bold>B</bold>) Lateral views of Squint-GFP (2 hpi) and Cyclops-GFP (4 hpi) signals from YSL-injection assays in wild-type compared to MZ<italic>oep<sup>tz57/tz57</sup></italic> embryos, and <italic>acvr1b-a<sup>-/-</sup></italic> mutant embryos injected with 0.4 ng <italic>acvr1b-b</italic> MO-1. Scale bar represents 250 µm. (<bold>C,D</bold>) Quantification of Squint-GFP (<bold>C</bold>) and Cyclops-GFP (<bold>D</bold>) distributions with modulated receptor (Acvr1) and co-receptor (Oep) levels at 2 or 4 hpi, respectively (see B). Graphs show the mean normalized background-subtracted Squint-GFP intensity (<bold>C</bold>) or the number of Cyclops-GFP puncta (<bold>D</bold>) as a function of distance from the YSL (see <italic>Materials and methods</italic>). The error bars (shaded regions) indicate SEM. The number of measured embryos is indicated in parentheses. (<bold>E</bold>) Effect of YSL-injections on Nodal mutant phenotypes. To determine the physiological relevance of the YSL-injection experiments, a titration of Nodal-encoding mRNA amounts was performed. Different amounts of mRNA encoding Squint-GFP were injected into Nodal ligand double mutant embryos (MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic>) and the resulting phenotype at 24 hpf was assessed. The analyzed embryos either displayed the full Nodal mutant phenotype (no somites, severe CNS mis-patterning, cyclopia), a partial rescue (somites were present and/or split eyes), partial gain-of-function (curled tails, shortened body axis) or full gain-of-function phenotypes. Lateral views of whole embryos or close-ups of embryo faces are shown. Arrowheads point to a single eye or split eyes. The investigated injection amounts were 0 pg (n=29), 50 pg (n=23), 100 pg (the amount used in the main figure) (n=15), 150 pg (n=25) and 200 pg (n=25). At lower concentrations the full mutant phenotype was dominant, at medium dosage partial rescue occurred, and at high levels gain-of-function phenotypes were dominant. Scale bar represents 250 µm. See the <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref> file for source data.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig5-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig5-figsupp1-v3.tif"/></fig></fig-group><p>In wild-type embryos, Squint-GFP and Cyclops-GFP were secreted from the transplanted clones or the YSL and formed graded distributions (<xref ref-type="fig" rid="fig5">Figure 5B-D</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B-D</xref>), similar to previously reported gradients with Squint-GFP being localized relatively diffusely in the extracellular space and Cyclops-GFP being distributed in a punctate pattern (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib84">Soh et al., 2020</xref>; <xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>). In line with <xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>, loss-of-function conditions for the co-receptor <italic>oep</italic> led to a broader Squint-GFP distribution (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). Similarly, disruption of the Type I receptors Acvr1b-a and Acvr1b-b expanded the range of Squint-GFP (<xref ref-type="fig" rid="fig5">Figure 5B,C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). Furthermore, Type I receptor or co-receptor loss of function had a drastic effect on the Cyclops-GFP gradient, broadening its range and increasing the number of Cyclops-GFP puncta (<xref ref-type="fig" rid="fig5">Figure 5B and D</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,D</xref>). Thus, similar to the co-receptor Oep (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>), the Nodal receptors Acvr1b-a/Acvr1b-b affect the dispersal of Nodal proteins in the embryo.</p></sec><sec id="s2-7"><title>Receptor binding influences signal propagation through multiple mechanisms</title><p>Receptors can affect signal propagation through embryonic tissues by several mechanisms. First, receptor availability can affect the clearance rate of bound ligands and thereby affect signal propagation by modulating protein stability (reviewed in <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib71">Rogers and Schier, 2011</xref>). Second, transient receptor binding might slow down signal diffusion (<xref ref-type="bibr" rid="bib16">Crank, 1979</xref>; <xref ref-type="bibr" rid="bib53">Miura et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>). Third, positive autoregulation through ligand-receptor interactions can extend a ligand’s expression domain by relay signaling (<xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>). To determine whether the receptors affect Nodal propagation by one of these mechanisms, we measured stability and diffusion of Nodal in the presence and absence of receptors and assessed the range of Nodal signaling with and without positive autoregulation.</p><p>It has previously been shown that Nodals bind to the Type II receptor Acvr2b-a with nanomolar affinity in living zebrafish embryos (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>). To test whether this interaction affects extracellular ligand stability, we used functional Squint-Dendra2 and Cyclops-Dendra2 in Fluorescence Decay After Photoconversion (FDAP) assays (<xref ref-type="bibr" rid="bib9">Bläßle and Müller, 2015</xref>; <xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Rogers et al., 2015</xref>). If binding of Nodals to Acvr2b-a affects ligand stability, elevated Acvr2b-a levels should increase the clearance of Squint-Dendra2 and Cyclops-Dendra2. However, overexpression of <italic>acvr2b-a</italic> did not markedly change Nodal clearance rate constants compared to wild-type embryos (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This suggests that the strong interaction between Nodals and Acvr2b-a (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>) is not sufficient to modulate Nodal protein stability. Similarly, the absence of Type I receptors did not cause a decrease in the clearance rate of Nodals (<xref ref-type="fig" rid="fig6">Figure 6A</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Influence of Nodal receptors on Nodal stability, diffusivity and autoregulatory signal propagation.</title><p>(<bold>A</bold>) Impact of <italic>acvr1</italic> loss-of-function and <italic>acvr2b-a</italic> overexpression on Squint- and Cyclops-Dendra2 clearance rate constants determined using FDAP measurements. For <italic>acvr1</italic> loss-of-function, 0.4 ng <italic>acvr1b-b</italic> MO-1 were injected into <italic>acvr1b-a<sup>-/-</sup></italic> mutant embryos. For overexpression, 100 pg <italic>acvr2b-a</italic> mRNA were injected into wild-type embryos. Mean extracellular clearance rate constants are displayed in red, and individual measurements are shown as black dots. Error bars represent 95% confidence intervals. See <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref> for representative fits. (<bold>B</bold>) Influence of receptor levels on Squint- and Cyclops-GFP diffusivities determined using FRAP measurements. For overexpression, either 50 pg <italic>oep</italic> mRNA or 100 pg <italic>acvr2b-a</italic> mRNA were injected into wild-type embryos at the one-cell stage. <italic>acvr1b-a</italic> mutants and 0.4 ng <italic>acvr1b-b</italic> transcriptional start site-targeting morpholino (MO-1) were used for receptor loss-of-function conditions. The mean diffusion coefficients are displayed in red, and individual measurements are shown as black dots. Error bars represent 95% confidence intervals. See <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref> for representative fits. Scale bars represents 100 µm. (<bold>C</bold>) Margin-to-animal pole transplantations show that Nodals at endogenous expression levels can signal to distant cells. Top panel: Experimental setup of the margin-to-animal pole transplantations, in which wild-type embryos or MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> embryos that lack Nodal relay were used as hosts. Bottom panel: Immunofluorescent stainings show that pSmad2/3-positive nuclei (green) are detected outside of the transplanted clones (magenta) in both wild-type (top row) and MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> (bottom row) hosts. (<bold>D</bold>) Margin-to-margin transplants show that Nodals at endogenous expression levels can signal to distant cells at the embryonic margin. Top panel: Experimental setup. Bottom panel: Representative maximum intensity projections of immunofluorescent stainings. Transplantations into wild-type embryos (top row) and MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> embryos (bottom row) are shown. Scale bars represent 200 µm. Animal pole views are shown in (<bold>A–D</bold>). See the <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref> file for source data and sample size.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig6-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Quantification of Nodal stability and diffusivity in receptor mutant or receptor overexpression embryos.</title><p>(<bold>A</bold>) Representative FDAP measurements and fits. The decrease of photoconverted Squint-Dendra2 and Cyclops-Dendra2 signal over time (black dots) was monitored and fitted with an exponentially decreasing function (red dashed line). The graphs show representative measurements performed in wild-type, <italic>acvr1</italic> loss-of-function, <italic>oep</italic> overexpression or <italic>acvr2b-a</italic> overexpression embryos (see also <xref ref-type="fig" rid="fig6">Figure 6A</xref>). (<bold>B</bold>) Representative FRAP measurements and fits. Graphs show the normalized Squint-GFP signal (black dots) as a function of time after photobleaching in embryos of the indicated condition (see also <xref ref-type="fig" rid="fig6">Figure 6B</xref>). The fitted recovery curve is shown in red, and dashed lines indicate the time at which signal recovery is 50%. See the <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref> file for source data.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig6-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig6-figsupp1-v3.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Increased pSmad2/3 signal intensities and ranges from transplants in Nodal-mutant hosts compared to wild-type hosts.</title><p>(<bold>A,B</bold>) Quantification of pSmad2/3 signal distributions from margin-to-animal pole (<bold>A</bold>) or margin-to-margin (<bold>B</bold>) transplants in wild-type and MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> hosts. Graphs show the mean background-subtracted pSmad2/3 intensities normalized to the number of transplanted cells (see (<bold>C</bold>)) as a function of distance from the transplantation site. The error bars (shaded regions) indicate SEM. The number of measured embryos is indicated in parentheses. (<bold>C</bold>) Number of GFP-positive cells transplanted to the animal pole or the margin of the indicated hosts. (<bold>D</bold>) pSmad2/3 intensities within margin-to-animal pole transplants normalized to the mean signal in wild-type embryos. (<bold>E</bold>) Number of pSmad2/3-positive nuclei extending from the distal-most end of margin-to-margin transplants in wild-type and MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> hosts. Mean intensities are displayed in red, individual measurements are shown as black dots, and error bars represent 95% confidence intervals in (<bold>C–E</bold>). See the <xref ref-type="supplementary-material" rid="fig6s2sdata1">Figure 6—figure supplement 2—source data 1</xref> file for source data and sample size.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-66397-fig6-figsupp2-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-66397-fig6-figsupp2-v3.tif"/></fig></fig-group><p>The diffusion of signals through tissues can be hindered by their transient binding (rapid binding and unbinding) to extracellular molecules (<xref ref-type="bibr" rid="bib10">Bläßle et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Kuhn et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">Mörsdorf and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>). To test whether receptor interactions can affect Nodal diffusion, we performed Fluorescence Recovery After Photobleaching (FRAP) assays (<xref ref-type="bibr" rid="bib2">Almuedo-Castillo et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Bläßle et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Pomreinke et al., 2017</xref>; <xref ref-type="bibr" rid="bib83">Soh and Müller, 2018</xref>). We assessed the effective diffusivity of functional Squint-GFP (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>) in wild-type embryos, in embryos overexpressing the Type II receptor <italic>acvr2b-a</italic> or the co-receptor <italic>oep</italic> and in embryos lacking the Type I receptors <italic>acvr1b-a</italic>/<italic>acvr1b-b</italic> (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Overexpression of <italic>acvr2b-a</italic> did not markedly change the effective diffusivity of Squint-GFP (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), suggesting that the strong interaction between Squint and Acvr2b-a previously shown in vivo (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>) is not sufficient to modulate Squint diffusivity. In contrast, <italic>oep</italic> overexpression reduced the effective diffusivity of Squint-GFP from about 2 µm<sup>2</sup>/s to ~1 µm<sup>2</sup>/s, consistent with the increased Nodal signaling range and distribution in the absence of <italic>oep</italic> (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>; <xref ref-type="fig" rid="fig5">Figure 5C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), the decreased Nodal distribution with overexpressed <italic>oep</italic> (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>) and the increased bound fraction upon <italic>oep</italic> overexpression in single-molecule tracking experiments (<xref ref-type="bibr" rid="bib39">Kuhn et al., 2022</xref>). Strikingly, the effective diffusivity of Squint-GFP in the absence of <italic>acvr1b-a/acvr1b-b</italic> increased to &gt;3 µm<sup>2</sup>/s, consistent with the broader Squint-GFP distribution in the absence of these Type I receptors (<xref ref-type="fig" rid="fig5">Figure 5C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Together, our results indicate that Oep, Acvr1b-a and Acvr1b-b serve not only to transduce signaling activity but also to regulate the spatial range of the signal by modulating its diffusion.</p><p>The Nodal signaling pathway features strong autoregulatory feedback by inducing the Nodal ligands Squint and Cyclops as well as the co-receptor Oep and the Type I receptor Acvr1b-a (<xref ref-type="fig" rid="fig1">Figure 1A and E–F</xref>; <xref ref-type="bibr" rid="bib5">Bennett et al., 2007</xref>; <xref ref-type="bibr" rid="bib19">Dougan et al., 2003</xref>; <xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Feldman et al., 2002</xref>). However, the role of this positive feedback for the propagation of Nodal signaling is currently unclear (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>; <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>). We found that the feedback-induced co-receptor Oep and the Type I receptors Acvr1b-a and Acvr1b-b act as diffusion regulators of Nodal (<xref ref-type="fig" rid="fig5">Figure 5</xref>; <xref ref-type="fig" rid="fig6">Figure 6B</xref>), implying that the range of Nodal propagation may – paradoxically – be increased in the absence of positive Nodal feedback in surrounding tissues. To test this prediction, we sought to visualize the activity range of endogenous Nodal signals.</p><p>Cyclops and Squint have been shown to activate target genes at a distance (<xref ref-type="bibr" rid="bib12">Chen and Schier, 2001</xref>), and the biophysical properties of tagged zebrafish Nodals support their function as short- to mid-range signals (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>). However, these findings are based on ectopic expression assays and the readout of target genes such as <italic>no tail</italic>, whose transcription is also activated by Nodal-induced FGFs and thus does not directly report Nodal activity (<xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>). It has therefore been debated whether endogenous Nodals act directly at a distance as initially proposed (<xref ref-type="bibr" rid="bib12">Chen and Schier, 2001</xref>) or whether they act exclusively at a short range and require relay through positive feedback on Nodal expression (<xref ref-type="bibr" rid="bib44">Liu et al., 2022</xref>; <xref ref-type="bibr" rid="bib69">Rodaway et al., 1999</xref>; <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>; <xref ref-type="bibr" rid="bib93">van Boxtel et al., 2018</xref>).</p><p>To examine whether untagged zebrafish Nodals can directly act on distant cells at endogenous expression levels and to test the relay model, we transplanted cells from the embryonic margin – where endogenous Nodal expression is highest – of H2A.F/Z:GFP embryos (<xref ref-type="bibr" rid="bib61">Pauls et al., 2001</xref>) into the animal pole – where Nodal expression is absent – of wild-type embryos or Nodal mutant embryos (MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic>; <xref ref-type="fig" rid="fig6">Figure 6C</xref>). Since MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> embryos cannot produce functional Nodals, there is no Nodal relay in this mutant background allowing us to directly assess the endogenous Nodal signaling range in the absence of Nodal autoinduction or confounding relay effects. To assess Nodal signaling after transplantation, pSmad2/3 immunofluorescence staining was performed on embryos fixed 2 hr post-transplantation. pSmad2/3 can clearly be detected in the nuclei of cells outside the transplant in both wild-type and mutant backgrounds (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). This indicates that Nodals do not require a relay mechanism to signal to distant cells. Interestingly, the pSmad2/3 intensities inside and around the transplants were higher in the MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> background than in the wild-type background (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A,D</xref>), and pSmad2/3-positive nuclei were found more frequently outside of transplanted clones in the MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> background (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), consistent with our prediction that the range of Nodal propagation should be increased in the absence of positive Nodal feedback in tissues surrounding the Nodal source. However, in the absence of Nodal signaling Leftys are not expressed (<xref ref-type="bibr" rid="bib23">Feldman et al., 2002</xref>; <xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>), which might also contribute to the extended Nodal signaling range in MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> mutants.</p><p>Endogenous Nodal signaling is active at the embryonic margin, and we therefore wanted to assess whether Nodals can also signal over a distance in marginal tissues, where the feedback-regulated receptors Oep and Acvr1b-a are expressed (<xref ref-type="fig" rid="fig1">Figure 1D–F</xref>; <xref ref-type="bibr" rid="bib94">Vopalensky et al., 2018</xref>). We therefore performed margin-to-margin transplantations of H2A.F/Z:GFP cells into MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> host embryos and found that Nodals can also act on distant cells at the margin (<xref ref-type="fig" rid="fig6">Figure 6D</xref>), where receptor expression is higher than in the animal pole (<xref ref-type="fig" rid="fig1">Figure 1D and F</xref>). In agreement with our prediction that the range of Nodal propagation should be increased with dampened positive feedback in tissues surrounding the Nodal source, MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> mutant embryos showed increased pSmad2/3 intensities and pSmad2/3-positive nuclei tended to be found more frequently outside of transplants compared to wild-type hosts, with a few cases even showing extremely extended ranges (<xref ref-type="fig" rid="fig6">Figure 6D</xref>; <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B,E</xref>). While our findings are consistent with the idea that positive feedback mediated by receptors and co-receptors restricts the range of Nodal signaling, we cannot rule out that the extended range we observed with margin transplantations in MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> hosts is also influenced by dampened negative feedback, which will have to be tested in MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup>;lft1<sup>-/-</sup>;lft2<sup>-/-</sup></italic> quadruple mutants in the future.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The Nodal signaling pathway is a key regulator of vertebrate development and is important for human disease and regenerative medicine (<xref ref-type="bibr" rid="bib40">Lee et al., 2010</xref>; <xref ref-type="bibr" rid="bib70">Roessler et al., 2008</xref>; <xref ref-type="bibr" rid="bib79">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib87">Tewary et al., 2019</xref>). Here, we systematically assessed putative Nodal Type I and Type II receptor homologs in zebrafish. We found that the transcripts of most of these putative Nodal receptors are maternally deposited and present during germ layer patterning, indicative of a potential role in early patterning. The Type I receptor Acvr1c (Alk7) is an exception and not expressed until 4 dpf, making it unlikely to be involved in germ layer formation. While single mutants of the Nodal co-receptor Oep and the signal transducer Smad2 display complete loss-of-function phenotypes (<xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>), the loss of individual Nodal ligands (Squint and Cyclops) only leads to partial defects (<xref ref-type="bibr" rid="bib19">Dougan et al., 2003</xref>; <xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib65">Rebagliati et al., 1998a</xref>; <xref ref-type="bibr" rid="bib66">Rebagliati et al., 1998b</xref>; <xref ref-type="bibr" rid="bib77">Sampath et al., 1998</xref>). This redundancy is mirrored in the function of the Type I and Type II receptors. For example, individual loss of <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> activity did not induce Nodal-related defects, whereas combined loss-of-function conditions for both <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> led to a complete Nodal mutant phenotype, suggesting that these Type I receptors redundantly mediate Nodal signaling during early embryogenesis.</p><p>Similar to the Type I receptors, only combinatorial loss of the putative Type II receptors Acvr2a-a, Acvr2a-b, Acvr2b-a, and Acvr2b-b caused embryonic patterning defects. In contrast to the Type I receptors, however, the loss of the Acvr2 receptors did not phenocopy Nodal loss-of-function phenotypes, caused an elevation rather than a reduction of pSmad2/3, and, in MZ<italic>oep</italic> embryos, led to patterning defects independent of Nodal (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). The phenotype observed upon quadruple <italic>acvr2</italic> receptor KO partly resembles the mutant phenotype of <italic>pgy<sup>dty40</sup></italic> (<xref ref-type="bibr" rid="bib58">Mullins et al., 1996</xref>), a hypomorphic mutation of the <italic>smad5</italic> gene (also called <italic>somitabun</italic>) with a weak antimorphic effect (<xref ref-type="bibr" rid="bib37">Kramer et al., 2002</xref>), which could indicate an influence of the receptors on the BMP signaling pathway. In line with this hypothesis, quadruple <italic>acvr2</italic> KO embryos showed a reduction in pSmad1/5/9 signal (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). However, this reduction in BMP signaling was only visible at late gastrulation, a few hours after the embryos displayed an increase in pSmad2/3. Moreover, some of the morphological defects, most obviously the reduction in head and eye size, deviated from the classical BMP loss-of-function phenotype. It is currently unknown how the loss of Acvr2 receptors causes these effects and through what mechanisms and signals the receptors mediate embryonic patterning. It is tempting to speculate that receptor promiscuity might play a role. Acvr2b-a, for example, has been shown to be able to mediate both Activin and BMP signaling by recruiting the respective Type I receptor Acvr1b-a or Bmpr1a (<xref ref-type="bibr" rid="bib59">Nagaso et al., 1999</xref>). Even a direct high-affinity interaction of Nodal with the BMP Type II receptor Bmpr2 has been shown in vitro (<xref ref-type="bibr" rid="bib4">Aykul et al., 2015</xref>). Furthermore the Type I receptor TGFβr1 can phosphorylate and thereby activate the Type I receptor Acvr1, indicating that Type I receptors can function like Type II receptors under certain conditions (<xref ref-type="bibr" rid="bib63">Ramachandran et al., 2018</xref>). Whether this dual function of Type I receptors affects endogenous Nodal signaling in zebrafish requires further investigation.</p><p>During germ layer patterning, Nodal is first expressed in the YSL, from which it spreads into the embryo to form a signaling gradient. There are currently two major models that can explain the propagation of Nodal signaling in this context. In the hindered diffusion model, Nodal is secreted from source cells and its free diffusion through the embryo is hindered by interactions with immobile diffusion regulators (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>; <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Kuhn et al., 2022</xref>). In the second model, Nodal ligands only act in a juxtacrine fashion, and propagation of Nodal signaling to adjacent cells is mediated by a relay mechanism involving positive feedback of Nodal expression (<xref ref-type="bibr" rid="bib44">Liu et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>; <xref ref-type="bibr" rid="bib74">Rogers and Müller, 2019</xref>; <xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>; <xref ref-type="bibr" rid="bib93">van Boxtel et al., 2018</xref>). To distinguish between these models, we transplanted cells expressing endogenous Nodal signals into Nodal-mutant backgrounds that are devoid of relay mechanisms involving feedback on Nodal expression. Consistent with the known function of Nodals as short- to mid-range signals (<xref ref-type="bibr" rid="bib12">Chen and Schier, 2001</xref>; <xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>), we found that Nodals do not exclusively act in a juxtacrine manner and can signal to distant cells even in the absence of Nodal relay (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). The importance of positive Nodal feedback as an additional mechanism to regulate Nodal signaling propagation is supported by the restriction of the Type I receptor Acvr1b-a and the co-receptor Oep to the marginal zone. This spatial restriction is mediated by Nodal ligands, which are also expressed at the margin (<xref ref-type="bibr" rid="bib5">Bennett et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Feldman et al., 2002</xref>; <xref ref-type="bibr" rid="bib51">Meno et al., 1999</xref>; <xref ref-type="bibr" rid="bib94">Vopalensky et al., 2018</xref>), suggesting a role for positive feedback to limit Nodal signaling to the embryonic margin. Although our data support the idea that Nodals function as classical morphogens and act directly at a distance as master regulators of mesendoderm formation (<xref ref-type="bibr" rid="bib12">Chen and Schier, 2001</xref>), complex germ layer patterning requires the interaction with other signaling molecules such as FGFs (<xref ref-type="bibr" rid="bib5">Bennett et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib92">van Boxtel et al., 2015</xref>; <xref ref-type="bibr" rid="bib93">van Boxtel et al., 2018</xref>), which act as secondary downstream relay factors to induce mesendodermal gene expression at the correct time and place.</p><p>The action range of Nodals has been proposed to be restricted by extracellular interactions (<xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>). In this hindered diffusion model, Nodal’s free diffusivity of approximately 40 µm<sup>2</sup>/s (<xref ref-type="bibr" rid="bib57">Müller et al., 2013</xref>; <xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>) would be slowed down by an order of magnitude through interactions with immobile diffusion regulators such as receptors (<xref ref-type="bibr" rid="bib95">Wang et al., 2016</xref>) or heparin sulfate proteoglycans (<xref ref-type="bibr" rid="bib48">Marjoram and Wright, 2011</xref>). Indeed, our recent single-molecule tracking experiments showed that individual Nodal molecules have binding times of tens of seconds in the extracellular space, leading to hindered diffusion on the nanometer to micrometer scale (<xref ref-type="bibr" rid="bib39">Kuhn et al., 2022</xref>). Here, we directly assessed the influence of Nodal receptors on the dispersal of Nodal ligands at the tissue scale. We found that embryos with reduced receptor levels displayed broader Nodal gradients (<xref ref-type="fig" rid="fig5">Figure 5B–D</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B-D</xref>). To elucidate whether the Type I receptors Acvr1b-a and Acvr1b-b as well as the co-receptor Oep directly regulate Nodal diffusivity, we used FRAP assays to measure Nodal mobility in intact embryos with modulated receptor levels. Consistent with our gradient analyses, receptor and co-receptor had a large impact on Nodal diffusivity (Cohen’s <italic>d</italic>=1.03 and 1.4 with p=0.028 and 0.003, respectively; see <italic>Materials and methods</italic>), indicating their importance not only for Nodal signaling, but also as a diffusion regulators during early embryogenesis. In agreement with our findings, it has recently been shown that the Nodal co-receptor Oep restricts Nodal’s distribution and signaling (<xref ref-type="bibr" rid="bib45">Lord et al., 2021</xref>) and can locally hinder Nodal diffusion by transient membrane trapping during zebrafish embryogenesis (<xref ref-type="bibr" rid="bib39">Kuhn et al., 2022</xref>). Previous research has demonstrated that Oep is critical for Nodal signaling (<xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>) and indicated that Oep mediates the interaction of Nodal with the Activin receptor complex (<xref ref-type="bibr" rid="bib6">Bianco et al., 2002</xref>; <xref ref-type="bibr" rid="bib67">Reissmann et al., 2001</xref>; <xref ref-type="bibr" rid="bib98">Yan et al., 2002</xref>; <xref ref-type="bibr" rid="bib99">Yeo and Whitman, 2001</xref>). Moreover, the Oep-Nodal interaction is crucial for the regulation of Nodal signaling, as chimeric Nodals that do not require Oep for signaling activity cannot be inhibited by Lefty (<xref ref-type="bibr" rid="bib13">Cheng et al., 2004</xref>). In mouse models, Nodal has been shown to directly interact with the Oep homolog Cripto already before secretion and processing of the Nodal protein, and Oep was also found to regulate Nodal endocytosis and subsequent signaling (<xref ref-type="bibr" rid="bib7">Blanchet et al., 2008a</xref>; <xref ref-type="bibr" rid="bib8">Blanchet et al., 2008b</xref>). While the influence of Oep/Cripto and the Type II receptors on Nodal propagation could be explained by their direct interaction, the Type I receptor Acvr1b-a is thought to require the presence of the co-receptor Oep/Cripto to interact with Nodal (<xref ref-type="bibr" rid="bib67">Reissmann et al., 2001</xref>). However, there is evidence that Nodal can also directly interact with Type I receptors (<xref ref-type="bibr" rid="bib11">Calvanese et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Reissmann et al., 2001</xref>). Alternatively, the observed impact of Type I receptor levels on Nodal dispersal might be due to a failure in assembling the full Nodal receptor complex, possibly affecting endocytosis of Nodal (<xref ref-type="bibr" rid="bib101">Zhou et al., 2004</xref>) and causing Nodal to accumulate in the extracellular space resulting in a broader Nodal gradient (<xref ref-type="bibr" rid="bib5">Bennett et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Dubrulle et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Feldman et al., 2002</xref>; <xref ref-type="bibr" rid="bib51">Meno et al., 1999</xref>; <xref ref-type="bibr" rid="bib94">Vopalensky et al., 2018</xref>).</p><p>In summary, we performed a systematic analysis of putative zebrafish Nodal receptors and found that the Type I receptors Acvr1b-a and Acvr1b-b as well as the co-receptor Oep can shape Nodal gradients during early embryogenesis by modulating ligand mobility and dispersal. In the future, it will be interesting to determine the function of receptor redundancy in Nodal signaling, to analyze the role of receptor and co-receptor feedback in robust embryogenesis (<xref ref-type="bibr" rid="bib86">Stapornwongkul et al., 2020</xref>; <xref ref-type="bibr" rid="bib102">Zhu et al., 2020</xref>) and to elucidate the mechanism through which the Acvr2 receptors pattern the early embryo.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Fish lines and husbandry</title><p>All procedures were executed in accordance with the guidelines of the State of Baden-Württemberg and approved by the Regierungspräsidium Tübingen and the Regierungspräsidium Freiburg. MZ<italic>oep<sup>tz57</sup></italic> embryos were generated as previously described (<xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>; <xref ref-type="bibr" rid="bib100">Zhang et al., 1998</xref>). The wild-type strain Tü was used for the generation of the <italic>acvr1c<sup>t06pm</sup></italic> mutant allele. For the generation of <italic>acvr1b-a<sup>t03pm</sup></italic> and <italic>acvr2b-a<sup>t08pm</sup></italic> mutants, the wild-type strain TE was used. The generated alleles contain indels leading to frameshifts resulting in premature stop codons within the first exons: a 4 bp deletion for <italic>acvr1b-a</italic>, a 2 bp deletion for <italic>acvr1c</italic> and a 4 bp deletion for <italic>acvr2b-a</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B,C</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). <italic>acvr2a-a<sup>sa34654</sup></italic> and <italic>acvr2a-b<sup>sa18285</sup></italic> mutants were obtained from the European Zebrafish Research Center (EZRC). These mutants carry single-nucleotide mutations leading to alternative splicing and a premature stop codon, respectively (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B,C</xref>). Unless otherwise stated, maternal-zygotic receptor mutant embryos were used. H2A.F/Z:GFP embryos were obtained from an incross of GFP-positive H2A.F/Z:GFP fish (<xref ref-type="bibr" rid="bib61">Pauls et al., 2001</xref>). MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> embryos were obtained from an incross of <italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> mutants (<xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib78">Schier et al., 1996</xref>) generated by germline transplantation (<xref ref-type="bibr" rid="bib14">Ciruna et al., 2002</xref>). The fish strain TE was used as a wild-type control in all experiments.</p></sec><sec id="s4-2"><title>Phylogenetic analysis</title><p>For phylogenetic analysis, human and mouse protein sequences of the Type I receptors Acvr1b and Acvr1c as well as protein sequences of the Type II receptors Acvr2a and Acvr2b were used for BLAST queries in Uniprot (RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002380">SCR_002380</ext-link>) to identify zebrafish homologs. The alignment of human, mouse and zebrafish sequences was performed using Clustal Omega (<xref ref-type="bibr" rid="bib47">Madeira et al., 2019</xref>). The phylogenetic tree was calculated with a neighbor-joining algorithm using the blosum62 matrix. Jalview version 2.10.3b1 was used for visualization (<xref ref-type="bibr" rid="bib96">Waterhouse et al., 2009</xref>). Branch lengths indicate evolutionary distance.</p></sec><sec id="s4-3"><title>5’RACE</title><p>To identify the start of <italic>acvr2a-b</italic>, 5’RACE (Rapid Amplification of cDNA Ends) was conducted. Total RNA was extracted from ten wild-type embryos at shield stage as described below. 5’RACE was performed using the 5′/3′ RACE Kit, 2<sup>nd</sup> Generation (Roche 03353621001) according to the manufacturer’s instruction. 1 µg of RNA was used as starting material, and the following gene-specific primers were used for cDNA synthesis (SP1) and PCR amplification (SP2), respectively:</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Primer</th><th align="left" valign="bottom">Binding site</th><th align="left" valign="bottom">Sequence (5<bold>’-&gt;3’</bold>)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>acvr2a-b</italic> SP1</td><td align="left" valign="bottom">exon 3 (previously annotated as exon 2)</td><td align="left" valign="bottom">GCTCAACCGTCTCTGGATTG</td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-b</italic> SP2</td><td align="left" valign="bottom">exon 3 (previously annotated as exon 2)</td><td align="left" valign="bottom">ACAAGTTTCCCTCGCAGCAG</td></tr></tbody></table></table-wrap><p>The resulting PCR products were sub-cloned using the Zero Blunt TOPO PCR Cloning Kit (Invitrogen) and analyzed by Sanger sequencing. The resulting sequences contained part of exon 3, the entire exon 2 (previously annotated as exon 2 and 1, respectively) and 143–450 bp upstream of the previously predicted transcriptional start of <italic>acvr2a-b</italic>’s mRNA. Using BLAT search (<xref ref-type="bibr" rid="bib34">Kent, 2002</xref>), the upstream sequence was mapped to chrUn_KN150226v1 with 100% sequence identity. While the exact length of <italic>acvr2a-b</italic>’s 5’ UTR varied by approximately 300 bp, all sequenced clones (9/9) supported the same transcriptional start of <italic>acvr2a-b</italic>’s coding sequence (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). The gene thus contains an additional exon (the new exon 1) at chrUn_KN150226v1:12292–12345 (+strand), which codes for most of the receptor’s signal peptide.</p></sec><sec id="s4-4"><title>Whole-mount in situ hybridization</title><p>To synthesize <italic>acvr1b-a, acvr1b-b, acvr1c, acvr2a-a, acvr2a-b, acvr2b-a,</italic> and <italic>acvr2b-b</italic> probes for in situ hybridization assays, full-length receptor-encoding sequences amplified from shield stage cDNA were cloned into TOPO Blunt plasmids (Thermo Fisher Scientific 45024) using the following primers:</p><table-wrap id="inlinetable2" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Receptor</th><th align="left" valign="bottom">Forward primer (5’-&gt;3’)</th><th align="left" valign="bottom">Reverse primer (5<bold>’-&gt;3’</bold>)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>acvr1b-a</italic></td><td align="left" valign="bottom">ATGCTAAGAGATGGGAATGTTGC</td><td align="left" valign="bottom">TCAGATCTTAATGTCTTCTTGGACG</td></tr><tr><td align="left" valign="bottom"><italic>acvr1b-b</italic></td><td align="left" valign="bottom">ATGGACCCACGGCAAATC</td><td align="left" valign="bottom">TCAGATTTTGAGATCCTCGT</td></tr><tr><td align="left" valign="bottom"><italic>acvr1c</italic></td><td align="left" valign="bottom">ATGTCTCATCCCAGGTGCTCAG</td><td align="left" valign="bottom">TTCTTTAACATCCTTGACCACAGTCAC</td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-a</italic></td><td align="left" valign="bottom">ATGGGACCTGCAACAAAGCT</td><td align="left" valign="bottom">TCATAGACTAGACTCCTTTG</td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-b</italic></td><td align="left" valign="bottom">ATGGCGAGCCACTGGACAAACT</td><td align="left" valign="bottom">TCATAGGCTGGACTCTTTAG</td></tr><tr><td align="left" valign="bottom"><italic>acvr2b-a</italic></td><td align="left" valign="bottom">ATGTTCGCTTCTCTGCTCACTTT</td><td align="left" valign="bottom">TCAGATGCTGGACTCTTTGGGC</td></tr><tr><td align="left" valign="bottom"><italic>acvr2b-b</italic></td><td align="left" valign="bottom">ATGTTTGTTCCCTGGCTGGC</td><td align="left" valign="bottom">TCAGGTGCTGGAGTCTTTGG</td></tr></tbody></table></table-wrap><p>For in situ probe synthesis, plasmids were linearized using SpeI or NotI restriction enzymes followed by in vitro transcription using SP6 or T7 polymerase (Roche) and digoxigenin (DIG)-modified ribonucleotides (Roche). RNA probes were purified using the RNeasy MinElute Cleanup kit (Qiagen 74204) according to the manufacturer’s protocol. Embryos fixed in 4% formaldehyde and transferred into methanol for storage were processed for in situ staining as previously described (<xref ref-type="bibr" rid="bib89">Thisse and Thisse, 2008</xref>), but without proteinase K treatment and pre-absorption of the anti-DIG antibody (Sigma-Aldrich, Roche 11093274910).</p></sec><sec id="s4-5"><title>mRNA synthesis</title><p>Full-length receptor-encoding sequences were amplified from cDNA of shield-stage wild-type TE embryos using the primers listed in the section <italic>Whole-mount in situ hybridization</italic>. The sequences were then re-amplified and cloned into pCS2 +vectors using the following primers and restriction enzyme (RE, obtained from NEB) combinations:</p><table-wrap id="inlinetable3" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Receptor</th><th align="left" valign="bottom">Forward primer (5’-&gt;3’)</th><th align="left" valign="bottom">Reverse primer (5’-&gt;3<bold>’</bold>)</th><th align="left" valign="bottom">RE</th></tr></thead><tbody><tr><td align="left" valign="middle"><italic>acvr1b-a</italic></td><td align="left" valign="bottom">TCCCATCGATGCCACCATGC<break/>TAAGAGATGGGAATGTTGC</td><td align="left" valign="bottom">AGAGGCCTTGAATTCGATCAG<break/>ATCTTAATGTCTTCTTGGACG</td><td align="left" valign="bottom">ClaI<break/>EcoRI</td></tr><tr><td align="left" valign="middle"><italic>acvr1b-b</italic></td><td align="left" valign="bottom">GATTCGAATTCGCCACCATG<break/>GACCCACGGCAAATC</td><td align="left" valign="bottom">AGAGGCTCGAGCCTTCAGATT<break/>TTGAGATCCTCGTCCA</td><td align="left" valign="bottom">EcoRI<break/>XhoI</td></tr><tr><td align="left" valign="middle"><italic>acvr2b-a</italic></td><td align="left" valign="bottom">AGGATCCCATCGATGCCACC<break/>ATGTTCGCTT</td><td align="left" valign="bottom">CACTATAGTTCTAGATCAGAT<break/>GCTGGACTCTT</td><td align="left" valign="bottom">ClaI<break/>XbaI</td></tr></tbody></table></table-wrap><p>Plasmids encoding Squint-GFP, Squint-Dendra2, Cyclops-GFP, Cyclops-Dendra, Lefty2-Dendra2 and Oep have been described before (<xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>; <xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib100">Zhang et al., 1998</xref>). For mRNA synthesis, plasmids were linearized with NotI-HF (NEB R3189). mRNA was generated using the mMessage mMachine SP6 Transcription Kit (Thermo Fisher Scientific AM1340). Synthesized mRNA was purified with RNeasy Mini kits (Qiagen 74104) and dissolved in nuclease-free water.</p></sec><sec id="s4-6"><title>Microinjections and embryo dechorionation</title><p>For mRNA, sgRNA and morpholino injections, embryos were injected at the one- or two-cell stage with the indicated amounts in a total of 1 nl or 2 nl. For CRISPR F0 KO, 1 nl or 2 nl RNP mixes (see <italic>CRISPR F0 KO</italic>) were injected into the yolk of early one-cell stage embryos. YSL injections were performed by injecting 2 nl of an injection mix containing 100 pg of <italic>squint-GFP</italic> or <italic>cyclops-GFP</italic> mRNA and 0.5 ng of Alexa Fluor 647 dextran (Invitrogen D22914) into the YSL of sphere-stage embryos. Imaging of YSL-injected embryos was started 2 hr post-injection (hpi) for <italic>squint-GFP</italic> injections and 4 hpi for c<italic>yclops-GFP</italic> injections. Ectopic Nodal signaling sources were generated by injecting 250 pg <italic>squint-GFP</italic> or <italic>cyclops-GFP</italic> mRNA and 100 pg of Alexa Fluor 647 dextran (Invitrogen D22914) in a volume of 2 nl into the cell of one-cell stage wild-type embryos. In each case, injected embryos were incubated at 28 °C, and unfertilized embryos were discarded at 4–5 hpf.</p><p>For fixation, imaging, transplantation and YSL injections, embryos were dechorionated manually using forceps or enzymatically using 0.1 mg/ml Pronase (Roche 11459643001) in 5 ml embryo medium (<xref ref-type="bibr" rid="bib72">Rogers et al., 2015</xref>).</p><p><italic>acvr1b-a</italic>, <italic>acvr1c</italic> and <italic>acvr2b-a</italic> mutants were generated using the CRISPR/Cas9 system (<xref ref-type="bibr" rid="bib25">Gagnon et al., 2014</xref>). Target sequences for guide RNAs were chosen using CHOPCHOP (<xref ref-type="bibr" rid="bib54">Montague et al., 2014</xref>). sgRNAs targeting <italic>acvr1b-a</italic> (a mix of sgRNAs targeting <named-content content-type="sequence">GCTACAGCAGTTCGTCGAGG</named-content> and <named-content content-type="sequence">GGATTACTAGCGGTCGGCGA</named-content>) and <italic>acvr1c</italic> (<named-content content-type="sequence">AGCGCTGCATCTGAGCACCT</named-content>) were synthesized as described previously (<xref ref-type="bibr" rid="bib25">Gagnon et al., 2014</xref>). <italic>acvr2b-a</italic> sgRNA (targeting <named-content content-type="sequence">GTTCGCTTCTCTGCTCACTT</named-content>) was procured from IDT. A total of 400 pg of Cas9-encoding mRNA (Addgene MLM3613) and 150 pg of sgRNA were co-injected into one- to two-cell-stage wild-type embryos.</p></sec><sec id="s4-7"><title>Genotyping</title><p>Genomic DNA was isolated from caudal fin tissue of adult zebrafish using the ‘hotshot’ method (<xref ref-type="bibr" rid="bib50">Meeker et al., 2007</xref>), and regions of interest were amplified using standard PCR conditions and the following primers:</p><table-wrap id="inlinetable4" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Mutant</th><th align="left" valign="bottom">Target</th><th align="left" valign="bottom">Forward primer (5’-&gt;3’)</th><th align="left" valign="bottom">Reverse primer (5’-&gt;3’)</th></tr></thead><tbody><tr><td align="left" valign="middle"><italic>acvr1b-a<sup>t03pm</sup></italic></td><td align="left" valign="middle">Exon 2</td><td align="left" valign="middle">TCGCTTGTCAATATCACACACA</td><td align="left" valign="middle">CTCTCTCTCCACACACCATCAG</td></tr><tr><td align="left" valign="middle"><italic>acvr1c<sup>t06pm</sup></italic></td><td align="left" valign="middle">Exon 1</td><td align="left" valign="middle">TCTGTCTACGTGTTGTCGCTTT</td><td align="left" valign="middle">AAAGTTGGTGTGTGCTGACAGT</td></tr><tr><td align="left" valign="middle"><italic>acvr2a-a<sup>sa34654</sup></italic></td><td align="left" valign="middle">Exon 2</td><td align="left" valign="middle">AACTACAACCCCAGCTTGGAGAA</td><td align="left" valign="middle">TTTGAAAATTCTTTGAAATCTTT</td></tr><tr><td align="left" valign="middle"><italic>acvr2a-b<sup>sa18285</sup></italic></td><td align="left" valign="middle">Exon 2 (previously annotated as exon1)</td><td align="left" valign="middle">TTTCCAGTTGTGTTTGATTCCATGT</td><td align="left" valign="middle">ACAAGTTTCCCTCGCAGCAG</td></tr><tr><td align="left" valign="middle"><italic>acvr2b-a<sup>t08pm</sup></italic></td><td align="left" valign="middle">Exon 1</td><td align="left" valign="middle">GTGGTGTGTGAGAGTGTGTGTG</td><td align="left" valign="middle">CAGGAGCATTTTAACAACACGA</td></tr></tbody></table></table-wrap><p>PCR amplicons were prepared for direct use in sequencing reactions by treatment with ExoI (NEB M0568) and rSAP (NEB M0371L), and the respective amplification primers were used in separate sequencing reactions. Mutations in the first generation were identified using PolyPeakParser (<xref ref-type="bibr" rid="bib30">Hill et al., 2014</xref>) and Hetindel (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018922">SCR_018922</ext-link>). Lasergene Seqman Pro 14 was used for subsequent genotyping analysis. Mutants were outcrossed to wild-type TE fish at least once before incrossing heterozygotes to obtain homozygous fish.</p></sec><sec id="s4-8"><title>Morpholino antisense oligonucleotides</title><p>For each receptor, several morpholinos targeting splice sites or the region surrounding the ATG start codon were designed. The following morpholinos (ATG start site targets underlined) were obtained from GeneTools (Philomath, OR):</p><table-wrap id="inlinetable5" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Target</th><th align="left" valign="bottom">Morpholino sequence (5’-&gt;3’)</th><th align="left" valign="bottom">Target site</th><th align="left" valign="bottom">Reference</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>acvr1b-a 1</italic></td><td align="left" valign="bottom">CTGCAACATTCC<underline>CAT</underline>CTCTTAGCAT</td><td align="left" valign="bottom">ATG start site</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Jazwińska et al., 2007</xref></td></tr><tr><td align="left" valign="bottom"><italic>acvr1b-a 2</italic></td><td align="left" valign="bottom">GTTTGGCCTGTACTGCTACCATTG</td><td align="left" valign="bottom">e2i2 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr1b-a 3</italic></td><td align="left" valign="bottom">ATAAACATGCAACTTACCAGACCCT</td><td align="left" valign="bottom">e3i3 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr1b-b 1</italic></td><td align="left" valign="bottom"><underline>CAT</underline>CCTTACAGGACTCCCATTGCAC</td><td align="left" valign="bottom">ATG start site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr1b-b 2</italic></td><td align="left" valign="bottom">CAAAGATTTGTTTTCAGCACCTCCA</td><td align="left" valign="bottom">e7i7 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr1c 1</italic></td><td align="left" valign="bottom">GATGAGA<underline>CAT</underline>GACATCTGTCACTTA</td><td align="left" valign="bottom">ATG start site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr1c 2</italic></td><td align="left" valign="bottom">TACTATTTTGTCCTGTCTTACCTGG</td><td align="left" valign="bottom">e2i2 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr1c 3</italic></td><td align="left" valign="bottom">TTAATGGGCACAGCCAGCTCTCACC</td><td align="left" valign="bottom">e3i3 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr2a-a 1</italic></td><td align="left" valign="bottom">GCAGGTCC<underline>CAT</underline>TTTTTCACTCTTCT</td><td align="left" valign="bottom">ATG start site</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Albertson et al., 2005</xref></td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-a 2</italic></td><td align="left" valign="bottom">AGCAGTAGGGAATACCTGTCATAGC</td><td align="left" valign="bottom">e2i2 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr2a-a 3</italic></td><td align="left" valign="bottom">TCGCTGAATGGAGCCTTACTCTGAA</td><td align="left" valign="bottom">e3i3 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr2a-b 1</italic></td><td align="left" valign="bottom">TCGATGGTCCCCGAGCGGTTCTTC</td><td align="left" valign="bottom">internal</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr2a-b 2</italic></td><td align="left" valign="bottom">TGGCTGCACACAAACACAGATTAAT</td><td align="left" valign="bottom">splice site</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Dogra et al., 2017</xref></td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-b 3</italic></td><td align="left" valign="bottom">TGACAGAAGTATTTACCTGTGACGG</td><td align="left" valign="bottom">e3i3 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr2b-a 1</italic></td><td align="left" valign="bottom">GCAGAGAAGCGAA<underline>CAT</underline>ATTCCTTT</td><td align="left" valign="bottom">ATG start site</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Albertson et al., 2005</xref></td></tr><tr><td align="left" valign="bottom"><italic>acvr2b-a 2</italic></td><td align="left" valign="bottom">TGAGCAGAGAAGCGAA<underline>CAT</underline>ATTCCT</td><td align="left" valign="bottom">ATG start site</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Dogra et al., 2017</xref></td></tr><tr><td align="left" valign="bottom"><italic>acvr2b-a 3</italic></td><td align="left" valign="bottom">AATGTTTAAGAGAGTCACCTGGTTC</td><td align="left" valign="bottom">e3i3 splice site</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>acvr2b-b</italic></td><td align="left" valign="bottom">AGCCAGCCAGGGAACAAA<underline>CAT</underline>ATTC</td><td align="left" valign="bottom">ATG start site</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib18">Dogra et al., 2017</xref></td></tr><tr><td align="left" valign="bottom"><italic>control</italic></td><td align="left" valign="bottom">CCTCTTACCTCAGTTACAATTTATA</td><td align="left" valign="bottom">n.a.</td><td align="left" valign="bottom">Gene Tools</td></tr></tbody></table></table-wrap><p>The <italic>acvr1b-b</italic> transcriptional start site-targeting morpholino (MO-1) is complementary to the start codon and the region upstream of the <italic>acvr1b-b</italic> coding sequence. Therefore, <italic>acvr1b-b</italic> MO-1 does not target the <italic>acvr1b-b</italic> mRNA synthesized for rescue experiments (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p></sec><sec id="s4-9"><title>CRISPR F0 KO</title><p>F0 knockout (KO) embryos were generated using the CRISPR-Cas9 method described by <xref ref-type="bibr" rid="bib38">Kroll et al., 2021</xref> following the protocol available at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.bs2rngd6">https://doi.org/10.17504/protocols.io.bs2rngd6</ext-link>. For each target gene, two or three synthetic guide RNAs (gRNAs), resulting from annealing a gene-specific crRNA to the Alt-R CRISPR-Cas9 tracrRNA (IDT, 1072532), were used. Each gRNA was assembled with Cas9 protein (Alt-R S.p. Cas9 Nuclease V3, IDT, 1081058) to a Cas9/gRNA ribonucleoprotein (RNP) and tested for its cutting efficiency using a T7 endonuclease I assay (see below, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). RNPs with low efficiency or toxic side effects were excluded from further experiments. RNPs targeting the same gene were subsequently pooled in equal amounts. For multi-gene KOs, respective RNP pools were mixed. Double <italic>acvr1b-a</italic>,<italic>acvr1b-b</italic> F0 KOs and quadruple <italic>acvr2a-a</italic>,<italic>acvr2a-b</italic>,<italic>acvr2b-a</italic>,<italic>avcr2b-b</italic> F0 KOs were generated by the injection of 2 nl RNP mix. In all other cases, an injection volume of 1 nl was used.</p><p>The following crRNAs, obtained from IDT, were used for F0 KO experiments:</p><table-wrap id="inlinetable6" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Target</th><th align="left" valign="bottom">Resulting RNP</th><th align="left" valign="bottom">Sequence</th><th align="left" valign="bottom">PAM</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="2"><italic>acvr1b-a</italic></td><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">GAACCAGGAACGTTCCTCCC</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">ACTACTCCGTCACAATCGAG</td><td align="left" valign="bottom">GGG</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>acvr1b-b</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">CAACTGGTGGCAGAGCTACG</td><td align="left" valign="bottom">AGG</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">TGGAGGAGAGCATTAACATG</td><td align="left" valign="bottom">AGG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">GAGGAACCAGCTTCTCCTTG</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="middle" rowspan="2"><italic>acvr2a-a</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">CTCGTTCCACGTCACTACGT</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">GCAACCTAGACATTGAGCTG</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>acvr2a-b</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">CGAGGACATTCCCAACCTGA</td><td align="left" valign="bottom">AGG</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">TCTGAGAATCGACATGTACG</td><td align="left" valign="bottom">CGG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">GCTGTTCACTGACCTGGACA</td><td align="left" valign="bottom">CGG</td></tr><tr><td align="left" valign="middle" rowspan="2"><italic>acvr2b-a</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">GAAGACGAACCGTAGCGGTG</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">GCGGGAGATGTTTTCCACTC</td><td align="left" valign="bottom">CGG</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>acvr2b-b</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">ACGAGGCACCAACCTTCAGA</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">ATTTCGGCAAGCATGTCCCG</td><td align="left" valign="bottom">AGG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">AGAGGCTTCAGTCCAACCAG</td><td align="left" valign="bottom">AGG</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>oep</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">GCCTGTCCGAAGTACTTCAC</td><td align="left" valign="bottom">CGG</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">TTCTGAACCCATTCTCCATG</td><td align="left" valign="bottom">TGG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">AAGAATTCAGCGTATTGCTT</td><td align="left" valign="bottom">TGG</td></tr></tbody></table></table-wrap><p>The <italic>acvr1b-b</italic> RNP1 has <italic>acvr1b-a</italic> as a predicted off-target with one mismatch in the gRNA’s seed-sequence. Since the ultimate goal was a double <italic>acvr1b-a,acvr1b-b</italic> F0 KO, this potential off-target was accepted.</p></sec><sec id="s4-10"><title>T7E1 assay</title><p>To estimate the cutting efficiency of RNPs used for the F0 KOs, T7 endonuclease I (T7E1) assays were performed. To this end, genomic DNA was isolated from a pool of ten F0 KO embryos at 1 dpf using the ‘hotshot’ method (<xref ref-type="bibr" rid="bib50">Meeker et al., 2007</xref>). A region of 190–290 bp surrounding the intended cut side was amplified using standard PCR conditions and the following primers:</p><table-wrap id="inlinetable7" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Target</th><th align="left" valign="bottom">RNP</th><th align="left" valign="bottom">Forward primer (5’-&gt;3’)</th><th align="left" valign="bottom">Reverse primer (5’-&gt;3<bold>’</bold>)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="2"><italic>acvr1b-a</italic></td><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">GTCTGAAAAGTGTTTTGCCTGTG</td><td align="left" valign="bottom">CAATGAAGCCCAAGATGTTTTCATG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">TTTCTTAGACAATGGCACATGGAC</td><td align="left" valign="bottom">CCTGGTTTCCCTGTAGGAGATC</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>acvr1b-b</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">ATTCATGAAGAATATCAGCTGCCC</td><td align="left" valign="bottom">GCTCTTCTATGAAGCTGACGGT</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">CACTGTCATCATGGCAAAACAAC</td><td align="left" valign="bottom">CAAAGATTTGTTTTCAGCACCTCC</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">GTTGTGTTTGCAGCTCTGTTGT</td><td align="left" valign="bottom">CTGTTGCAGTAGTCGGTGTAGC</td></tr><tr><td align="left" valign="middle" rowspan="2"><italic>acvr2a-a</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">GTTAATTGTATTGCAGGCTGATGC</td><td align="left" valign="bottom">CCTAAAAACGCAGACGAGACAG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">CTTAGGACAAACTGTCTTGGCAG</td><td align="left" valign="bottom">TAACGATATGTGATGGCAGAGGG</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>acvr2a-b</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">TGTGTGTCTGTGTTCAGGGTTC</td><td align="left" valign="bottom">GGATGATGATGACGTTTCAGGTG</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">TTAATGCAATGATGTGTCTTTTGTGTG</td><td align="left" valign="bottom">TCTCTCTCTCTTACCGTCAGCC</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">GTTCTGTGTTCAGGATCCAGGT</td><td align="left" valign="bottom">AGAAACCCAGAAATGTCAAAAGGC</td></tr><tr><td align="left" valign="middle" rowspan="2"><italic>acvr2b-a</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">GTGTGTTTGTTTACAGACCCCAG</td><td align="left" valign="bottom">CTGTCGTAGCAGTTGAAGTCGT</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">CACTTTTGTCCAAATCGTCTGGT</td><td align="left" valign="bottom">CCAGAACTCCATCTCCAGGTTAG</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>acvr2b-b</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">CATGGCAGAACGAAAGAGACATT</td><td align="left" valign="bottom">AAAATGCAGCCATTACGAGTTTTC</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">GTTCGCTGACAGATTACCTGAAG</td><td align="left" valign="bottom">ACTTTCTTTGGACGACCTACCAG</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">AGAGGCATCCATATTTTCAAAGCAG</td><td align="left" valign="bottom">ACAGCCACATATTCGCTCAGTA</td></tr><tr><td align="left" valign="middle" rowspan="3"><italic>oep</italic></td><td align="left" valign="bottom">RNP1</td><td align="left" valign="bottom">GCGTTTGCAACCTTGTGTAATATC</td><td align="left" valign="bottom">TGGAATAACACCACAATCCCTGT</td></tr><tr><td align="left" valign="bottom">RNP2</td><td align="left" valign="bottom">CAGGAGCTGTGAATACGATGAAC</td><td align="left" valign="bottom">GAAGCAATGCAAAAGTCCATATCC</td></tr><tr><td align="left" valign="bottom">RNP3</td><td align="left" valign="bottom">AGCTGTTTCACTCGAGTCAGG</td><td align="left" valign="bottom">TTGCGTTAATGACAATCTCACCTC</td></tr></tbody></table></table-wrap><p>Without further purification, the resulting PCR product was annealed and digested with T7E1 (NEB, M0302) according to the manufacturer’s instructions. For each sample, a ‘no enzyme’ (T7E1 -) control was included. The digested fragments were subsequently analyzed on 2% agarose gels.</p></sec><sec id="s4-11"><title>qRT-PCR</title><p>For qRT-PCR experiments, single embryos (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) or groups of 10 embryos (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E-F</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>) were collected at shield stage, and total RNA was isolated using NucleoZol (Macherey-Nagel 740404.200) according to the manufacturer’s protocol. 100 ng of RNA were used for cDNA synthesis with SuperScript III Reverse Transcriptase (Invitrogen 18080044) according to the manufacturer’s protocol. qRT-PCR was performed with Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen 1173304) on a CFX Connect Real-Time System (Bio-Rad 1855201). Two µl of 1:5 diluted cDNA were used as a template. The following primers were used for qRT-PCR analysis:</p><table-wrap id="inlinetable8" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Target</th><th align="left" valign="bottom">Forward primer (5’-&gt;3’)</th><th align="left" valign="bottom">Reverse primer (5’-&gt;3’)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>eF1α</italic></td><td align="left" valign="bottom">AGAAGGAAGCCGCTGAGATGG</td><td align="left" valign="bottom">TCCGTTCTTGGAGATACCAGCC</td></tr><tr><td align="left" valign="bottom"><italic>acvr1b-a</italic></td><td align="left" valign="bottom">CGCCATGAAAACATCTTGG</td><td align="left" valign="bottom">GTGTCCATGTGCCATTGTCT</td></tr><tr><td align="left" valign="bottom"><italic>acvr1b-b</italic></td><td align="left" valign="bottom">CTCTCCACCTCAGGATCAGG</td><td align="left" valign="bottom">GTACGAGCCACGGTCCTTT</td></tr><tr><td align="left" valign="bottom"><italic>acvr1c</italic></td><td align="left" valign="bottom">GAGATTATTGGCACCCAAGG</td><td align="left" valign="bottom">AACCAGGATGTTCTTTGACTTTATG</td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-a</italic></td><td align="left" valign="bottom">GGTGTCCTCACAACATTG</td><td align="left" valign="bottom">TCACCGGTCACTCGACAC</td></tr><tr><td align="left" valign="bottom"><italic>acvr2a-b</italic></td><td align="left" valign="bottom">GTGACACACACGGACAGGTT</td><td align="left" valign="bottom">AAACTGATCGCTCCTTCCAG</td></tr><tr><td align="left" valign="bottom"><italic>acvr2b-a</italic></td><td align="left" valign="bottom">CAAACCAGCCATCGCACA</td><td align="left" valign="bottom">TCACACCAGTCTACGACC</td></tr><tr><td align="left" valign="bottom"><italic>acvr2b-b</italic></td><td align="left" valign="bottom">ACACGTCGACATCGGACAG</td><td align="left" valign="bottom">AGGCTTCAGTCCAACCAGAG</td></tr></tbody></table></table-wrap><p>Transcript levels were normalized to the expression of the internal control <italic>eF1α</italic> using the ΔΔC<sub>t</sub> method. Technical duplicates and biological triplicates were performed for each sample.</p></sec><sec id="s4-12"><title>Testing the splice-blocking <italic>acvr1b-b</italic> morpholino</title><p>To test the morpholino <italic>acvr1b-b</italic> 2 (MO-2) targeting the <italic>e7i7</italic> splice site, embryos were injected with 0.4 ng or 2 ng MO-2 or left uninjected. In each case, 10 embryos at the 512 cell stage and 10 embryos at shield stage were used to prepare cDNA as described above. The cDNA subsequently served as a template to PCR-amplify fragments specific to (i) the unspliced <italic>acvr1b-b</italic> transcript still containing intron 7 and (ii) the spliced transcript. The PCR was conducted using KOD Hot Start DNA Polymerase (Novagen, 71086) according to the manufacturer’s instructions with the following primers:</p><table-wrap id="inlinetable9" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Primer</th><th align="left" valign="bottom" rowspan="2">Sequence</th><th align="left" valign="bottom" rowspan="2">Binding site</th><th align="center" valign="bottom" colspan="2">Product size (bp)</th></tr><tr><th align="center" valign="bottom">Spliced transcript</th><th align="center" valign="bottom">Unspliced transcript</th></tr></thead><tbody><tr><td align="left" valign="bottom">(i) forward</td><td align="left" valign="bottom">CAAAAATGCCTACTGAGACAGCC</td><td align="left" valign="bottom">intron 7</td><td align="center" valign="bottom">/</td><td align="center" valign="bottom">334</td></tr><tr><td align="left" valign="bottom">(ii) forward</td><td align="left" valign="bottom">ATGTGCTGATATCTACGCTCTGG</td><td align="left" valign="bottom">exon 7</td><td align="center" valign="bottom">171</td><td align="center" valign="bottom">(2218)</td></tr><tr><td align="left" valign="bottom">reverse</td><td align="left" valign="bottom">ATGTTGGGTCGTAATCTCTGGTC</td><td align="left" valign="bottom">exon 8</td><td align="center" valign="bottom"/><td align="center" valign="bottom"/></tr></tbody></table></table-wrap><p>An extension time of 10 s was used to suppress the 2218 bp PCR product expected for the PCR (ii) in the case of unspliced <italic>acvr1b-b</italic> transcripts.</p></sec><sec id="s4-13"><title>pSmad2/3 and pSmad2/3-pSmad1/5/9 double immunostainings</title><p>Embryos were fixed in 4% formaldehyde in PBS overnight at 4 °C, dehydrated in 100% methanol and stored at –20 °C. For pSmad2/3 immunofluorescence stainings, fixed embryos were incubated in acetone for 7 min, washed three times for 5 min with PBST (PBS +0.1% Tween 20), blocked for at least 1 hr with 10% FBS (Biochrom S0415) in PBST and incubated with 1:5000 rabbit anti-phospho-Smad2/Smad3 primary antibody (Cell Signaling Technologies 8828, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2631089">AB_2631089</ext-link>) in blocking solution at 4 °C overnight. The following day, embryos were washed 8 times for 15 min with PBST, blocked for at least 1 hr with blocking solution and incubated with 1:500 goat anti-rabbit horseradish peroxidase secondary antibody (Jackson ImmunoResearch 111-035-003, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2313567">AB_2313567</ext-link>) in blocking solution at 4 °C overnight. Embryos were then washed eight times for 15 min with PBST, incubated in TSA 1×amplification buffer (TSA Plus Fluorescein Kit, Perkin Elmer, NEL741001KT) for 15 min and stained by incubation in 75 μl 1:75 fluorescein-TSA in 1×amplification buffer for 45 min. Embryos were washed three times for 5 min with PBST, 30 min with methanol and washed twice more with PBST before incubating them in 1:5000 DAPI in PBST at room temperature (RT) for at least 1 hr, followed by at least three washes with PBST. Embryos were then transferred into methanol and stored at –20 °C before imaging.</p><p>Dual staining of pSmad2/3 with pSmad1/5/9 was performed as described previously (<xref ref-type="bibr" rid="bib84">Soh et al., 2020</xref>). Staining of pSmad2/3 with fluorescein-TSA and subsequent washes with PBST (see above) were followed by a 3 hr incubation in methanol. The embryos were then washed three times for 10 min in PBST and blocked for at least 1 hr with blocking solution before being incubated with 1:100 rabbit anti-phospho-Smad1/Smad5/Smad9 primary antibody (Cell Signaling Technologies 13820 S, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2493181">AB_2493181</ext-link>) in blocking solution at 4 °C overnight. Following ten PBST washes of 15 min each and at least 1 hr in blocking solution, the embryos were incubated with 1:100 anti-rabbit Alexa647 IgG (Invitrogen A21245, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141775">AB_141775</ext-link>) in blocking solution at 4 °C overnight. The next day, embryos were washed eight times with PBST for 15 min each before being imaged using a light-sheet microscope.</p></sec><sec id="s4-14"><title>Imaging</title><p>Brightfield images for the documentation of embryo morphology were taken using an Axio Zoom.V16 (ZEISS) microscope with a PlanNeoFluar Z 1×objective or a M205 FCA (Leica) microscope with a Planapo 1.0×M-Series objective.</p><p>Fluorescence images of fixed and live embryos were obtained using a Lightsheet Z.1 microscope (ZEISS). For mounting, the samples were drawn into 1.5% low-melting point agarose (Lonza 50080) with a size 3 glass capillary sample holder (ZEISS). If not noted otherwise, embryos were imaged using a W Plan-Apochromat 20×objective with 0.7×zoom and 5 μm intervals between z-slices. For imaging of pSmad2/3 immunostainings (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig6">Figure 6</xref>), embryos were imaged from different angles using a 488 nm laser at 2% power with 100 ms exposure time. For DAPI stainings, embryos were imaged using a 405 nm laser at 10% laser power with 70 ms exposure time. For YSL injections, z-stacks comprising 15 slices were taken using a 488 nm laser with 100% laser power and 70 ms exposure time to image GFP and a 638 nm far-red laser at 1% laser power and 20 ms exposure time to detect Alexa Fluor 647 dextran. pSmad2/3-pSmad1/5/9 double immunostainings (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>) and transplanted Nodal clones (<xref ref-type="fig" rid="fig5">Figure 5</xref>) were imaged using a W Plan-Apochromat 10×objective with 1×zoom and 1.82 µm intervals between z-slices. For pSmad2/3-pSmad1/5/9 double immunostainings, a laser power of 1% and 10% was used for the 488 nm and the 638 nm laser, respectively, with an exposure time of 70 ms. For transplanted Nodal clones, 488 nm and 638 nm lasers were used at a power of 15% and 10%, respectively, and 250 ms exposure time.</p><p>FRAP and FDAP measurements were performed using an LSM 780 NLO confocal microscope (ZEISS) with an LD C-Apochromat 40×/1.1 W Korr objective. Embryos were mounted in 1.5% low-melting point agarose in glass-bottom petri dishes (MatTek Corporation P35G-1.5–20 C). After solidification, the agarose was covered with embryo medium to protect the embryos from drying out. FRAP and FDAP measurements were performed and analyzed as previously described (<xref ref-type="bibr" rid="bib9">Bläßle and Müller, 2015</xref>; <xref ref-type="bibr" rid="bib10">Bläßle et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Müller et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Rogers et al., 2015</xref>; <xref ref-type="bibr" rid="bib83">Soh and Müller, 2018</xref>). FRAP and FDAP data sets that were poorly fit by the diffusion-production-clearance model (overall R<sup>2</sup> &lt;0.8, high local variability, linear increase, or severe mismatch between early recovery kinetics) or the exponentially decreasing function (overall R<sup>2</sup> &lt;0.88 or bleed-through artifacts), respectively, were excluded. Within the FDAP data sets, single frames were excluded in rare cases of signal saturation or signal artifacts, for example from transient bubbles in the oil resulting from multi-position imaging.</p></sec><sec id="s4-15"><title>Quantification of pSmad2/3 immunofluorescence signal levels</title><p>Levels of pSmad2/3 immunofluorescence were quantified on maximum intensity projections of samples recorded on the same day using Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). A mask generated from the DAPI channel was used to exclude non-nuclear pSmad2/3 signals. Manually drawn regions of interest on the dorsal or lateral side were used to obtain line intensity profiles from the embryo’s margin to the animal pole in the corresponding domain. Background subtraction was performed for each embryo individually using the median intensity of a region close to the animal pole. The profiles were normalized to the value of the average wild-type marginal zone signal on the lateral side.</p></sec><sec id="s4-16"><title>YSL-injection image analysis</title><p>Images obtained from embryos that had been YSL-injected with Nodal-encoding mRNA were analyzed using Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). To exclude fluorescent signal in the YSL, the far-red channel was converted into a mask with the mean thresholding algorithm in Fiji. Ten marginal z-slices of the GFP channel were then used for a maximum intensity projection. Before the region of interest around the embryo was defined, the maximum intensity projections were rotated, so that the YSL was on the left, parallel to the image margin. Pixels outside of the embryo and bright staining artifacts were set to <italic>n.a</italic>. to avoid distortion of the calculated averages. For Squint-GFP, the <italic>plot profile</italic> function in Fiji was used to extract the averaged intensities from the embryo. Background levels determined by measuring uninjected embryos were subtracted from the gradient profiles. The profiles were normalized following previously described procedures (<xref ref-type="bibr" rid="bib27">Gregor et al., 2007</xref>; <xref ref-type="bibr" rid="bib75">Rogers et al., 2020</xref>) with the model <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mover><mml:mi>c</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> , relating the mean intensity profile <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>c</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> of all data points to each embryo’s intensity profile <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> through the embryo-specific proportionality constant <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and the non-specific background <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> . <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> were determined by minimizing the sum of squared differences between the model and the intensity profiles using the function <italic>fminsearch</italic> in MATLAB 7.10.0 (<xref ref-type="bibr" rid="bib75">Rogers et al., 2020</xref>). Finally, each profile was normalized to the intensity at a distance of 0 µm from the YSL.</p><p>The Fiji <italic>find maxima</italic> function was used to identify Cyclops-GFP puncta. Uninjected embryos were used to verify that this approach only identified single maxima in order to exclude artifacts. The x- and y-coordinates of the puncta were extracted using the function <italic>measure</italic>, and the distribution of puncta as a function of distance from the YSL was plotted.</p></sec><sec id="s4-17"><title>Transplantation of Cyclops-GFP or Squint-GFP clones</title><p>Ectopic Nodal signaling sources were generated by transplanting Cyclops-GFP or Squint-GFP expressing clones from donor embryos into wild-type, MZ<italic>oep</italic>, or Type I receptor loss-of-function (<italic>acvr1b-a<sup>-/-</sup></italic>+0.4 ng <italic>acvr1b-b</italic> MO-1) host embryos. Donor embryos were generated by the injection of <italic>squint-GFP</italic> or <italic>cyclops-GFP</italic> mRNA and Alexa Fluor 647 dextran into one-cell stage wild-type embryos (see <italic>Microinjections and embryo dechorionation</italic>). For control experiments, donor embryos injected only with Alexa Fluor 647 dextran were used. Dechorionated sphere-stage host and donor embryos were transferred to Ringer’s solution (116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl<sub>2</sub>, 5 mM HEPES pH 7.2) and animal pole to animal pole cell transplantation was performed as described previously (<xref ref-type="bibr" rid="bib85">Soh et al., 2021</xref>; <xref ref-type="bibr" rid="bib84">Soh et al., 2020</xref>). Typically, two clones were derived from each donor embryo. After transplantation, embryos were kept in Ringer’s solution for 60 min (30 min at RT and 30 min at 28 °C).</p><p>To determine the distribution of Squint-GFP and Cyclops-GFP, host embryos were mounted in 1.5% low-melting point agarose (Lonza) with the animal-vegetal axis orthogonal to the agarose column and imaged using a Lightsheet Z.1 microscope (ZEISS) 60 min post-transplantation (see <italic>Imaging</italic>). The dispersal of Squint-GFP and Cyclops-GFP secreted from the clone into the host embryos was measured using Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). To this end, maximum intensity projections of 15 z-slices (~27 µm) were generated covering the embryo’s animal pole at a depth of approximately 51 µm – 78 µm. Linear regions-of-interest of ~70 µm width and variable length were drawn radially from the edge of the transplanted clone (determined as an intensity value of 700 in the far-red channel) towards the embryo’s outline. GFP signal intensity profiles were obtained from these regions-of-interest and averaged for each embryo. Background levels were determined as the median of GFP intensities obtained from control transplantations performed on the same day and subtracted from the intensity profiles. The background-subtracted intensity profile of each embryo was then normalized to the intensity at a distance of 0 µm from the transplantation site. Embryos with leaking yolk or a damaged clone were excluded from the analysis (3 out of 45). For image presentation (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), Sébastien Tosi’s Fiji macro &quot;deStripe2&quot; (<xref ref-type="bibr" rid="bib91">Tosi, 2020</xref>) was used.</p></sec><sec id="s4-18"><title>Transplantation of marginal cells</title><p>Donor embryos were obtained from an H2A.F/Z:GFP incross. Wild-type TE as well as MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> host embryos were collected 1 hr later. Only H2A.F/Z:GFP embryos exhibiting strong fluorescence were used as donors. The embryos were transferred to Ringer’s solution (116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl<sub>2</sub>, 5 mM HEPES pH 7.2) for margin transplantations. Margin cells were taken from donors around the 30–40% epiboly stage and transplanted into the animal pole or the marginal region of hosts (hosts were around sphere stage) as described in <xref ref-type="bibr" rid="bib85">Soh et al., 2021</xref> using glass needles with an inner tip diameter of ~80–90 μm. Typically, two margin transplants were derived from each donor embryo (taken from opposing regions). To keep the experimental groups as similar as possible, transplantations were performed such that TE and MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> embryos were used as hosts in an alternating manner. The embryos were kept in Ringer’s solution for 30 min at RT, transferred to embryo medium at 28 °C and then fixed 2 hr post-transplantation in PBS with 4% formaldehyde.</p><p>After overnight fixation at 4 °C, embryos were processed for pSmad2/3 immunostainings as described above and additionally used for GFP immunostainings with 1:1000 anti-GFP antibody (Aves Labs #GFP-1020, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000240">AB_10000240</ext-link>) at 4 °C overnight. The samples were briefly rinsed with PBST and then washed six times for 20 min each before blocking with 500 μl blocking solution for 1.5 hr. The blocking solution was removed, and a 1:500 dilution of Alexa Fluor 568-conjugated anti-chicken IgY (Abcam 175477) in blocking solution was added to the samples, which were then kept shaking at 4 °C overnight. PBST was added to briefly rinse the samples, and the samples were then washed twelve times for approximately 20 min each. They were stored in PBST containing 1 mg/l DAPI at 4 °C until imaging on a Lightsheet Z.1 microscope (ZEISS) with a W Plan-Apochromat 20×/1.0 objective. The samples were mounted in 1.5% low-melting point agarose (Lonza) in embryo medium and imaged in water. All samples and controls from one experiment were imaged on the same day to ensure comparable fluorescence between embryos. The embryos were mounted with the animal-vegetal axis orthogonal (margin-to-animal pole transplantations) or parallel (margin-to-margin transplantations) to the agarose column. z-stacks covering 130 μm from the animal pole were acquired (13 slices with 10 μm steps), and maximum intensity projections over 110 μm (ignoring the two animal-most slices) were generated using Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). The outline of the transplants was drawn around cells that exhibited immunofluorescence signal for GFP. For each experimental setup, three independent transplantation experiments were performed on 2 days. All fixed samples per experimental setup were immunostained in parallel.</p><p>To measure the distribution of the pSmad2/3 signal extending from the transplants into the host embryos, signal intensity profiles of manually drawn rectangular regions of interest were obtained using Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). These regions of interest were 100 µm in height and variable in width, ranging from the edge of the transplanted cell cluster to the animal pole in the case of margin transplants or the direction of maximal pSmad2/3 signal distribution for animal pole transplants. Background levels, determined from embryonic regions without nuclear pSmad2/3 signal, were subtracted from the profiles. To account for differences in transplant size, individual profiles were normalized to the number of transplanted cells. The number of transplanted cells was determined as the number of GFP-positive nuclei within the z-stack using the particle detection of TrackMate (<xref ref-type="bibr" rid="bib90">Tinevez et al., 2017</xref>), an open-source plugin for Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). To this end, spots of an estimated diameter of 8 µm were detected and subsequently filtered based on a manually adapted quality threshold. Remaining spurious spots (for example, located outside of the embryo) were removed manually.</p><p>The pSmad2/3 intensities within the transplants were measured in a circular region of defined size using Fiji (<xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref>). The intensities in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref> are given relative to the mean wild-type intensity. To count animal pole-facing pSmad2/3 positive nuclei (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2E</xref>), a line parallel to the margin was drawn just above the animal-most transplanted nucleus. pSmad2/3 positive nuclei on the animal side of this line were counted.</p></sec><sec id="s4-19"><title>Statistical analysis</title><p>p-values for differences between experimental conditions were calculated using two-tailed Student’s t-tests assuming equal variance in Excel for <xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref>, and <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>. Since an F test in R (<xref ref-type="bibr" rid="bib64">R Development Core Team, 2017</xref>) showed that the two experimental conditions in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> did not have equal variance, a Student’s t-test with unequal variance was performed in Excel for this data. A Shapiro-Wilk test in R showed that the data in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2E</xref> was not normally distributed, and a Wilcoxon rank sum test was therefore performed to calculate a p-value (note that due to the presence of ties, the p-value is not exact in this case but a normal approximation). Cohen’s <italic>d</italic> (Hedges bias corrected) as a measure for effect size was determined using Robert Coe’s Effect Size Calculator (<xref ref-type="bibr" rid="bib15">Coe, 2002</xref>).</p></sec><sec id="s4-20"><title>p-values for <xref ref-type="fig" rid="fig1">Figure 1E</xref></title><table-wrap id="inlinetable10" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="bottom" colspan="5"><bold><italic>oep</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">0.005</td><td align="center" valign="bottom">&lt;0.001</td><td align="center" valign="bottom">0.003</td><td align="center" valign="bottom">0.631</td></tr><tr><td align="center" valign="bottom" colspan="5"><bold><italic>acvr1b-a</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">&lt;0.001</td><td align="center" valign="bottom">&lt;0.001</td><td align="center" valign="bottom">0.003</td><td align="center" valign="bottom">0.001</td></tr><tr><td align="center" valign="bottom" colspan="5"><bold><italic>acvr1b-b</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">0.503</td><td align="center" valign="bottom">0.587</td><td align="center" valign="bottom">0.395</td><td align="center" valign="bottom">0.980</td></tr><tr><td align="center" valign="bottom" colspan="5"><bold><italic>acvr2a-a</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">0.188</td><td align="center" valign="bottom">0.401</td><td align="center" valign="bottom">0.419</td><td align="center" valign="bottom">0.705</td></tr><tr><td align="center" valign="bottom" colspan="5"><bold><italic>acvr2a-b</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">0.014</td><td align="center" valign="bottom">0.278</td><td align="center" valign="bottom">0.777</td><td align="center" valign="bottom">0.883</td></tr><tr><td align="center" valign="bottom" colspan="5"><bold><italic>acvr2b-a</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">0.108</td><td align="center" valign="bottom">0.110</td><td align="center" valign="bottom">0.182</td><td align="center" valign="bottom">0.920</td></tr><tr><td align="center" valign="bottom" colspan="5"><bold><italic>acvr2b-b</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">+<italic>squint-GFP</italic></td><td align="center" valign="bottom">+<italic>cyclops-GFP</italic></td><td align="center" valign="bottom">+<italic>lefty-D2</italic></td><td align="center" valign="bottom">+SB-505124</td></tr><tr><td align="center" valign="bottom">Uninjected</td><td align="center" valign="bottom">0.101</td><td align="center" valign="bottom">0.260</td><td align="center" valign="bottom">0.897</td><td align="center" valign="bottom">0.797</td></tr></tbody></table></table-wrap></sec><sec id="s4-21"><title>p-values for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E, F</xref></title><table-wrap id="inlinetable11" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="bottom" colspan="3"><bold><italic>acvr2a-b</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom"><italic>acvr2a-a<sup>SA34654</sup></italic></td><td align="center" valign="bottom"><italic>acvr2b-a<sup>t08pm</sup></italic></td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.076</td><td align="center" valign="bottom">0.016</td></tr><tr><td align="center" valign="bottom" colspan="3"><bold><italic>acvr2b-b</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom"><italic>acvr2a-a<sup>SA34654</sup></italic></td><td align="center" valign="bottom"><italic>acvr2b-a<sup>t08pm</sup></italic></td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.068</td><td align="center" valign="bottom">0.081</td></tr></tbody></table></table-wrap></sec><sec id="s4-22"><title>p-values for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref></title><table-wrap id="inlinetable12" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="bottom" colspan="2"><bold><italic>acvr1b-b</italic></bold></td></tr><tr><td align="center" valign="bottom"/><td align="center" valign="bottom"><italic>acvr1b-a<sup>t03pm</sup></italic></td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.376</td></tr></tbody></table></table-wrap></sec><sec id="s4-23"><title>p-values for <xref ref-type="fig" rid="fig4">Figure 4B</xref></title><table-wrap id="inlinetable13" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="bottom"/><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic></td><td align="center" valign="bottom">Wild type<break/><italic>+acvr1b-b</italic> MO-1</td><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic><break/><italic>+acvr1b-b</italic> MO-1</td><td align="center" valign="bottom">Wild type<break/><italic>+acvr1b-b</italic> MO-1<break/><italic>+acvr1b-a</italic> mRNA</td><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic><break/><italic>+acvr1b-b</italic> MO-1<break/><italic>+acvr1b-a</italic> mRNA</td><td align="center" valign="bottom">Wild type<break/><italic>+acvr1b-b</italic> MO-1<break/><italic>+acvr1b-b</italic> mRNA</td><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic><break/><italic>+acvr1b-b</italic> MO-1<break/><italic>+acvr1b-b</italic> mRNA</td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.203</td><td align="center" valign="bottom">0.785</td><td align="center" valign="bottom">&lt;0.001</td><td align="center" valign="bottom">0.783</td><td align="center" valign="bottom">0.041</td><td align="center" valign="bottom">0.286</td><td align="center" valign="bottom">0.097</td></tr></tbody></table></table-wrap></sec><sec id="s4-24"><title>p-values and Cohen’s <italic>d</italic> for <xref ref-type="fig" rid="fig6">Figure 6A</xref></title><table-wrap id="inlinetable14" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="bottom" rowspan="2"/><td align="center" valign="bottom" colspan="2"><bold>Squint-Dendra2</bold></td><td align="center" valign="bottom" colspan="2"><bold>Cyclops-Dendra2</bold></td></tr><tr><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic><break/><italic>+acvr1b-b</italic> MO-1</td><td align="center" valign="bottom">Wild type<break/>+<italic>acvr2b-a</italic> mRNA</td><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic><break/><italic>+acvr1b-b</italic> MO-1</td><td align="center" valign="bottom">Wild type<break/>+<italic>acvr2b-a</italic> mRNA</td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.458, 0.30</td><td align="center" valign="bottom">0.147, 0.73</td><td align="center" valign="bottom">0.006, 1.99</td><td align="center" valign="bottom">0.175, 0.82</td></tr></tbody></table></table-wrap></sec><sec id="s4-25"><title>p-values and Cohen’s <italic>d</italic> for <xref ref-type="fig" rid="fig6">Figure 6B</xref></title><table-wrap id="inlinetable15" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="bottom" rowspan="2"/><td align="center" valign="bottom" colspan="3"><bold>Squint-GFP</bold></td></tr><tr><td align="center" valign="bottom">Wild type<break/>+<italic>oep</italic> mRNA</td><td align="center" valign="bottom"><italic>acvr1b-a<sup>-/-</sup></italic><break/><italic>+acvr1b-b</italic> MO-1</td><td align="center" valign="bottom">Wild type<break/><italic>+acvr2b-a</italic> mRNA</td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.003, –1.40</td><td align="center" valign="bottom">0.028, 1.03</td><td align="center" valign="bottom">0.531, –0.31</td></tr></tbody></table></table-wrap></sec><sec id="s4-26"><title>p-value and Cohen’s <italic>d</italic> for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref></title><table-wrap id="inlinetable16" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="bottom"/><td align="center" valign="bottom" colspan="2">MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic></td></tr><tr><td align="left" valign="bottom"/><td align="center" valign="bottom">Animal pole transplants</td><td align="center" valign="bottom">Margin transplants</td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.201, 0.42</td><td align="center" valign="bottom">0.697, –0.13</td></tr></tbody></table></table-wrap></sec><sec id="s4-27"><title>p-value and Cohen’s <italic>d</italic> for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref></title><table-wrap id="inlinetable17" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic></td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">&lt;0.001, 2.21</td></tr></tbody></table></table-wrap></sec><sec id="s4-28"><title>p-value and Cohen’s <italic>d</italic> for <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2E</xref></title><table-wrap id="inlinetable18" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="bottom"/><td align="center" valign="bottom">MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic></td></tr><tr><td align="center" valign="bottom">Wild type</td><td align="center" valign="bottom">0.148, 0.56</td></tr></tbody></table></table-wrap></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Software, Formal analysis, Validation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Data curation, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All procedures were executed in accordance with the guidelines of the State of Baden-Württemberg and approved by the Regierungspräsidium Tübingen and the Regierungspräsidium Freiburg.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-66397-transrepform1-v3.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Source data files containing the numerical data used to generate the figures have been provided.</p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>JE</given-names></name><name><surname>Wali</surname><given-names>N</given-names></name><name><surname>Dooley</surname><given-names>CM</given-names></name><name><surname>Busch-Nentwich</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Baseline_expression_from_transcriptional_profiling_of_zebrafish_developmental_stages</data-title><source>EBI</source><pub-id pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB7244">PRJEB7244</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Christine Henzler, Sarah Keim, Jens Dominik Maile and Hannah Wild for technical support and discussions. We are grateful to the European Zebrafish Research Center (EZRC) for providing the <italic>acvr2a-a<sup>sa34654</sup></italic> and <italic>acvr2a-b<sup>sa18285</sup></italic> zebrafish lines. This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 637840 (QUANTPATTERN) and grant agreement No 863952 (ACE-OF-SPACE)). This work was also funded by the Max Planck Society and the International Max Planck Research School “From Molecules to Organisms”.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albertson</surname><given-names>RC</given-names></name><name><surname>Payne-Ferreira</surname><given-names>TL</given-names></name><name><surname>Postlethwait</surname><given-names>J</given-names></name><name><surname>Yelick</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Zebrafish acvr2a and acvr2b exhibit distinct roles in craniofacial development</article-title><source>Developmental Dynamics</source><volume>233</volume><fpage>1405</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20480</pub-id><pub-id pub-id-type="pmid">15977175</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almuedo-Castillo</surname><given-names>M</given-names></name><name><surname>Bläßle</surname><given-names>A</given-names></name><name><surname>Mörsdorf</surname><given-names>D</given-names></name><name><surname>Marcon</surname><given-names>L</given-names></name><name><surname>Soh</surname><given-names>GH</given-names></name><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Scale-invariant patterning by size-dependent inhibition of Nodal signalling</article-title><source>Nature Cell Biology</source><volume>20</volume><fpage>1032</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0155-7</pub-id><pub-id pub-id-type="pmid">30061678</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attisano</surname><given-names>L</given-names></name><name><surname>Wrana</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Signal transduction by the TGF-beta superfamily</article-title><source>Science</source><volume>296</volume><fpage>1646</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1126/science.1071809</pub-id><pub-id pub-id-type="pmid">12040180</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aykul</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>W</given-names></name><name><surname>Mutatu</surname><given-names>W</given-names></name><name><surname>Martinez-Hackert</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human cerberus prevents nodal-receptor binding, inhibits nodal signaling, and suppresses nodal-mediated phenotypes</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0114954</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0114954</pub-id><pub-id pub-id-type="pmid">25603319</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JT</given-names></name><name><surname>Joubin</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Aanstad</surname><given-names>P</given-names></name><name><surname>Herwig</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>M</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nodal signaling activates differentiation genes during zebrafish gastrulation</article-title><source>Developmental Biology</source><volume>304</volume><fpage>525</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.01.012</pub-id><pub-id pub-id-type="pmid">17306247</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Adkins</surname><given-names>HB</given-names></name><name><surname>Wechselberger</surname><given-names>C</given-names></name><name><surname>Seno</surname><given-names>M</given-names></name><name><surname>Normanno</surname><given-names>N</given-names></name><name><surname>De Luca</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Kenney</surname><given-names>N</given-names></name><name><surname>Ebert</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>KP</given-names></name><name><surname>Sanicola</surname><given-names>M</given-names></name><name><surname>Salomon</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial cells</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>2586</fpage><lpage>2597</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.8.2586-2597.2002</pub-id><pub-id pub-id-type="pmid">11909953</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchet</surname><given-names>MH</given-names></name><name><surname>Le Good</surname><given-names>JA</given-names></name><name><surname>Mesnard</surname><given-names>D</given-names></name><name><surname>Oorschot</surname><given-names>V</given-names></name><name><surname>Baflast</surname><given-names>S</given-names></name><name><surname>Minchiotti</surname><given-names>G</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Constam</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2008">2008a</year><article-title>Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>2580</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.174</pub-id><pub-id pub-id-type="pmid">18772886</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanchet</surname><given-names>MH</given-names></name><name><surname>Le Good</surname><given-names>JA</given-names></name><name><surname>Oorschot</surname><given-names>V</given-names></name><name><surname>Baflast</surname><given-names>S</given-names></name><name><surname>Minchiotti</surname><given-names>G</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Constam</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2008">2008b</year><article-title>Cripto localizes Nodal at the limiting membrane of early endosomes</article-title><source>Science Signaling</source><volume>1</volume><elocation-id>ra13</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.1165027</pub-id><pub-id pub-id-type="pmid">19001664</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bläßle</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PyFDAP: automated analysis of fluorescence decay after photoconversion (FDAP) experiments</article-title><source>Bioinformatics</source><volume>31</volume><fpage>972</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu735</pub-id><pub-id pub-id-type="pmid">25380959</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bläßle</surname><given-names>A</given-names></name><name><surname>Soh</surname><given-names>G</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Mörsdorf</surname><given-names>D</given-names></name><name><surname>Preiß</surname><given-names>H</given-names></name><name><surname>Jordan</surname><given-names>BM</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Quantitative diffusion measurements using the open-source software PyFRAP</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1582</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03975-6</pub-id><pub-id pub-id-type="pmid">29679054</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvanese</surname><given-names>L</given-names></name><name><surname>Sandomenico</surname><given-names>A</given-names></name><name><surname>Caporale</surname><given-names>A</given-names></name><name><surname>Focà</surname><given-names>A</given-names></name><name><surname>Focà</surname><given-names>G</given-names></name><name><surname>D’Auria</surname><given-names>G</given-names></name><name><surname>Falcigno</surname><given-names>L</given-names></name><name><surname>Ruvo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Conformational features and binding affinities to Cripto, ALK7 and ALK4 of Nodal synthetic fragments</article-title><source>Journal of Peptide Science</source><volume>21</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1002/psc.2733</pub-id><pub-id pub-id-type="pmid">25588905</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The zebrafish Nodal signal Squint functions as a morphogen</article-title><source>Nature</source><volume>411</volume><fpage>607</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1038/35079121</pub-id><pub-id pub-id-type="pmid">11385578</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SK</given-names></name><name><surname>Olale</surname><given-names>F</given-names></name><name><surname>Brivanlou</surname><given-names>AH</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors</article-title><source>PLOS Biology</source><volume>2</volume><elocation-id>E30</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0020030</pub-id><pub-id pub-id-type="pmid">14966532</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciruna</surname><given-names>B</given-names></name><name><surname>Weidinger</surname><given-names>G</given-names></name><name><surname>Knaut</surname><given-names>H</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Raz</surname><given-names>E</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Production of maternal-zygotic mutant zebrafish by germ-line replacement</article-title><source>PNAS</source><volume>99</volume><fpage>14919</fpage><lpage>14924</lpage><pub-id pub-id-type="doi">10.1073/pnas.222459999</pub-id><pub-id pub-id-type="pmid">12397179</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Coe</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>It’s the effect size, stupid - What effect size is and why it is important</article-title><conf-name>Annual Conference of the British Educational Research Association</conf-name></element-citation></ref><ref id="bib16"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Crank</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1979">1979</year><source>The Mathematics of Diffusion</source><publisher-name>Clarendon Press</publisher-name></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DaCosta Byfield</surname><given-names>S</given-names></name><name><surname>Major</surname><given-names>C</given-names></name><name><surname>Laping</surname><given-names>NJ</given-names></name><name><surname>Roberts</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7</article-title><source>Molecular Pharmacology</source><volume>65</volume><fpage>744</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1124/mol.65.3.744</pub-id><pub-id pub-id-type="pmid">14978253</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogra</surname><given-names>D</given-names></name><name><surname>Ahuja</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>HT</given-names></name><name><surname>Rasouli</surname><given-names>SJ</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name><name><surname>Reischauer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Opposite effects of Activin type 2 receptor ligands on cardiomyocyte proliferation during development and repair</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1902</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01950-1</pub-id><pub-id pub-id-type="pmid">29196619</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougan</surname><given-names>ST</given-names></name><name><surname>Warga</surname><given-names>RM</given-names></name><name><surname>Kane</surname><given-names>DA</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The role of the zebrafish nodal-related genes squint and cyclops in patterning of mesendoderm</article-title><source>Development</source><volume>130</volume><fpage>1837</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1242/dev.00400</pub-id><pub-id pub-id-type="pmid">12642489</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubrulle</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>BM</given-names></name><name><surname>Akhmetova</surname><given-names>L</given-names></name><name><surname>Farrell</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Response to Nodal morphogen gradient is determined by the kinetics of target gene induction</article-title><source>eLife</source><volume>4</volume><elocation-id>e05042</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05042</pub-id><pub-id pub-id-type="pmid">25869585</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Brolosy</surname><given-names>MA</given-names></name><name><surname>Kontarakis</surname><given-names>Z</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Kuenne</surname><given-names>C</given-names></name><name><surname>Günther</surname><given-names>S</given-names></name><name><surname>Fukuda</surname><given-names>N</given-names></name><name><surname>Kikhi</surname><given-names>K</given-names></name><name><surname>Boezio</surname><given-names>GLM</given-names></name><name><surname>Takacs</surname><given-names>CM</given-names></name><name><surname>Lai</surname><given-names>S-L</given-names></name><name><surname>Fukuda</surname><given-names>R</given-names></name><name><surname>Gerri</surname><given-names>C</given-names></name><name><surname>Giraldez</surname><given-names>AJ</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic compensation triggered by mutant mRNA degradation</article-title><source>Nature</source><volume>568</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1064-z</pub-id><pub-id pub-id-type="pmid">30944477</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B.</given-names></name><name><surname>Gates</surname><given-names>MA</given-names></name><name><surname>Egan</surname><given-names>ES</given-names></name><name><surname>Dougan</surname><given-names>ST</given-names></name><name><surname>Rennebeck</surname><given-names>G</given-names></name><name><surname>Sirotkin</surname><given-names>HI</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Zebrafish organizer development and germ-layer formation require nodal-related signals</article-title><source>Nature</source><volume>395</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1038/26013</pub-id><pub-id pub-id-type="pmid">9744277</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Concha</surname><given-names>ML</given-names></name><name><surname>Saúde</surname><given-names>L</given-names></name><name><surname>Parsons</surname><given-names>MJ</given-names></name><name><surname>Adams</surname><given-names>RJ</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Lefty antagonism of Squint is essential for normal gastrulation</article-title><source>Current Biology</source><volume>12</volume><fpage>2129</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(02)01361-1</pub-id><pub-id pub-id-type="pmid">12498688</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funkenstein</surname><given-names>B</given-names></name><name><surname>Krol</surname><given-names>E</given-names></name><name><surname>Esterin</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structural and functional characterizations of activin type 2B receptor (acvr2b) ortholog from the marine fish, gilthead sea bream, Sparus aurata: evidence for gene duplication of acvr2b in fish</article-title><source>Journal of Molecular Endocrinology</source><volume>49</volume><fpage>175</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1530/JME-12-0075</pub-id><pub-id pub-id-type="pmid">22911153</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name><name><surname>Thyme</surname><given-names>SB</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Akhmetova</surname><given-names>L</given-names></name><name><surname>Ahkmetova</surname><given-names>L</given-names></name><name><surname>Pauli</surname><given-names>A</given-names></name><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Richter</surname><given-names>C</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98186</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098186</pub-id><pub-id pub-id-type="pmid">24873830</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>RR</given-names></name><name><surname>Bally-Cuif</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>SE</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Ni</surname><given-names>X</given-names></name><name><surname>Hew</surname><given-names>CL</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cloning of zebrafish activin type IIB receptor (ActRIIB) cDNA and mRNA expression of ActRIIB in embryos and adult tissues</article-title><source>Molecular and Cellular Endocrinology</source><volume>153</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/s0303-7207(99)00044-1</pub-id><pub-id pub-id-type="pmid">10459865</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregor</surname><given-names>T</given-names></name><name><surname>Tank</surname><given-names>DW</given-names></name><name><surname>Wieschaus</surname><given-names>EF</given-names></name><name><surname>Bialek</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Probing the limits to positional information</article-title><source>Cell</source><volume>130</volume><fpage>153</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.05.025</pub-id><pub-id pub-id-type="pmid">17632062</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gritsman</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Heckscher</surname><given-names>E</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The EGF-CFC protein one-eyed pinhead is essential for nodal signaling</article-title><source>Cell</source><volume>97</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80720-5</pub-id><pub-id pub-id-type="pmid">10199408</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Simpson</surname><given-names>BB</given-names></name><name><surname>Lei</surname><given-names>H</given-names></name><name><surname>Feijen</surname><given-names>A</given-names></name><name><surname>van den Eijnden-van Raaij</surname><given-names>J</given-names></name><name><surname>Donahoe</surname><given-names>PK</given-names></name><name><surname>Li</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse</article-title><source>Genes &amp; Development</source><volume>12</volume><fpage>844</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1101/gad.12.6.844</pub-id><pub-id pub-id-type="pmid">9512518</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JT</given-names></name><name><surname>Demarest</surname><given-names>BL</given-names></name><name><surname>Bisgrove</surname><given-names>BW</given-names></name><name><surname>Su</surname><given-names>YC</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Poly peak parser: method and software for identification of unknown indels using Sanger sequencing of polymerase chain reaction products</article-title><source>Developmental Dynamics</source><volume>243</volume><fpage>1632</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1002/dvdy.24183</pub-id><pub-id pub-id-type="pmid">25160973</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spatial and temporal control of NODAL signaling</article-title><source>Current Opinion in Cell Biology</source><volume>51</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.10.005</pub-id><pub-id pub-id-type="pmid">29153705</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>WY</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Maeder</surname><given-names>ML</given-names></name><name><surname>Tsai</surname><given-names>SQ</given-names></name><name><surname>Sander</surname><given-names>JD</given-names></name><name><surname>Peterson</surname><given-names>RT</given-names></name><name><surname>Yeh</surname><given-names>JRJ</given-names></name><name><surname>Joung</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Efficient genome editing in zebrafish using a CRISPR-Cas system</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>227</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/nbt.2501</pub-id><pub-id pub-id-type="pmid">23360964</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jazwińska</surname><given-names>A</given-names></name><name><surname>Badakov</surname><given-names>R</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Activin-betaA signaling is required for zebrafish fin regeneration</article-title><source>Current Biology</source><volume>17</volume><fpage>1390</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2007.07.019</pub-id><pub-id pub-id-type="pmid">17683938</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>BLAT -- the BLAST-like alignment tool</article-title><source>Genome Research</source><volume>12</volume><fpage>656</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1101/gr.229202</pub-id><pub-id pub-id-type="pmid">11932250</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishimoto</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Zon</surname><given-names>L</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Schulte-Merker</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The molecular nature of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning</article-title><source>Development</source><volume>124</volume><fpage>4457</fpage><lpage>4466</lpage><pub-id pub-id-type="doi">10.1242/dev.124.22.4457</pub-id><pub-id pub-id-type="pmid">9409664</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosaki</surname><given-names>R</given-names></name><name><surname>Gebbia</surname><given-names>M</given-names></name><name><surname>Kosaki</surname><given-names>K</given-names></name><name><surname>Lewin</surname><given-names>M</given-names></name><name><surname>Bowers</surname><given-names>P</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Casey</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Left-Right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB</article-title><source>American Journal of Medical Genetics</source><volume>82</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19990101)82:1&lt;70::aid-ajmg14&gt;3.0.co;2-y</pub-id><pub-id pub-id-type="pmid">9916847</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>C</given-names></name><name><surname>Mayr</surname><given-names>T</given-names></name><name><surname>Nowak</surname><given-names>M</given-names></name><name><surname>Schumacher</surname><given-names>J</given-names></name><name><surname>Runke</surname><given-names>G</given-names></name><name><surname>Bauer</surname><given-names>H</given-names></name><name><surname>Wagner</surname><given-names>DS</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Mullins</surname><given-names>MC</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Maternally supplied Smad5 is required for ventral specification in zebrafish embryos prior to zygotic BMP signaling</article-title><source>Developmental Biology</source><volume>250</volume><fpage>263</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1006/dbio.2002.0805</pub-id><pub-id pub-id-type="pmid">12376102</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>F</given-names></name><name><surname>Powell</surname><given-names>GT</given-names></name><name><surname>Ghosh</surname><given-names>M</given-names></name><name><surname>Gestri</surname><given-names>G</given-names></name><name><surname>Antinucci</surname><given-names>P</given-names></name><name><surname>Hearn</surname><given-names>TJ</given-names></name><name><surname>Tunbak</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Dennis</surname><given-names>HW</given-names></name><name><surname>Fernandez</surname><given-names>JM</given-names></name><name><surname>Whitmore</surname><given-names>D</given-names></name><name><surname>Dreosti</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name><name><surname>Hoffman</surname><given-names>EJ</given-names></name><name><surname>Rihel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A simple and effective F0 knockout method for rapid screening of behaviour and other complex phenotypes</article-title><source>eLife</source><volume>10</volume><elocation-id>e59683</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.59683</pub-id><pub-id pub-id-type="pmid">33416493</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>T</given-names></name><name><surname>Landge</surname><given-names>AN</given-names></name><name><surname>Mörsdorf</surname><given-names>D</given-names></name><name><surname>Coßmann</surname><given-names>J</given-names></name><name><surname>Gerstenecker</surname><given-names>J</given-names></name><name><surname>Čapek</surname><given-names>D</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name><name><surname>Gebhardt</surname><given-names>JCM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-molecule tracking of Nodal and Lefty in live zebrafish embryos supports hindered diffusion model</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>6101</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-33704-z</pub-id><pub-id pub-id-type="pmid">36243734</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C-C</given-names></name><name><surname>Jan</surname><given-names>H-J</given-names></name><name><surname>Lai</surname><given-names>J-H</given-names></name><name><surname>Ma</surname><given-names>H-I</given-names></name><name><surname>Hueng</surname><given-names>D-Y</given-names></name><name><surname>Lee</surname><given-names>Y-CG</given-names></name><name><surname>Cheng</surname><given-names>Y-Y</given-names></name><name><surname>Liu</surname><given-names>L-W</given-names></name><name><surname>Wei</surname><given-names>H-W</given-names></name><name><surname>Lee</surname><given-names>H-M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Nodal promotes growth and invasion in human gliomas</article-title><source>Oncogene</source><volume>29</volume><fpage>3110</fpage><lpage>3123</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.55</pub-id><pub-id pub-id-type="pmid">20383200</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leerberg</surname><given-names>DM</given-names></name><name><surname>Hopton</surname><given-names>RE</given-names></name><name><surname>Draper</surname><given-names>BW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fibroblast growth factor receptors function redundantly during zebrafish embryonic development</article-title><source>Genetics</source><volume>212</volume><fpage>1301</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302345</pub-id><pub-id pub-id-type="pmid">31175226</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y-F</given-names></name><name><surname>Canário</surname><given-names>AVM</given-names></name><name><surname>Power</surname><given-names>DM</given-names></name><name><surname>Campinho</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ioxynil and diethylstilbestrol disrupt vascular and heart development in zebrafish</article-title><source>Environment International</source><volume>124</volume><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2019.01.009</pub-id><pub-id pub-id-type="pmid">30685453</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>SC</given-names></name><name><surname>Mullins</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis</article-title><source>Nature Cell Biology</source><volume>11</volume><fpage>637</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/ncb1870</pub-id><pub-id pub-id-type="pmid">19377468</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Nemashkalo</surname><given-names>A</given-names></name><name><surname>Rezende</surname><given-names>L</given-names></name><name><surname>Jung</surname><given-names>JY</given-names></name><name><surname>Chhabra</surname><given-names>S</given-names></name><name><surname>Guerra</surname><given-names>MC</given-names></name><name><surname>Heemskerk</surname><given-names>I</given-names></name><name><surname>Warmflash</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Nodal is a short-range morphogen with activity that spreads through a relay mechanism in human gastruloids</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>497</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28149-3</pub-id><pub-id pub-id-type="pmid">35079017</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>ND</given-names></name><name><surname>Carte</surname><given-names>AN</given-names></name><name><surname>Abitua</surname><given-names>PB</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The pattern of nodal morphogen signaling is shaped by co-receptor expression</article-title><source>eLife</source><volume>10</volume><elocation-id>e54894</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54894</pub-id><pub-id pub-id-type="pmid">34036935</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macías-Silva</surname><given-names>M</given-names></name><name><surname>Abdollah</surname><given-names>S</given-names></name><name><surname>Hoodless</surname><given-names>PA</given-names></name><name><surname>Pirone</surname><given-names>R</given-names></name><name><surname>Attisano</surname><given-names>L</given-names></name><name><surname>Wrana</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling</article-title><source>Cell</source><volume>87</volume><fpage>1215</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81817-6</pub-id><pub-id pub-id-type="pmid">8980228</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madeira</surname><given-names>F</given-names></name><name><surname>Park</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Buso</surname><given-names>N</given-names></name><name><surname>Gur</surname><given-names>T</given-names></name><name><surname>Madhusoodanan</surname><given-names>N</given-names></name><name><surname>Basutkar</surname><given-names>P</given-names></name><name><surname>Tivey</surname><given-names>ARN</given-names></name><name><surname>Potter</surname><given-names>SC</given-names></name><name><surname>Finn</surname><given-names>RD</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The EMBL-EBI search and sequence analysis tools APIs in 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W636</fpage><lpage>W641</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz268</pub-id><pub-id pub-id-type="pmid">30976793</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marjoram</surname><given-names>L</given-names></name><name><surname>Wright</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid differential transport of Nodal and Lefty on sulfated proteoglycan-rich extracellular matrix regulates left-right asymmetry in Xenopus</article-title><source>Development</source><volume>138</volume><fpage>475</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1242/dev.056010</pub-id><pub-id pub-id-type="pmid">21205792</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matzuk</surname><given-names>MM</given-names></name><name><surname>Kumar</surname><given-names>TR</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Different phenotypes for mice deficient in either activins or activin receptor type II</article-title><source>Nature</source><volume>374</volume><fpage>356</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/374356a0</pub-id><pub-id pub-id-type="pmid">7885474</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meeker</surname><given-names>ND</given-names></name><name><surname>Hutchinson</surname><given-names>SA</given-names></name><name><surname>Ho</surname><given-names>L</given-names></name><name><surname>Trede</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Method for isolation of PCR-ready genomic DNA from zebrafish tissues</article-title><source>BioTechniques</source><volume>43</volume><elocation-id>610, 612, 614</elocation-id><pub-id pub-id-type="doi">10.2144/000112619</pub-id><pub-id pub-id-type="pmid">18072590</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Gritsman</surname><given-names>K</given-names></name><name><surname>Ohishi</surname><given-names>S</given-names></name><name><surname>Ohfuji</surname><given-names>Y</given-names></name><name><surname>Heckscher</surname><given-names>E</given-names></name><name><surname>Mochida</surname><given-names>K</given-names></name><name><surname>Shimono</surname><given-names>A</given-names></name><name><surname>Kondoh</surname><given-names>H</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation</article-title><source>Molecular Cell</source><volume>4</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(00)80331-7</pub-id><pub-id pub-id-type="pmid">10518210</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>A</given-names></name><name><surname>Van de Peer</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>From 2R to 3R: evidence for a fish-specific genome duplication (FSGD)</article-title><source>BioEssays</source><volume>27</volume><fpage>937</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1002/bies.20293</pub-id><pub-id pub-id-type="pmid">16108068</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Hartmann</surname><given-names>D</given-names></name><name><surname>Kinboshi</surname><given-names>M</given-names></name><name><surname>Komada</surname><given-names>M</given-names></name><name><surname>Ishibashi</surname><given-names>M</given-names></name><name><surname>Shiota</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The cyst-branch difference in developing chick lung results from a different morphogen diffusion coefficient</article-title><source>Mechanisms of Development</source><volume>126</volume><fpage>160</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2008.11.006</pub-id><pub-id pub-id-type="pmid">19073251</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Cruz</surname><given-names>JM</given-names></name><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Church</surname><given-names>GM</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W401</fpage><lpage>W407</lpage><pub-id pub-id-type="doi">10.1093/nar/gku410</pub-id><pub-id pub-id-type="pmid">24861617</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mörsdorf</surname><given-names>D</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tuning protein diffusivity with membrane tethers</article-title><source>Biochemistry</source><volume>58</volume><fpage>177</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.8b01150</pub-id><pub-id pub-id-type="pmid">30562001</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>P</given-names></name><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Jordan</surname><given-names>BM</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Robson</surname><given-names>D</given-names></name><name><surname>Ramanathan</surname><given-names>S</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential diffusivity of Nodal and Lefty underlies a reaction-diffusion patterning system</article-title><source>Science</source><volume>336</volume><fpage>721</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1126/science.1221920</pub-id><pub-id pub-id-type="pmid">22499809</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>P</given-names></name><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Yu</surname><given-names>SR</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Morphogen transport</article-title><source>Development</source><volume>140</volume><fpage>1621</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1242/dev.083519</pub-id><pub-id pub-id-type="pmid">23533171</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>MC</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Kane</surname><given-names>DA</given-names></name><name><surname>Odenthal</surname><given-names>J</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>van Eeden</surname><given-names>FJ</given-names></name><name><surname>Furutani-Seiki</surname><given-names>M</given-names></name><name><surname>Granato</surname><given-names>M</given-names></name><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Heisenberg</surname><given-names>CP</given-names></name><name><surname>Jiang</surname><given-names>YJ</given-names></name><name><surname>Kelsh</surname><given-names>RN</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes</article-title><source>Development</source><volume>123</volume><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1242/dev.123.1.81</pub-id><pub-id pub-id-type="pmid">9007231</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagaso</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Tada</surname><given-names>M</given-names></name><name><surname>Ueno</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Dual specificity of activin type II receptor ActRIIb in dorso-ventral patterning during zebrafish embryogenesis</article-title><source>Development, Growth &amp; Differentiation</source><volume>41</volume><fpage>119</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1046/j.1440-169x.1999.00418.x</pub-id><pub-id pub-id-type="pmid">10223708</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>SP</given-names></name><name><surname>Li</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse</article-title><source>Genes &amp; Development</source><volume>11</volume><fpage>1812</fpage><lpage>1826</lpage><pub-id pub-id-type="doi">10.1101/gad.11.14.1812</pub-id><pub-id pub-id-type="pmid">9242489</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>S</given-names></name><name><surname>Geldmacher-Voss</surname><given-names>B</given-names></name><name><surname>Campos-Ortega</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A zebrafish histone variant H2A.F/Z and A transgenic H2A.F/Z:GFP fusion protein for in vivo studies of embryonic development</article-title><source>Development Genes and Evolution</source><volume>211</volume><fpage>603</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1007/s00427-001-0196-x</pub-id><pub-id pub-id-type="pmid">11819118</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomreinke</surname><given-names>AP</given-names></name><name><surname>Soh</surname><given-names>GH</given-names></name><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Bergmann</surname><given-names>JK</given-names></name><name><surname>Bläßle</surname><given-names>AJ</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamics of BMP signaling and distribution during zebrafish dorsal-ventral patterning</article-title><source>eLife</source><volume>6</volume><elocation-id>e25861</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.25861</pub-id><pub-id pub-id-type="pmid">28857744</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>A</given-names></name><name><surname>Vizán</surname><given-names>P</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Chakravarty</surname><given-names>P</given-names></name><name><surname>Vogt</surname><given-names>J</given-names></name><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name><name><surname>Hinck</surname><given-names>AP</given-names></name><name><surname>Sapkota</surname><given-names>GP</given-names></name><name><surname>Hill</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TGF-β uses a novel mode of receptor activation to phosphorylate Smad1/5 and induce epithelial-to-mesenchymal transition</article-title><source>eLife</source><volume>7</volume><elocation-id>e31756</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.31756</pub-id><pub-id pub-id-type="pmid">29376829</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2017">2017</year><data-title>R: a language and environment for statistical computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org">https://www.R-project.org</ext-link></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebagliati</surname><given-names>MR</given-names></name><name><surname>Toyama</surname><given-names>R</given-names></name><name><surname>Fricke</surname><given-names>C</given-names></name><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Dawid</surname><given-names>IB</given-names></name></person-group><year iso-8601-date="1998">1998a</year><article-title>Zebrafish nodal-related genes are implicated in axial patterning and establishing left-right asymmetry</article-title><source>Developmental Biology</source><volume>199</volume><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1006/dbio.1998.8935</pub-id><pub-id pub-id-type="pmid">9698446</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebagliati</surname><given-names>MR</given-names></name><name><surname>Toyama</surname><given-names>R</given-names></name><name><surname>Haffter</surname><given-names>P</given-names></name><name><surname>Dawid</surname><given-names>IB</given-names></name></person-group><year iso-8601-date="1998">1998b</year><article-title>Cyclops encodes a nodal-related factor involved in midline signaling</article-title><source>PNAS</source><volume>95</volume><fpage>9932</fpage><lpage>9937</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.17.9932</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reissmann</surname><given-names>E</given-names></name><name><surname>Jörnvall</surname><given-names>H</given-names></name><name><surname>Blokzijl</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>O</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Minchiotti</surname><given-names>G</given-names></name><name><surname>Persico</surname><given-names>MG</given-names></name><name><surname>Ibáñez</surname><given-names>CF</given-names></name><name><surname>Brivanlou</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The orphan receptor ALK7 and the activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development</article-title><source>Genes &amp; Development</source><volume>15</volume><fpage>2010</fpage><lpage>2022</lpage><pub-id pub-id-type="doi">10.1101/gad.201801</pub-id><pub-id pub-id-type="pmid">11485994</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renucci</surname><given-names>A</given-names></name><name><surname>Lemarchandel</surname><given-names>V</given-names></name><name><surname>Rosa</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>An activated form of type I serine/threonine kinase receptor TARAM-A reveals a specific signalling pathway involved in fish head organiser formation</article-title><source>Development</source><volume>122</volume><fpage>3735</fpage><lpage>3743</lpage><pub-id pub-id-type="doi">10.1242/dev.122.12.3735</pub-id><pub-id pub-id-type="pmid">9012495</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodaway</surname><given-names>A</given-names></name><name><surname>Takeda</surname><given-names>H</given-names></name><name><surname>Koshida</surname><given-names>S</given-names></name><name><surname>Broadbent</surname><given-names>J</given-names></name><name><surname>Price</surname><given-names>B</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Patient</surname><given-names>R</given-names></name><name><surname>Holder</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Induction of the mesendoderm in the zebrafish germ ring by yolk cell-derived TGF-beta family signals and discrimination of mesoderm and endoderm by FGF</article-title><source>Development</source><volume>126</volume><fpage>3067</fpage><lpage>3078</lpage><pub-id pub-id-type="doi">10.1242/dev.126.14.3067</pub-id><pub-id pub-id-type="pmid">10375499</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessler</surname><given-names>E</given-names></name><name><surname>Ouspenskaia</surname><given-names>MV</given-names></name><name><surname>Karkera</surname><given-names>JD</given-names></name><name><surname>Vélez</surname><given-names>JI</given-names></name><name><surname>Kantipong</surname><given-names>A</given-names></name><name><surname>Lacbawan</surname><given-names>F</given-names></name><name><surname>Bowers</surname><given-names>P</given-names></name><name><surname>Belmont</surname><given-names>JW</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Goldmuntz</surname><given-names>E</given-names></name><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly</article-title><source>American Journal of Human Genetics</source><volume>83</volume><fpage>18</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2008.05.012</pub-id><pub-id pub-id-type="pmid">18538293</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Morphogen gradients: from generation to interpretation</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>27</volume><fpage>377</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154148</pub-id><pub-id pub-id-type="pmid">21801015</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Blässle</surname><given-names>A</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Measuring protein stability in living zebrafish embryos using fluorescence decay after photoconversion (FDAP)</article-title><source>Journal of Visualized Experiments</source><volume>52266</volume><elocation-id>52266</elocation-id><pub-id pub-id-type="doi">10.3791/52266</pub-id><pub-id pub-id-type="pmid">25650549</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Lord</surname><given-names>ND</given-names></name><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Pauli</surname><given-names>A</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Aksel</surname><given-names>DC</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>SQ</given-names></name><name><surname>Joung</surname><given-names>JK</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nodal patterning without Lefty inhibitory feedback is functional but fragile</article-title><source>eLife</source><volume>6</volume><elocation-id>e28785</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.28785</pub-id><pub-id pub-id-type="pmid">29215332</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nodal and BMP dispersal during early zebrafish development</article-title><source>Developmental Biology</source><volume>447</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.04.002</pub-id><pub-id pub-id-type="pmid">29653088</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>KW</given-names></name><name><surname>ElGamacy</surname><given-names>M</given-names></name><name><surname>Jordan</surname><given-names>BM</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Optogenetic investigation of BMP target gene expression diversity</article-title><source>eLife</source><volume>9</volume><elocation-id>e58641</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.58641</pub-id><pub-id pub-id-type="pmid">33174840</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Kontarakis</surname><given-names>Z</given-names></name><name><surname>Gerri</surname><given-names>C</given-names></name><name><surname>Nolte</surname><given-names>H</given-names></name><name><surname>Hölper</surname><given-names>S</given-names></name><name><surname>Krüger</surname><given-names>M</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic compensation induced by deleterious mutations but not gene knockdowns</article-title><source>Nature</source><volume>524</volume><fpage>230</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/nature14580</pub-id><pub-id pub-id-type="pmid">26168398</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampath</surname><given-names>K</given-names></name><name><surname>Rubinstein</surname><given-names>AL</given-names></name><name><surname>Cheng</surname><given-names>AM</given-names></name><name><surname>Liang</surname><given-names>JO</given-names></name><name><surname>Fekany</surname><given-names>K</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Korzh</surname><given-names>V</given-names></name><name><surname>Halpern</surname><given-names>ME</given-names></name><name><surname>Wright</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Induction of the zebrafish ventral brain and floorplate requires cyclops/nodal signalling</article-title><source>Nature</source><volume>395</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1038/26020</pub-id><pub-id pub-id-type="pmid">9744278</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Neuhauss</surname><given-names>SC</given-names></name><name><surname>Harvey</surname><given-names>M</given-names></name><name><surname>Malicki</surname><given-names>J</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name><name><surname>Zwartkruis</surname><given-names>F</given-names></name><name><surname>Abdelilah</surname><given-names>S</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name><name><surname>Rangini</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Driever</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Mutations affecting the development of the embryonic zebrafish brain</article-title><source>Development</source><volume>123</volume><fpage>165</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1242/dev.123.1.165</pub-id><pub-id pub-id-type="pmid">9007238</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nodal morphogens</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>1</volume><elocation-id>a003459</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a003459</pub-id><pub-id pub-id-type="pmid">20066122</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>J-Y</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nodal signaling: developmental roles and regulation</article-title><source>Development</source><volume>134</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1242/dev.000166</pub-id><pub-id pub-id-type="pmid">17287255</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Massagué</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mechanisms of TGF-beta signaling from cell membrane to the nucleus</article-title><source>Cell</source><volume>113</volume><fpage>685</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00432-x</pub-id><pub-id pub-id-type="pmid">12809600</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soh</surname><given-names>GH</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FRAP analysis of extracellular diffusion in zebrafish embryos</article-title><source>Methods in Molecular Biology</source><volume>1863</volume><fpage>107</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-8772-6_6</pub-id><pub-id pub-id-type="pmid">30324594</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soh</surname><given-names>GH</given-names></name><name><surname>Pomreinke</surname><given-names>AP</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integration of Nodal and BMP signaling by mutual signaling effector antagonism</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107487</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.051</pub-id><pub-id pub-id-type="pmid">32268105</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soh</surname><given-names>GH</given-names></name><name><surname>Kögler</surname><given-names>AC</given-names></name><name><surname>Müller</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A simple and effective transplantation device for zebrafish embryos</article-title><source>Journal of Visualized Experiments</source><volume>10</volume><elocation-id>3791</elocation-id><pub-id pub-id-type="doi">10.3791/62767</pub-id><pub-id pub-id-type="pmid">34398162</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stapornwongkul</surname><given-names>KS</given-names></name><name><surname>de Gennes</surname><given-names>M</given-names></name><name><surname>Cocconi</surname><given-names>L</given-names></name><name><surname>Salbreux</surname><given-names>G</given-names></name><name><surname>Vincent</surname><given-names>J-P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Patterning and growth control in vivo by an engineered GFP gradient</article-title><source>Science</source><volume>370</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1126/science.abb8205</pub-id><pub-id pub-id-type="pmid">33060356</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tewary</surname><given-names>M</given-names></name><name><surname>Dziedzicka</surname><given-names>D</given-names></name><name><surname>Ostblom</surname><given-names>J</given-names></name><name><surname>Prochazka</surname><given-names>L</given-names></name><name><surname>Shakiba</surname><given-names>N</given-names></name><name><surname>Heydari</surname><given-names>T</given-names></name><name><surname>Aguilar-Hidalgo</surname><given-names>D</given-names></name><name><surname>Woodford</surname><given-names>C</given-names></name><name><surname>Piccinini</surname><given-names>E</given-names></name><name><surname>Becerra-Alonso</surname><given-names>D</given-names></name><name><surname>Vickers</surname><given-names>A</given-names></name><name><surname>Louis</surname><given-names>B</given-names></name><name><surname>Rahman</surname><given-names>N</given-names></name><name><surname>Danovi</surname><given-names>D</given-names></name><name><surname>Geens</surname><given-names>M</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name><name><surname>Zandstra</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-Throughput micropatterning platform reveals Nodal-dependent bisection of peri-gastrulation-associated versus preneurulation-associated fate patterning</article-title><source>PLOS Biology</source><volume>17</volume><elocation-id>e3000081</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000081</pub-id><pub-id pub-id-type="pmid">31634368</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Antivin, a novel and divergent member of the TGFbeta superfamily, negatively regulates mesoderm induction</article-title><source>Development</source><volume>126</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1242/dev.126.2.229</pub-id><pub-id pub-id-type="pmid">9847237</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-Resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>Perry</surname><given-names>N</given-names></name><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Hoopes</surname><given-names>GM</given-names></name><name><surname>Reynolds</surname><given-names>GD</given-names></name><name><surname>Laplantine</surname><given-names>E</given-names></name><name><surname>Bednarek</surname><given-names>SY</given-names></name><name><surname>Shorte</surname><given-names>SL</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TrackMate: an open and extensible platform for single-particle tracking</article-title><source>Methods</source><volume>115</volume><fpage>80</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2016.09.016</pub-id><pub-id pub-id-type="pmid">27713081</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Tosi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>DeStripe2</data-title><version designator="1.0">1.0</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/SebastienTs/deStripe/blob/master/deStripe2.ijm">https://github.com/SebastienTs/deStripe/blob/master/deStripe2.ijm</ext-link></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Boxtel</surname><given-names>AL</given-names></name><name><surname>Chesebro</surname><given-names>JE</given-names></name><name><surname>Heliot</surname><given-names>C</given-names></name><name><surname>Ramel</surname><given-names>M-C</given-names></name><name><surname>Stone</surname><given-names>RK</given-names></name><name><surname>Hill</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A temporal window for signal activation dictates the dimensions of a nodal signaling domain</article-title><source>Developmental Cell</source><volume>35</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.09.014</pub-id><pub-id pub-id-type="pmid">26506307</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Boxtel</surname><given-names>AL</given-names></name><name><surname>Economou</surname><given-names>AD</given-names></name><name><surname>Heliot</surname><given-names>C</given-names></name><name><surname>Hill</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Long-range signaling activation and local inhibition separate the mesoderm and endoderm lineages</article-title><source>Developmental Cell</source><volume>44</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.11.021</pub-id><pub-id pub-id-type="pmid">29275993</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vopalensky</surname><given-names>P</given-names></name><name><surname>Pralow</surname><given-names>S</given-names></name><name><surname>Vastenhouw</surname><given-names>NL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Reduced expression of the Nodal co-receptor Oep causes loss of mesendodermal competence in zebrafish</article-title><source>Development</source><volume>145</volume><elocation-id>dev158832</elocation-id><pub-id pub-id-type="doi">10.1242/dev.158832</pub-id><pub-id pub-id-type="pmid">29440298</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wohland</surname><given-names>T</given-names></name><name><surname>Sampath</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Extracellular interactions and ligand degradation shape the nodal morphogen gradient</article-title><source>eLife</source><volume>5</volume><elocation-id>e13879</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13879</pub-id><pub-id pub-id-type="pmid">27101364</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waterhouse</surname><given-names>AM</given-names></name><name><surname>Procter</surname><given-names>JB</given-names></name><name><surname>Martin</surname><given-names>DMA</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Barton</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Jalview version 2 -- a multiple sequence alignment editor and analysis workbench</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1189</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id><pub-id pub-id-type="pmid">19151095</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>RJ</given-names></name><name><surname>Collins</surname><given-names>JE</given-names></name><name><surname>Sealy</surname><given-names>IM</given-names></name><name><surname>Wali</surname><given-names>N</given-names></name><name><surname>Dooley</surname><given-names>CM</given-names></name><name><surname>Digby</surname><given-names>Z</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name><name><surname>Murphy</surname><given-names>DN</given-names></name><name><surname>Billis</surname><given-names>K</given-names></name><name><surname>Hourlier</surname><given-names>T</given-names></name><name><surname>Füllgrabe</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>MP</given-names></name><name><surname>Enright</surname><given-names>AJ</given-names></name><name><surname>Busch-Nentwich</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A high-resolution mRNA expression time course of embryonic development in zebrafish</article-title><source>eLife</source><volume>6</volume><elocation-id>e30860</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30860</pub-id><pub-id pub-id-type="pmid">29144233</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>YT</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Chaosu</surname><given-names>E</given-names></name><name><surname>Haltiwanger</surname><given-names>RS</given-names></name><name><surname>Abate-Shen</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>4439</fpage><lpage>4449</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.13.4439-4449.2002</pub-id><pub-id pub-id-type="pmid">12052855</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>C</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms</article-title><source>Molecular Cell</source><volume>7</volume><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(01)00249-0</pub-id><pub-id pub-id-type="pmid">11389842</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation</article-title><source>Cell</source><volume>92</volume><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80918-6</pub-id><pub-id pub-id-type="pmid">9458048</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Scolavino</surname><given-names>S</given-names></name><name><surname>Funderburk</surname><given-names>SF</given-names></name><name><surname>Ficociello</surname><given-names>LF</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Klibanski</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Receptor internalization-independent activation of Smad2 in activin signaling</article-title><source>Molecular Endocrinology</source><volume>18</volume><fpage>1818</fpage><lpage>1826</lpage><pub-id pub-id-type="doi">10.1210/me.2004-0079</pub-id><pub-id pub-id-type="pmid">15087470</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Scaling a DPP morphogen gradient through feedback control of receptors and co-receptors</article-title><source>Developmental Cell</source><volume>53</volume><fpage>724</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.05.029</pub-id><pub-id pub-id-type="pmid">32574592</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-chicken IgY Alexa Fluor 568-conjungated (Goat polyclonal)</td><td align="left" valign="top">Abcam</td><td align="char" char="." valign="top">175477</td><td align="char" char="." valign="top">1:500</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Digoxigenin-AP, Fab-Fragmente (Sheep polyclonal)</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Roche-11093274910, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2734716">AB_2734716</ext-link></td><td align="char" char="." valign="top">1:5000</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-GFP antibody (Chicken polyclonal)</td><td align="left" valign="top">Aves Lab</td><td align="left" valign="top">#GFP-1020, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000240">AB_10000240</ext-link></td><td align="char" char="." valign="top">1:1000</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-phospho-Smad2/Smad3 (Rabbit monoclonal)</td><td align="left" valign="top">Cell Signaling Technology</td><td align="left" valign="top">8828, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2631089">AB_2631089</ext-link></td><td align="char" char="." valign="top">1:5000</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-phospho-Smad1/Smad5/Smad9 (Rabbit monoclonal)</td><td align="left" valign="top">Cell Signaling Technologies</td><td align="left" valign="top">13820 S, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2493181">AB_2493181</ext-link></td><td align="char" char="." valign="top">1:100</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-rabbit Alexa647 IgG (Goat polyclonal)</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">A21245, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141775">AB_141775</ext-link></td><td align="char" char="." valign="top">1:100</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-rabbit horseradish peroxidase (Goat polyclonal)</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">111-035-003, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2313567">AB_2313567</ext-link></td><td align="char" char="." valign="top">1:500</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">DAPI</td><td align="left" valign="top">Life Technologies</td><td align="left" valign="top">D1306</td><td align="char" char="." valign="top">1:5000</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">FBS</td><td align="left" valign="top">Biochrom</td><td align="left" valign="top">S0415</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Nodal inhibitor SB-505124</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">S4696-5MG</td><td align="left" valign="top">10 µM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">NucleoZol</td><td align="left" valign="top">Macherey-Nagel</td><td align="char" char="." valign="top">740404.200</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Pronase</td><td align="left" valign="top">Roche</td><td align="char" char="." valign="top">11459643001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">5′/3′ RACE Kit, 2<sup>nd</sup> Generation</td><td align="left" valign="top">Roche</td><td align="char" char="." valign="top">03353621001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">pCR-bluntII TOPO kit</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="char" char="." valign="top">450245</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">Platinum SYBR Green qPCR SuperMix-UDG</td><td align="left" valign="top">Invitrogen</td><td align="char" char="." valign="top">1173304</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">RNeasy MinElute Cleanup kit</td><td align="left" valign="top">Qiagen</td><td align="char" char="." valign="top">74204</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">RNeasy Mini kit</td><td align="left" valign="top">Qiagen</td><td align="char" char="." valign="top">74104</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">SP6 mMessage</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">AM1340</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">SuperScript III Reverse Transcriptase</td><td align="left" valign="top">Invitrogen</td><td align="char" char="." valign="top">18080044</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">TSA Plus Fluorescein Kit</td><td align="left" valign="top">Perkin Elmer</td><td align="left" valign="top">NEL741001KT</td><td align="left" valign="top">TSA plus cyanine 3</td></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">Wizard SV Gel and PCR Clean-Up System</td><td align="left" valign="top">Promega</td><td align="left" valign="top">A9282</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr1b-a</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-980526–527</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr1b-b</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-131120–9</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr1c</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-181207–1</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2a-a</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-980526–227</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2a-b</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-120215–23</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2b-a</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-980526–549</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2b-b</italic></td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">zfin.org</ext-link></td><td align="left" valign="top">ZDB-GENE-170621–5</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Alexa Fluor 647 dextran</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">D22914</td><td align="left" valign="top">See Materials and methods, <italic>Microinjections and embryo dechorionation</italic></td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Low-melting point agarose</td><td align="left" valign="top">Lonza</td><td align="char" char="." valign="top">50080</td><td align="left" valign="top">Mounting of samples for lightsheet microscopy</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Human ACVR1B</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">P36896</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Human ACVR1C</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">Q8NER5</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Human ACVR2A</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">P27037</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Human ACVR2B</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">Q13705</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Mouse ACVR1B</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">Q61271</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Mouse ACVR1C</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">Q8K348</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Mouse ACVR2A</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">P27038</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Mouse ACVR2B</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">P27040</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr1b-a</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">P79689</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr1b-b</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">F1QZF0</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr1c</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">E7F0I3</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr2a-a</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">F1QG01</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr2a-b</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">A0A0R4ISZ9</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr2b-a</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">Q9YGU4</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zebrafish Acvr2b-b</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">A0A0G2KN81</td><td align="left" valign="top">Protein sequence</td></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">BamHI</td><td align="left" valign="top">NEB</td><td align="left" valign="top">R3136</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Alt-R S.p. Cas9 Nuclease V3</td><td align="left" valign="top">IDT</td><td align="char" char="." valign="top">1081058</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">ClaI-HF</td><td align="left" valign="top">NEB</td><td align="left" valign="top">R0197</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">EcoRI-HF</td><td align="left" valign="top">NEB</td><td align="left" valign="top">R3101</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Exonuclease I (ExoI)</td><td align="left" valign="top">NEB</td><td align="left" valign="top">M0568</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">NotI-HF</td><td align="left" valign="top">NEB</td><td align="left" valign="top">R3189</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Recombinant Shrimp Alkaline Phospatase (rSAP)</td><td align="left" valign="top">NEB</td><td align="left" valign="top">M0371L</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">StuI (Eco147I)</td><td align="left" valign="top">Thermo Fisher</td><td align="left" valign="top">FD0424</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">T7 endonuclease I (T7E1)</td><td align="left" valign="top">NEB</td><td align="left" valign="top">M0302</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">XbaI</td><td align="left" valign="top">NEB</td><td align="left" valign="top">R0145</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">XhoI</td><td align="left" valign="top">NEB</td><td align="left" valign="top">R0146</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">Cas9 nuclease (<italic>Streptococcus pyogenes</italic>) from CMV and T7 promoters</td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib32">Hwang et al., 2013</xref></td><td align="left" valign="top">MLM3613 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_42251">Addgene_42251</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr1b-a</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr1b-b</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr1c</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr2a-a</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr2a-b</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr2b-a</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pCS2+-<italic>acvr2b-b</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>mRNA synthesis</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr1b-a</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr1b-b</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr1c</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr2a-a</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr2a-b</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr2b-a</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">TOPO-<italic>acvr2b-b</italic> (plasmid)</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"><break/></td><td align="left" valign="top">See Materials and methods, <italic>Whole-mount in situ hybridization</italic></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">Morpholino antisense oligo control</td><td align="left" valign="top">Gene Tools, LLC</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">Gene-specific crRNA</td><td align="left" valign="top">IDT</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">Alt-R CRISPR-Cas9 tracrRNA</td><td align="left" valign="top">IDT</td><td align="char" char="." valign="top">1072532</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Blast</td><td align="left" valign="top">Uniprot</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002380">SCR_002380</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">CFX Manager Software</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">1845000, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017251">SCR_017251</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">CHOPCHOP</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib54">Montague et al., 2014</xref></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015723">SCR_015723</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Clustal Omega</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib47">Madeira et al., 2019</xref></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001591">SCR_001591</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Excel</td><td align="left" valign="top">Microsoft</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016137">SCR_016137</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Fiji</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib80">Schindelin et al., 2012</xref></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Hetindel, Version 1</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://github.com/najasplus/hetindel_shinyapp">https://github.com/najasplus/hetindel_shinyapp</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018922">SCR_018922</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Jalview version 2.10.3b1</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib96">Waterhouse et al., 2009</xref></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006459">SCR_006459</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Lasergene Seqman Pro 14</td><td align="left" valign="top">DNASTAR</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Matlab</td><td align="left" valign="top">Mathworks</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="http://mathworks.com">http://mathworks.com</ext-link> RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001622">SCR_001622</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">PolyPeakParser</td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib30">Hill et al., 2014</xref></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">PyFDAP</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib9">Bläßle and Müller, 2015</xref></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022664">SCR_022664</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">PyFRAP</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib10">Bläßle et al., 2018</xref></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022665">SCR_022665</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">R</td><td align="left" valign="top">R-Core-Team</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, stain background (<italic>E. coli</italic>)</td><td align="left" valign="top">DH5α</td><td align="left" valign="top">In-house</td><td align="left" valign="top"/><td align="left" valign="top">Chemically competent</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr1b-a<sup>t03pm</sup></italic> zebrafish mutant</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Fish lines and husbandry</italic></td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr1c<sup>t06pm</sup></italic> zebrafish mutant</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Fish lines and husbandry</italic></td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2a-a<sup>sa34654</sup></italic> zebrafish mutant</td><td align="left" valign="top">EZRC</td><td align="left" valign="top">sa34654</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2a-b<sup>sa18285</sup></italic> zebrafish mutant</td><td align="left" valign="top">EZRC</td><td align="left" valign="top">sa18285</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>acvr2b-a<sup>t08pm</sup></italic> zebrafish mutant</td><td align="left" valign="top">Generated in this study</td><td align="left" valign="top"/><td align="left" valign="top">See Materials and methods, <italic>Fish lines and husbandry</italic></td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top">H2A.F/Z:GFP</td><td align="char" char="." valign="top"><xref ref-type="bibr" rid="bib61">Pauls et al., 2001</xref></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top">MZ<italic>sqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic></td><td align="left" valign="top"><xref ref-type="bibr" rid="bib22">Feldman et al., 1998</xref>; <xref ref-type="bibr" rid="bib78">Schier et al., 1996</xref>; <xref ref-type="bibr" rid="bib14">Ciruna et al., 2002</xref></td><td align="left" valign="top"/><td align="left" valign="top">Mutants were obtained by germ line transplantation</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top"><italic>oep<sup>tz57</sup></italic> zebrafish mutant</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib28">Gritsman et al., 1999</xref>; <xref ref-type="bibr" rid="bib100">Zhang et al., 1998</xref></td><td align="left" valign="top">tz57</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Danio rerio</italic>)</td><td align="left" valign="top">TE zebrafish</td><td align="left" valign="top">In-house</td><td align="left" valign="top"/><td align="left" valign="top">Wild type</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66397.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Solnica-Krezel</surname><given-names>Lilianna</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>While the Nodal signaling pathway plays essential roles in germ layer induction and patterning during development, the precise function of different zebrafish Nodal receptors had not been determined. Here, the authors identify seven genes encoding Type I and Type II Nodal receptors in zebrafish and use a combination of genetic approaches to show that the Type I receptors Acvr1b-a and Acvr1b-b act redundantly as major mediators of Nodal signaling. Whereas the Acvr2 Type II receptors function partly redundantly and partially independently of Nodal in embryo patterning. Moreover, Type I receptor and co-receptor levels can modulate Nodal distribution, providing a mechanism for the spatial restriction of Nodal signaling during embryo patterning.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66397.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Solnica-Krezel</surname><given-names>Lilianna</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for sending your article entitled &quot;Regulation of Nodal signaling propagation by receptor interactions and positive feedback&quot; for peer review at <italic>eLife</italic>. Your article is being evaluated by 3 peer reviewers, and the evaluation is being overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor.</p><p>The major concerns of reviewers include:</p><p>1. The heavy reliance on morpholinos for loss-of-function studies. The reviewers thought that generation of acvr1b-b mutant and analyses of acvr1b-a/b double mutant would significantly strengthen the conclusion. Likewise, they wondered that while the authors generated or obtained mutant lines for 3 of the 4 type II receptors, redundancy of these genes was not tested by generating double and triple mutants, but by simultaneously knocking down all 4 paralogous genes using MOs. Mutations should be generated for acvr1b-b and acvr2b-b, which should then be tested in combination with other receptor mutations. This is especially important for the type II receptors, because the severe but non-specific phenotypes of quadruple morphant embryos are so difficult to interpret (Figure 3).</p><p>2. Overexpression of fluorescently tagged Nodal ligand is not a reliable method for determining signaling range. To make any interpretation of these data, the authors would need to measure how the levels of the injected Nodal compare with endogenous levels and to see how the results vary when varying doses of Nodal are injected,</p><p>3. Referring to Figure 6B – the Reviewers wondered how do the timescales for binding and unbinding to receptors compare to that for diffusion? The FRAP dataset requires a clear model for its interpretation.</p><p>4. The Reviewers questioned why the quantification of nodal signaling in acvr1b-a and acvr1b-b loss of function and rescue experiments is measured as the number of tiers of cells (distance from ligand source) of pSmad2/3? Instead, for a more accurate measure of signaling level, the amount of pSmad2/3 (fluorescence intensity) should be measured in discreet regions of the embryo.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>While the essential roles of Nodal signaling during early development are well described, the precise function of different zebrafish Nodal receptor paralogs had not been determined. Here, the authors identify 7 genes encoding type I and type II Nodal receptors in zebrafish, 6 of which are maternally deposited and expressed during germ layer specification. Loss-of-function analysis reveals that none of these Nodal receptors is strictly necessary for development, and that loss of both Acvr1b type I receptors is required to yield a Nodal-deficient phenotype. This double loss-of-function was achieved by injecting acvr1b-b morpholino oligonucleotide (MOs) into acvr1b-a mutant embryos, raising the question, why didn't the authors generate mutations in both genes to examine double mutant phenotypes? And while the authors generated or obtained mutant lines for 3 of the 4 type II receptors, they tested for redundancy of these genes not by generating double and triple mutants, but by simultaneously knocking down all 4 paralogous genes using MOs. Because such high doses of MO cause pleiotropic and non-specific defects, the phenotypes of these embryos are difficult to interpret.</p><p>Nodal signaling is largely restricted to the margin of pre-gastrulation zebrafish embryos, a gradient that is thought to form through interactions of highly diffusible extracellular Lefty antagonists and less diffusible Nodal ligands. It was recently shown (Lord et al., 2019) that the Oep/Tdgf1 co-receptor restricts Nodal signaling range, and here the authors hypothesized that Nodal type I and II receptors slow the diffusion of Nodal ligands to limit their signaling range. They directly demonstrate that fluorescently tagged Nodal ligands diffuse farther in the absence of both Acvr1b type I receptors and in oep-/- mutants. Using Fluorescence Decay After Photoconversion (FDAP) and Fluorescent Recovery After Photobleaching (FRAP), they determine that Nodal receptors limit ligand range by slowing their diffusion and not through ligand clearance or relay signaling. Namely, FRAP-detected ligand diffusion was found to increase upon loss of type I receptors but remained unchanged upon overexpression of type II receptors, suggesting that type I receptors may play a larger role in ligand distribution (despite the fact that type II receptors are thought to directly and strongly bind Nodal ligands). FDAP experiments revealed no effect on ligand clearance type II receptor overexpression, but it was not examined whether loss of type I receptors alters ligand clearance as it alters ligand diffusion.</p><p>Together, these results identify redundancy in Nodal receptor function during early zebrafish development and propose a creative, seemingly paradoxical model in which feed-forward Nodal signaling actually decreases signaling range by boosting expression of receptors that limit ligand diffusion.</p><p>1. The authors conclude that, because neither genetic mutations nor translation blocking MOs targeting Nodal receptors produce phenotypes, no genetic compensation is occurring. It would be more convincing to show by qRT-PCR that expression levels of paralogous genes are not altered upon mutation of a receptor gene.</p><p>2. Because homozygous loss of any Nodal receptor gene is not lethal, it should be straightforward to generate double mutant embryos and bypass the use of MOs to determine functional redundancy. Mutations should be generated for acvr1b-b and acvr2b-b, which should then be tested in combination with other receptor mutations. This is especially important for the type II receptors, because the severe but non-specific phenotypes of quadruple morphant embryos are so difficult to interpret (Figure 3).</p><p>3. The authors state that embryos lacking acvr1b-a or -b alone &quot;had a Nodal signaling range very similar to untreated WT embryos&quot; (line 214), but in Figure 4A these conditions look quite different from one another. Particularly, the pSmad2 signal at the (presumed) dorsal midline looks similar to WT, but appears much dimmer at other positions around the margin of acvr1b LOF embryos. Were the measurement in Figure 4B taken from a single, dorsal region of the margin, which could explain the normal number of pSmad2+ nuclei despite the abnormal appearance of these embryos? Or are these images not representative of the embryos quantified?</p><p>4. In figure 5B, it would be nice to see images of Nodal ligand diffusion upon loss of Nodal receptors in addition to loss of oep.</p><p>5. Given that type II receptors are reported to interact directly and strongly with Nodal ligands, it is surprising that altering levels of type I receptors affected ligand diffusion while type II levels did not. To test this further, I would like to see measurements of ligand clearance / diffusion upon both loss and gain of function of both type I and type II receptors (rather than only loss of type I and only gain of type II). Because acvr1b mutants exhibit increased diffusion (Figure 6B), I would be interested to know if ligand clearance (stability) is also affected in these mutants? This would help determine if ligand clearance does not actually regulate signaling in this system, or if acvr2b overexpression simply doesn't cause phenotypes (Figures 6A-B).</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Preiß et al., investigate how Nodal receptors regulate Nodal signaling. They first discover several possible new Type I and Type II receptors based on homology to mammalian sequences. They show combined loss of two type I receptors results in a phenotype indicative of loss of nodal signaling. They then perform experiments to suggest that the range of Nodal signaling is regulated by the expression of the type I receptor. The discovery of additional type I receptors is certainly useful, and the phenotype of removing two of them is clear, however, several other claims are not justified by the data. I detail my concerns below.</p><p>1. The authors state that Figure 1F shows that inhibition of nodal signaling reduces expression of acvr1b-a, however, I do not see this in the figure where there still appears to be signal in the in situ. If anything, the range of signal appears expanded over the animal pole of the embryo.</p><p>2. In Figure 3, the authors show that combining MO against acvr1b-a and acvr1b-b produces a &quot;pinhead&quot; phenotype. Can they speculate why this phenotype is not seen in Figure 3C when knockout of acvr1a-a is combined with MO against acvr1a-b?</p><p>3. Figure 3 – in the absence of functional data to support the role of the newly identified type II receptors, given that the loss of function yielded no phenotype, the authors should avoid making a strong claim that these receptors play a role in Nodal signaling.</p><p>4. In Figure 4a there seems to be a clear difference in signal intensity between the wildtype and acvr1b-a mutant in the uninflected case. In the mutant much of the margin appears to have reduced or no signal for pSmad2. This should be noted.</p><p>5. Figure 5 – results based on overexpression of fluorescently tagged Nodal ligand is not a reliable method for determining signaling range. It is clear from the current study as well as several other that the stoichometry of ligand and receptors will influence the result and so no faith can be put in the results of overexpression. To make any interpretation of this data at all, the authors would need to measure how the levels of the injected Nodal compare with endogenous levels and to see how the results vary when varying doses of Nodal are injected, however, even in this case, much caution is required when drawing conclusions about the range of Nodal in general.</p><p>6. Figure 5 – the results shown in C,D are not consistent with what would be expected if binding to the receptor restricted the range of Nodal. In that case, when the receptor is downregulated and Nodal can diffuse more freely, one would expect lower levels near the source but a broader distribution. In this case, there is simply more Nodal everywhere which indicates either the receptor is somehow post-translationally regulating the expression of Nodal or else these embryos simply had more Nodal mRNA injected. Also, quantification is shown for receptor loss of function but not images are shown in B, these should be included.</p><p>7. Figure 6 A, B – the authors should show the data from the photoconversion and FRAP experiments and the fit to these curves and then the parameters that were extracted from this.</p><p>8. Figure 6A – loss of function for the receptor should be performed as well. If most of the Nodal is already bound, overexpressing the receptor would not be expected to have an effect but loss of function might.</p><p>9. Figure 6B – I do not understand the model for diffusion the authors are proposing. How do the timescales for binding and unbinding to receptors compare to that for diffusion? If they are slow, then one expects that the receptor binding would show up in an immobile fraction in the experiment rather than in lowering the diffusion constant. Or are the authors suggesting that the receptor bound Nodal diffuses within the plasma membrane, but more slowly, in which case the data would need to be fit to a two component model. In any event, this FRAP data requires a clear model for its interpretation.</p><p>10. Figure 6C, D – quantification is essential for these experiments including quantifying the number of donor cells as well as the induced gradient on pSmad2 in the host.</p><p>11. Figure 6C, D – in both cases there only appears to be active signaling immediately adjacent to the graft. This is not consistent with the authors investigation of &quot;medium-range&quot; Nodal signaling. This is important because the authors are trying to investigate whether a relay is essential for this medium range signal, however, if there is no signaling at a distance in the wildtype transplant then it is impossible to draw any conclusion from the transplant into the knockout.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The nodal signaling pathway plays essential roles in germ-layer induction and patterning during development. While the ligands and co-receptor responsible for nodal activation during zebrafish development have been previously identified, it is still unclear which receptors are required for early zebrafish nodal signaling. Based on loss of function analysis, the authors identify two type I receptors that are redundantly required for nodal signaling during early development. The authors also perform experiments to suggest nodal ligand interactions with the type I receptor can affect ligand diffusion and help shape the nodal signaling gradient.</p><p>Strengths:</p><p>The identification and characterization of all seven receptors predicted to mediate nodal signaling serves as a nice reference for future studies of this pathway. The genetic loss of function of five of these supports a model where each of the five individually are not required for signaling. The combined loss of function of two type I receptors produces a nodal loss of function phenotype, suggesting that these two function redundantly during early zebrafish development.</p><p>The authors present a novel finding that the type I receptor normally functions to limit the diffusion of ligand, which in turn shapes the nodal gradient. This builds upon previous work showing that the nodal co-receptor oep and the nodal antagonist lefty influence the nodal gradient.</p><p>The authors show that endogenous levels of nodal ligand can directly activate signaling in cells several cell diameters away without a secondary relay system, which is an important aspect of our understanding of how nodal ligands function in a morphogenetic gradient.</p><p>Weaknesses:</p><p>Much of the combinatorial receptor loss of function data relies on the use of morpholinos. Given the lack of phenotype of single mutants, the absence of phenotypes in combinatorial loss of function using morpholinos may indicate that those particular receptors are dispensable, or rather that the morpholinos are not efficiently knocking down the gene product, and thus prevents definitive conclusions from being drawn regarding those particular experiments. However the distinctive nodal loss of function phenotype observed in the particular loss of function combination of acvr1b-a (genetic loss of function) and acvr1b-b (morpholino loss of function) provides strong support that these two receptors act redundantly during in zebrafish nodal signaling. These two genes are the central focus of the paper.</p><p>The manuscript would be strengthened by adding images for embryos where there are nodal loss or gain of function phenotypes. Although example images of phenotypes are provided, it is not clear what the manipulation was that generated them. In particular there should be images of the acvr1b-a and acvr1b-b combined loss of function phenotype.</p><p>The conclusion that acvr1b-a and acvr1b-b function maternally during early zebrafish development needs to be further supported by confirming that the acvr1b-b splice blocking morpholino disrupts splicing of the zygotic transcript.</p><p>Suggestions for authors:</p><p>Although example images were presented for phenotype classification, it is important to show an example image of the nodal loss of function phenotype generated specifically from the acvr1b-a and acvr1b-b dual loss of function embryos (perhaps in a supplemental figure).</p><p>The authors conclude that the maternal transcripts of acvr1b-a and acvr1b-b are critical for nodal signaling based on the strong nodal loss of function phenotype using the acvr1b-b translation blocking MO, and lack of phenotype from the acvr1b-b splice blocking MO. In order to make this conclusion though the authors need to show that the splice blocking MO is actually disrupting the acvr1b-b transcript, as opposed to the lack of phenotype being due to the MO not effectively inhibiting splicing (or causing an in-frame cryptic splice site usage).</p><p>Regarding the previous point, something that seems to suggest that the splice blocking acvr1b-b MO is not inhibiting acvr1b-b function is that there is no zygotic nodal loss of function phenotype in the splice-blocking acvr1b-b MO injected acvr1b-a MZ mutants (figure 3C).</p><p>It is not clear to me why the quantification of nodal signaling in acvr1b-a and acvr1b-b loss of function and rescue experiments is measured as the number of tiers of cells (distance from ligand source) of pSmad2/3? The ligand distribution should either not be changed or perhaps increased based on receptor loss. Instead, for a more accurate measure of signaling level, the amount of pSmad2/3 (fluorescence intensity) should be measured in discreet regions of the embryo. In the images shown, it appears that the acvr1b-a mutant alone has weaker staining compared to wild-type, which may indicate lower signaling activity even in the absence of a morphological phenotype.</p><p>In the FRAP experiment in figure 6B, the example image of acvr1b-a and acvr1b-b loss of function seems to have worse fluorescence recovery than the wild-type embryos, which is opposite of the general trend in the graph of all of the data. When I went to look at the source data to clarify, I just see the final diffusion coefficient numbers that were used to generate the plot. It would be helpful to have the raw fluorescence intensity measurements in this data set.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66397.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>The major concerns of reviewers include:</p><p>1. The heavy reliance on morpholinos for loss-of-function studies. The reviewers thought that generation of acvr1b-b mutant and analyses of acvr1b-a/b double mutant would significantly strengthen the conclusion. Likewise, they wondered that while the authors generated or obtained mutant lines for 3 of the 4 type II receptors, redundancy of these genes was not tested by generating double and triple mutants, but by simultaneously knocking down all 4 paralogous genes using MOs. Mutations should be generated for acvr1b-b and acvr2b-b, which should then be tested in combination with other receptor mutations. This is especially important for the type II receptors, because the severe but non-specific phenotypes of quadruple morphant embryos are so difficult to interpret (Figure 3).</p></disp-quote><p>We agree that additional mutants would strengthen our study. As proposed in our revision action plan, we have used a CRISPR knockout strategy to generate combinatorial mutations disrupting both <italic>acvr1</italic> homologs and all four <italic>acvr2</italic> genes. This strategy, recently published by Jason Rihel and colleagues in a breakthrough paper in <italic>eLife</italic>, is “[…] capable of converting &gt;90% of injected embryos directly into F0 biallelic knockouts” and “[…] sufficiently robust to knockout multiple genes in the same animal […]” (https://elifesciences.org/articles/59683, Kroll et al., 2021).</p><p>For the Type I receptors Acvr1b-a and Acvr1b-b, the new CRISPR knockouts validated the specificity of our previous experiments, showing that the receptors redundantly mediate Nodal signaling (new Figure 3). Using the same approach, we found that Acvr2 receptors function partly redundantly to pattern the early zebrafish embryo, do not fulfill the function of classical Type II Nodal receptors and act at least partially independently of Nodal (new Figure 2, new Figure 2 —figure supplement 2).</p><p>In the revised manuscript, we have now used a total of three different methods to generate combinatorial loss-of-function conditions for <italic>acvr1b-a</italic>/<italic>acvr1b-b</italic> and <italic>acvr2a-a</italic>/<italic>acvr2a-b</italic>/<italic>acvr2b-a</italic>/<italic>acvr2b-b</italic>: (1) Morpholino-mediated knockdown, (2) CRISPR knockouts and (3) stable mutants in combination with the former two techniques. Using these different methods we obtained the same results, strengthening our conclusions. For example, the phenotypes observed upon quadruple <italic>acvr2</italic> gene knockout (new Figure 2A,B) were recapitulated by both the quadruple knockdown and the knockout of <italic>acvr2b-b</italic> in triple mutants homozygous for <italic>acvr2a-a</italic><sup><italic>-/-</italic></sup>, <italic>acvr2a-b</italic><sup><italic>-/-</italic></sup> and <italic>acvr2b-a</italic><sup><italic>-/-</italic></sup> (new Figure 2 —figure supplement 2A-C).</p><disp-quote content-type="editor-comment"><p>2. Overexpression of fluorescently tagged Nodal ligand is not a reliable method for determining signaling range. To make any interpretation of these data, the authors would need to measure how the levels of the injected Nodal compare with endogenous levels and to see how the results vary when varying doses of Nodal are injected,</p></disp-quote><p>We agree that it is important to ensure that endogenous receptors are not saturated by ectopic fluorescently tagged Nodal in gradient formation assays. Unfortunately, endogenous Nodal levels are unknown and currently impossible to determine precisely due to the lack of appropriate antibodies and transgenic lines. In order to visualize the distribution of Nodal signals in zebrafish embryos, expression of fluorescently tagged proteins by mRNA injection is currently the best approach and well recapitulates the endogenous signaling range and dynamics (e.g. Müller et al., 2012; Soh et al., 2020; Kuhn et al., 2022; also see Stapornwongkul and Briscoe 2022). Fluorescently tagged Nodal ligands expressed from localized ectopic sources can even induce the formation of a full secondary axis in zebrafish embryos, demonstrating that these fusion proteins have full biological activity and relevant signaling ranges to orchestrate complex morphogenetic processes (Soh et al., 2020). In our gradient formation assays (new Figure 5, New Figure 5 —figure supplement 1), we observe clear differences in the distribution of Nodal-GFP in receptor mutants compared to wild-type embryos, indicating that Nodal-GFP expression does not lead to saturation of endogenous Nodal receptors.</p><p>To further validate the physiological relevance of the Nodal-GFP levels in our gradient formation assays, we have now performed additional experiments and injected different amounts of mRNA encoding Nodal-GFP into maternal-zygotic <italic>squint</italic>;<italic>cyclops</italic> mutants devoid of any endogenous Nodal source (new Figure 5 —figure supplement 1E). Importantly, the amount of mRNA that we had used in the YSL gradient formation assay rescued the mutant <italic>squint</italic>;<italic>cyclops</italic> phenotype the best, suggesting that the amount of Nodal-GFP in our gradient formation experiments is near physiological levels.</p><disp-quote content-type="editor-comment"><p>3. Referring to Figure 6B – the Reviewers wondered how do the timescales for binding and unbinding to receptors compare to that for diffusion? The FRAP dataset requires a clear model for its interpretation.</p></disp-quote><p>We assume rapid binding and relatively slow unbinding of Nodal ligands and receptors, and in the revised manuscript we now refer to our previous theoretical and experimental studies that provide detailed models (Müller et al., 2012; Müller et al., 2013; Bläßle et al., 2018; Mörsdorf and Müller 2019; Kuhn et al., 2022). Specifically, in our recent single-molecule tracking experiments (Kuhn et al., 2022), we have measured binding times of 16 s for fluorescently tagged Cyclops and 11 s for fluorescently tagged Squint in zebrafish embryos on a nanometer-to-micrometer scale. These experimental measurements are in remarkable agreement with our previous FRAP-based tissue-scale binding time predictions of 18 s and 4 s for Cyclops-GFP and Squint-GFP, respectively (Müller et al., 2012). Importantly, these binding times can directly explain how the effective diffusion timescale of Nodal in FRAP experiments arises from local interactions with immobile receptors (Müller et al., 2012; Müller et al., 2013; Bläßle et al., 2018; Mörsdorf and Müller 2019; Kuhn et al., 2022).</p><disp-quote content-type="editor-comment"><p>4. The Reviewers questioned why the quantification of nodal signaling in acvr1b-a and acvr1b-b loss of function and rescue experiments is measured as the number of tiers of cells (distance from ligand source) of pSmad2/3? Instead, for a more accurate measure of signaling level, the amount of pSmad2/3 (fluorescence intensity) should be measured in discreet regions of the embryo.</p></disp-quote><p>Thank you for the suggestion. We originally performed the quantification of pSmad2/3 signal as a function of cell tiers from the margin since the number of pSmad2/3-positive nuclei can be easily manually counted and the approach is well accepted in the field (e.g. van Boxtel et al., 2015). To corroborate our findings, we have now complemented our analyses with the suggested measurements of pSmad2/3 fluorescence intensities in discrete regions of the embryo. Specifically, we performed line-average measurements of pSmad2/3 distributions in lateral and dorsal domains, and the resulting quantifications confirmed our previous conclusions (new Figure 4 —figure supplement 1, Figure 4).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>While the essential roles of Nodal signaling during early development are well described, the precise function of different zebrafish Nodal receptor paralogs had not been determined. Here, the authors identify 7 genes encoding type I and type II Nodal receptors in zebrafish, 6 of which are maternally deposited and expressed during germ layer specification. Loss-of-function analysis reveals that none of these Nodal receptors is strictly necessary for development, and that loss of both Acvr1b type I receptors is required to yield a Nodal-deficient phenotype. This double loss-of-function was achieved by injecting acvr1b-b morpholino oligonucleotide (MOs) into acvr1b-a mutant embryos, raising the question, why didn't the authors generate mutations in both genes to examine double mutant phenotypes? And while the authors generated or obtained mutant lines for 3 of the 4 type II receptors, they tested for redundancy of these genes not by generating double and triple mutants, but by simultaneously knocking down all 4 paralogous genes using MOs. Because such high doses of MO cause pleiotropic and non-specific defects, the phenotypes of these embryos are difficult to interpret.</p></disp-quote><p>We agree that additional mutants would strengthen our study. As proposed in our revision action plan, we have used a CRISPR knockout strategy to generate combinatorial mutations disrupting both <italic>acvr1</italic> homologs and all four <italic>acvr2</italic> genes. This strategy, recently published by Jason Rihel and colleagues in a breakthrough paper in <italic>eLife</italic>, is “[…] capable of converting &gt;90% of injected embryos directly into F0 biallelic knockouts” and “[…] sufficiently robust to knockout multiple genes in the same animal […]” (https://elifesciences.org/articles/59683, Kroll et al., 2021).</p><p>For the Type I receptors Acvr1b-a and Acvr1b-b, the new CRISPR knockouts validated the specificity of our previous experiments, showing that the receptors redundantly mediate Nodal signaling (new Figure 3). Using the same approach, we found that Acvr2 receptors function partly redundantly to pattern the early zebrafish embryo, do not fulfill the function of classical Type II Nodal receptors and act at least partially independently of Nodal (new Figure 2, new Figure 2 —figure supplement 2).</p><p>In the revised manuscript, we have now used a total of three different methods to generate combinatorial loss-of-function conditions for <italic>acvr1b-a</italic>/<italic>acvr1b-b</italic> and <italic>acvr2a-a</italic>/<italic>acvr2a-b</italic>/<italic>acvr2b-a</italic>/<italic>acvr2b-b</italic>: (1) Morpholino-mediated knockdown, (2) CRISPR knockouts and (3) stable mutants in combination with the former two techniques. Using these different methods we obtained the same results, strengthening our conclusions. For example, the phenotypes observed upon quadruple <italic>acvr2</italic> gene knockout (new Figure 2A,B) were recapitulated by both the quadruple knockdown and the knockout of <italic>acvr2b-b</italic> in triple mutants homozygous for <italic>acvr2a-a</italic><sup><italic>-/-</italic></sup>, <italic>acvr2a-b</italic><sup><italic>-/-</italic></sup> and <italic>acvr2b-a</italic><sup><italic>-/-</italic></sup> (new Figure 2 —figure supplement 2A-C).</p><disp-quote content-type="editor-comment"><p>Nodal signaling is largely restricted to the margin of pre-gastrulation zebrafish embryos, a gradient that is thought to form through interactions of highly diffusible extracellular Lefty antagonists and less diffusible Nodal ligands. It was recently shown (Lord et al., 2019) that the Oep/Tdgf1 co-receptor restricts Nodal signaling range, and here the authors hypothesized that Nodal type I and II receptors slow the diffusion of Nodal ligands to limit their signaling range. They directly demonstrate that fluorescently tagged Nodal ligands diffuse farther in the absence of both Acvr1b type I receptors and in oep-/- mutants. Using Fluorescence Decay After Photoconversion (FDAP) and Fluorescent Recovery After Photobleaching (FRAP), they determine that Nodal receptors limit ligand range by slowing their diffusion and not through ligand clearance or relay signaling. Namely, FRAP-detected ligand diffusion was found to increase upon loss of type I receptors but remained unchanged upon overexpression of type II receptors, suggesting that type I receptors may play a larger role in ligand distribution (despite the fact that type II receptors are thought to directly and strongly bind Nodal ligands). FDAP experiments revealed no effect on ligand clearance type II receptor overexpression, but it was not examined whether loss of type I receptors alters ligand clearance as it alters ligand diffusion.</p></disp-quote><p>In the revised manuscript, we now include FDAP measurements in <italic>acvr1b-a;acvr1b-b</italic> loss-of-function conditions (Figure 6A). We found that the absence of the Type I receptors does not cause a decrease in the clearance rate of Squint-GFP or Cyclops-GFP, showing that the broadening of the gradients (new Figure 5, new Figure 5 —figure supplement 1) cannot be explained through increased protein stability.</p><disp-quote content-type="editor-comment"><p>Together, these results identify redundancy in Nodal receptor function during early zebrafish development and propose a creative, seemingly paradoxical model in which feed-forward Nodal signaling actually decreases signaling range by boosting expression of receptors that limit ligand diffusion.</p><p>1. The authors conclude that, because neither genetic mutations nor translation blocking MOs targeting Nodal receptors produce phenotypes, no genetic compensation is occurring. It would be more convincing to show by qRT-PCR that expression levels of paralogous genes are not altered upon mutation of a receptor gene.</p></disp-quote><p>We apologize for the confusion. We did not want to claim that no genetic compensation is occurring, but argue that morpholino-mediated knockdown on the mRNA level could help to reveal effects masked by genetic compensation in the mutants. As suggested, we have now included qRT-PCR experiments in the revised manuscript (new Figure 2 —figure supplement 1E,F and new Figure 3 —figure supplement 1D). The results suggest that in some instances genetic compensation might indeed occur. We now refer to these new results in the main text to more clearly motivate the use of morpholinos as tools that may reveal phenotypes that could be masked by genetic compensation.</p><disp-quote content-type="editor-comment"><p>2. Because homozygous loss of any Nodal receptor gene is not lethal, it should be straightforward to generate double mutant embryos and bypass the use of MOs to determine functional redundancy. Mutations should be generated for acvr1b-b and acvr2b-b, which should then be tested in combination with other receptor mutations. This is especially important for the type II receptors, because the severe but non-specific phenotypes of quadruple morphant embryos are so difficult to interpret (Figure 3).</p></disp-quote><p>As detailed above, we have executed the suggested experiments to corroborate our findings.</p><disp-quote content-type="editor-comment"><p>3. The authors state that embryos lacking acvr1b-a or -b alone &quot;had a Nodal signaling range very similar to untreated WT embryos&quot; (line 214), but in Figure 4A these conditions look quite different from one another. Particularly, the pSmad2 signal at the (presumed) dorsal midline looks similar to WT, but appears much dimmer at other positions around the margin of acvr1b LOF embryos. Were the measurement in Figure 4B taken from a single, dorsal region of the margin, which could explain the normal number of pSmad2+ nuclei despite the abnormal appearance of these embryos? Or are these images not representative of the embryos quantified?</p></disp-quote><p>In Figure 4B, we indeed measured Nodal signaling range on the dorsal side. We have now stated this more clearly in the figure legend and in the main text of the revised manuscript. Moreover, we have complemented our analyses with pSmad2/3 intensity quantifications in dorsal and lateral regions (new Figure 4 —figure supplement 1). These new analyses confirmed that embryos lacking Acvr1b-a or Acvr1b-b have a similar Nodal signaling range as wild-type embryos in dorsal regions. In lateral domains, at a distance of more than 30 µm from the margin, the pSmad2/3 intensities are slightly lower in <italic>acvr1b-a<sup>-/-</sup></italic> compared to wild-type embryos (new Figure 4 —figure supplement 1). We have noted this in the text and selected example images better representing these results.</p><disp-quote content-type="editor-comment"><p>4. In figure 5B, it would be nice to see images of Nodal ligand diffusion upon loss of Nodal receptors in addition to loss of oep.</p></disp-quote><p>Thank you, we have included these images in the revised manuscript (new Figure 5 —figure supplement 1D).</p><disp-quote content-type="editor-comment"><p>5. Given that type II receptors are reported to interact directly and strongly with Nodal ligands, it is surprising that altering levels of type I receptors affected ligand diffusion while type II levels did not. To test this further, I would like to see measurements of ligand clearance / diffusion upon both loss and gain of function of both type I and type II receptors (rather than only loss of type I and only gain of type II). Because acvr1b mutants exhibit increased diffusion (Figure 6B), I would be interested to know if ligand clearance (stability) is also affected in these mutants? This would help determine if ligand clearance does not actually regulate signaling in this system, or if acvr2b overexpression simply doesn't cause phenotypes (Figures 6A-B).</p></disp-quote><p>We have included FDAP measurements for Squint-Dendra2 and Cyclops-Dendra2 in Acvr1 loss-of-function embryos in our revised manuscript (new Figure 6A). Our results show that the broadening of the Nodal gradient observed upon loss of the Type I receptors (Figure 5) cannot be explained by increased stability of the Nodal proteins (new Figure 6A).</p><p>For Acvr2, the new combinatorial knockout experiments suggest that the receptors function partly redundantly and at least partially independently of Nodal (new Figure 2, new Figure 2 —figure supplement 2), requiring a set of additional experiments beyond the scope of the present work. We will therefore elucidate the mechanism-of-action and precise function of Acvr2 receptors in a follow-up study.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Preiß et al., investigate how Nodal receptors regulate Nodal signaling. They first discover several possible new Type I and Type II receptors based on homology to mammalian sequences. They show combined loss of two type I receptors results in a phenotype indicative of loss of nodal signaling. They then perform experiments to suggest that the range of Nodal signaling is regulated by the expression of the type I receptor. The discovery of additional type I receptors is certainly useful, and the phenotype of removing two of them is clear, however, several other claims are not justified by the data. I detail my concerns below.</p><p>1. The authors state that Figure 1F shows that inhibition of nodal signaling reduces expression of acvr1b-a, however, I do not see this in the figure where there still appears to be signal in the in situ. If anything, the range of signal appears expanded over the animal pole of the embryo.</p></disp-quote><p>We apologize for the poor quality of the staining in the previous picture, where the apparent background signal likely resulted from overstaining. To corroborate our findings, we have now carefully repeated the in situ staining and replaced the respective image in Figure 1F. The new image demonstrates the lack of signal more clearly, recapitulating the strong downregulation of <italic>acvr1b-a</italic> upon Nodal signaling inhibition determined by qRT-PCR (Figure 1E).</p><disp-quote content-type="editor-comment"><p>2. In Figure 3, the authors show that combining MO against acvr1b-a and acvr1b-b produces a &quot;pinhead&quot; phenotype. Can they speculate why this phenotype is not seen in Figure 3C when knockout of acvr1a-a is combined with MO against acvr1a-b?</p></disp-quote><p>The pinhead phenotype in <italic>acvr1b-a</italic>;<italic>acvr1b-b</italic> morphants is reminiscent of the phenotype in zygotic <italic>oep</italic> mutants, whereas the full Nodal loss-of-function phenotype in <italic>acvr1b-a</italic> mutants injected with <italic>acvr1b-b</italic> morpholino is similar to the phenotype in maternal-zygotic <italic>oep</italic> mutants (Gritsman et al., 1999). This suggests that the <italic>acvr1b-a</italic> morpholino does not fully abolish Acvr1b-a activity. We have included this speculation in the revised manuscript as follows:</p><p>“Morpholino mediated double knockdown of acvr1b-a and acvr1b-b resulted in a clear loss of head mesoderm at 1 dpf, leading to the distinctive fused-eye phenotype and a curved body axis associated with loss of Nodal signaling (Figure 3 —figure supplement 2A,B). However, somites still formed in the trunk region, suggesting an incomplete loss of Nodal signaling possibly due to maternal deposition of receptor proteins or incomplete mRNA knockdown”.</p><disp-quote content-type="editor-comment"><p>3. Figure 3 – in the absence of functional data to support the role of the newly identified type II receptors, given that the loss of function yielded no phenotype, the authors should avoid making a strong claim that these receptors play a role in Nodal signaling.</p></disp-quote><p>We fully agree. We have now extended our analysis of the putative Type II receptors <italic>acvr2a-a</italic>, <italic>acvr2a-b</italic>, <italic>acvr2b-a</italic> and <italic>acvr2b-b</italic> by generating quadruple knockout embryos (new Figure 2A,B) and by combining the knockout of <italic>acvr2b-b</italic> with triple homozygous <italic>acvr2a-a<sup>-/-</sup>, acvr2a-b<sup>-/-</sup></italic> and <italic>acvr2b-a<sup>-/-</sup></italic> mutants (new Figure 2 —figure supplement 2A-C). The morphological and molecular phenotypes that we observe in these embryos show that receptors function partly redundantly to pattern the early zebrafish embryo and that they do so at least partially independently of Nodal. In the revised manuscript we now emphasize that the receptors do not fulfill the function of classical Type II Nodal receptors.</p><disp-quote content-type="editor-comment"><p>4. In Figure 4a there seems to be a clear difference in signal intensity between the wildtype and acvr1b-a mutant in the uninflected case. In the mutant much of the margin appears to have reduced or no signal for pSmad2. This should be noted.</p></disp-quote><p>This was also noticed by Reviewer #1 in specific point 3. As suggested, we now point out more clearly that we measured the number of pSmad2/3-positive cell tiers only on the dorsal side.</p><p>Furthermore, we have included measurements in lateral regions in addition to the dorsal domain (new Figure 4 —figure supplement 1). In lateral regions, <italic>acvr1b‑a<sup>-</sup></italic><sup>/<italic>-</italic></sup> mutants showed a slight reduction in pSmad2/3 signal intensity at distances above 30 µm from the margin compared to wild-type embryos. We have noted this in the revised manuscript as suggested.</p><disp-quote content-type="editor-comment"><p>5. Figure 5 – results based on overexpression of fluorescently tagged Nodal ligand is not a reliable method for determining signaling range. It is clear from the current study as well as several other that the stoichometry of ligand and receptors will influence the result and so no faith can be put in the results of overexpression. To make any interpretation of this data at all, the authors would need to measure how the levels of the injected Nodal compare with endogenous levels and to see how the results vary when varying doses of Nodal are injected, however, even in this case, much caution is required when drawing conclusions about the range of Nodal in general.</p></disp-quote><p>We agree that it is important to ensure that endogenous receptors are not saturated by ectopic fluorescently tagged Nodal in gradient formation assays. Unfortunately, endogenous Nodal levels are unknown and currently impossible to determine precisely due to the lack of appropriate antibodies and transgenic lines. In order to visualize the distribution of Nodal signals in zebrafish embryos, expression of fluorescently tagged proteins by mRNA injection is currently the best approach and well recapitulates the endogenous signaling range and dynamics (e.g. Müller et al., 2012; Soh et al., 2020; Kuhn et al., 2022; also see Stapornwongkul and Briscoe 2022). Fluorescently tagged Nodal ligands expressed from localized ectopic sources can even induce the formation of a full secondary axis in zebrafish embryos, demonstrating that these fusion proteins have full biological activity and relevant signaling ranges to orchestrate complex morphogenetic processes (Soh et al., 2020). In our gradient formation assays (new Figure 5, New Figure 5 —figure supplement 1), we observe clear differences in the distribution of Nodal-GFP in receptor mutants compared to wild-type embryos (Figure 5, Figure 5 —figure supplement 1), indicating that Nodal-GFP expression does not lead to saturation of endogenous Nodal receptors.</p><p>To further validate the physiological relevance of the Nodal-GFP levels in our gradient formation assays, we have now performed additional experiments and injected different amounts of mRNA encoding Nodal-GFP into maternal-zygotic <italic>squint</italic>;<italic>cyclops</italic> mutants devoid of any endogenous Nodal source (new Figure 5 —figure supplement 1E). Importantly, the amount of mRNA that we had used in the YSL gradient formation assay rescued the mutant <italic>squint</italic>;<italic>cyclops</italic> phenotype the best, suggesting that the amount of Nodal-GFP in our gradient formation experiments is near physiological levels.</p><disp-quote content-type="editor-comment"><p>6. Figure 5 – the results shown in C,D are not consistent with what would be expected if binding to the receptor restricted the range of Nodal. In that case, when the receptor is downregulated and Nodal can diffuse more freely, one would expect lower levels near the source but a broader distribution. In this case, there is simply more Nodal everywhere which indicates either the receptor is somehow post-translationally regulating the expression of Nodal or else these embryos simply had more Nodal mRNA injected. Also, quantification is shown for receptor loss of function but not images are shown in B, these should be included.</p></disp-quote><p>To account for differences in fluorescence intensities in the YSL gradient formation assay possibly caused by differences in microscopy settings, laser power or injected Nodal mRNA amounts, we have now calculated normalized signal distributions (new Figure 5 —figure supplement 1C). As also suggested by Reviewer #1, we have additionally included images of Squint-GFP and Cyclops-GFP in receptor loss-of-function conditions in the revised manuscript (new Figure 5 —figure supplement 1B).</p><p>To corroborate our findings of broadened gradients when the receptor is downregulated, we have performed additional experiments and measured the distributions of Squint-GFP and Cyclops-GFP expressed from localized cell clones as an alternative to the YSL gradient formation assay (new Figure 5). In agreement with our previous results, the distributions of Squint-GFP and Cyclops-GFP were broadened in the absence of the Nodal Type I receptors and co-receptors, consistent with the increased effective diffusivity measured by FRAP experiments (Figure 6B).</p><disp-quote content-type="editor-comment"><p>7. Figure 6 A, B – the authors should show the data from the photoconversion and FRAP experiments and the fit to these curves and then the parameters that were extracted from this.</p></disp-quote><p>Thank you for this suggestion. We have included representative fits and raw data for the FDAP and FRAP experiments in Figure 6 —figure supplement 1.</p><disp-quote content-type="editor-comment"><p>8. Figure 6A – loss of function for the receptor should be performed as well. If most of the Nodal is already bound, overexpressing the receptor would not be expected to have an effect but loss of function might.</p></disp-quote><p>We agree with the reviewer and have included these additional FDAP experiments in the revised manuscript (new Figure 6A). The results demonstrate that the absence of the Type I receptors does not cause a decrease in the clearance rate of Squint-GFP or Cyclops-GFP, showing that the broadening of the gradients (Figure 5) cannot be explained through increased protein stability.</p><disp-quote content-type="editor-comment"><p>9. Figure 6B – I do not understand the model for diffusion the authors are proposing. How do the timescales for binding and unbinding to receptors compare to that for diffusion? If they are slow, then one expects that the receptor binding would show up in an immobile fraction in the experiment rather than in lowering the diffusion constant. Or are the authors suggesting that the receptor bound Nodal diffuses within the plasma membrane, but more slowly, in which case the data would need to be fit to a two component model. In any event, this FRAP data requires a clear model for its interpretation.</p></disp-quote><p>We assume rapid binding and relatively slow unbinding of Nodal ligands and receptors, and in the revised manuscript we now refer to our previous theoretical and experimental studies that provide detailed models (Müller et al., 2012; Müller et al., 2013; Bläßle et al., 2018; Mörsdorf and Müller 2019; Kuhn et al., 2022).</p><p>Specifically, we used the simple synthesis-diffusion-clearance model</p><p><inline-formula><mml:math id="sa2m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>D</mml:mi><mml:msup><mml:mi mathvariant="normal">∇</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> with our previously measured clearance rate constants <italic>k<sub>1</sub></italic> for Squint and Cyclops (Müller et al., 2012), uniform production <italic>k<sub>2</sub></italic> and the effective diffusion coefficient <italic>D</italic> as the fitting parameter for the time-dependent recovery of the fluorescence intensity <italic>c</italic> (Müller et al., 2012; Pomreinke et al., 2017; Bläßle et al., 2018; Mörsdorf and Müller 2019). It can be shown that the effective diffusion coefficient <italic>D</italic> of a molecule is equivalent to <inline-formula><mml:math id="sa2m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mtext>free</mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mtext>Receptor</mml:mtext><mml:mo>]</mml:mo></mml:mrow><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mtext>off</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mtext>on</mml:mtext></mml:mrow></mml:msub></mml:mfrac></mml:mfrac><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula> when binding of a ligand with the local free diffusion coefficient <italic>D</italic><sub>free</sub> to an immobile receptor with the on-rate <italic>k</italic><sub>on</sub> and the off-rate <italic>k</italic><sub>off</sub> is fast and reversible (Crank 1979; Sprague et al., 2004; Thorne et al., 2008; Miura et al., 2009; Müller et al., 2012; Müller et al., 2013; Bläßle et al., 2018; Mörsdorf and Müller 2019).</p><p>In our recent single-molecule tracking experiments (Kuhn et al., 2022), we have measured binding times of 16 s for fluorescently tagged Cyclops and 11 s for fluorescently tagged Squint in zebrafish embryos on a local nanometer-to-micrometer scale. These experimental measurements are in remarkable agreement with our previous FRAP-based tissue-scale binding time predictions of 18 s and 4 s for Cyclops-GFP and Squint-GFP, respectively (Müller et al., 2012). Importantly, these binding times can directly explain how the effective diffusion timescale of Nodal in FRAP experiments arises from local interactions with immobile receptors (Müller et al., 2012; Müller et al., 2013; Bläßle et al., 2018; Mörsdorf and Müller 2019; Kuhn et al., 2022).</p><disp-quote content-type="editor-comment"><p>10. Figure 6C, D – quantification is essential for these experiments including quantifying the number of donor cells as well as the induced gradient on pSmad2 in the host.</p></disp-quote><p>We have included these suggested quantifications in the revised paper (new Figure 6 —figure supplement 2A-C). We found that the number of transplanted donor cells was not significantly different between wild-type and MZ<italic>sqt</italic><sup><italic>-/-</italic></sup>;<italic>cyc</italic><sup><italic>-/-</italic></sup> hosts (see Materials and methods – Statistical analysis in the revised manuscript). In addition, the pSmad2/3 gradient normalized to the number of transplanted cells was broader and of higher intensity in MZ<italic>sqt</italic><sup><italic>-/-</italic></sup>;<italic>cyc</italic><sup><italic>-/-</italic></sup> compared to wild-type host embryos, confirming our previous conclusions.</p><disp-quote content-type="editor-comment"><p>11. Figure 6C, D – in both cases there only appears to be active signaling immediately adjacent to the graft. This is not consistent with the authors investigation of &quot;medium-range&quot; Nodal signaling. This is important because the authors are trying to investigate whether a relay is essential for this medium range signal, however, if there is no signaling at a distance in the wildtype transplant then it is impossible to draw any conclusion from the transplant into the knockout.</p></disp-quote><p>The idea that the spreading of endogenous Nodal signaling requires relay is widely discussed in the current literature (e.g. van Boxtel et al., 2015; Rogers and Müller 2019; Liu et al., 2022). In these relay models, Nodal has at best a short diffusion range and requires a chain of signaling between adjacent cells to act over longer distances. For example, the Warmflash lab has recently stated that in an open micropatterned hESC-based 2D gastruloid system “Nodal does not travel more than one cell diameter in any context we examined” (Liu et al., 2022). This contrasts with the considerable number of pSmad2/3 positive nuclei (on average 4 and up to 15) that we found outside of margin-derived transplants in wild-type embryos and the even higher number (on average 8 and up to 31) in <italic>MZsqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> hosts (Figure 6 —figure supplement 2E). Together with the longer Nodal signaling range in <italic>MZsqt<sup>-/-</sup>;cyc<sup>-/-</sup></italic> hosts (Figure 6 —figure supplement 2B) this demonstrates that in an embryonic context Nodal can indeed act directly over a distance.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The nodal signaling pathway plays essential roles in germ-layer induction and patterning during development. While the ligands and co-receptor responsible for nodal activation during zebrafish development have been previously identified, it is still unclear which receptors are required for early zebrafish nodal signaling. Based on loss of function analysis, the authors identify two type I receptors that are redundantly required for nodal signaling during early development. The authors also perform experiments to suggest nodal ligand interactions with the type I receptor can affect ligand diffusion and help shape the nodal signaling gradient.</p><p>Strengths:</p><p>The identification and characterization of all seven receptors predicted to mediate nodal signaling serves as a nice reference for future studies of this pathway. The genetic loss of function of five of these supports a model where each of the five individually are not required for signaling. The combined loss of function of two type I receptors produces a nodal loss of function phenotype, suggesting that these two function redundantly during early zebrafish development.</p><p>The authors present a novel finding that the type I receptor normally functions to limit the diffusion of ligand, which in turn shapes the nodal gradient. This builds upon previous work showing that the nodal co-receptor oep and the nodal antagonist lefty influence the nodal gradient.</p><p>The authors show that endogenous levels of nodal ligand can directly activate signaling in cells several cell diameters away without a secondary relay system, which is an important aspect of our understanding of how nodal ligands function in a morphogenetic gradient.</p></disp-quote><p>We thank the reviewer for appreciating the strengths of our study.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>Much of the combinatorial receptor loss of function data relies on the use of morpholinos. Given the lack of phenotype of single mutants, the absence of phenotypes in combinatorial loss of function using morpholinos may indicate that those particular receptors are dispensable, or rather that the morpholinos are not efficiently knocking down the gene product, and thus prevents definitive conclusions from being drawn regarding those particular experiments. However the distinctive nodal loss of function phenotype observed in the particular loss of function combination of acvr1b-a (genetic loss of function) and acvr1b-b (morpholino loss of function) provides strong support that these two receptors act redundantly during in zebrafish nodal signaling. These two genes are the central focus of the paper.</p><p>The manuscript would be strengthened by adding images for embryos where there are nodal loss or gain of function phenotypes.</p></disp-quote><p>As suggested, we have included these images in our revised manuscript (new Figure 2 —figure supplement 2, new Figure 3A, new Figure 5 —figure supplement 1E).</p><disp-quote content-type="editor-comment"><p>Although example images of phenotypes are provided, it is not clear what the manipulation was that generated them. In particular there should be images of the acvr1b-a and acvr1b-b combined loss of function phenotype.</p></disp-quote><p>We have included additional more detailed example images for the individual conditions in our revised manuscript and more clearly pointed out what the manipulation was that generated them (new Figure 2A and new Figure 3A).</p><disp-quote content-type="editor-comment"><p>The conclusion that acvr1b-a and acvr1b-b function maternally during early zebrafish development needs to be further supported by confirming that the acvr1b-b splice blocking morpholino disrupts splicing of the zygotic transcript.</p></disp-quote><p>We have performed the suggested analysis and included the results in our revised manuscript (new Figure 3 —figure supplement 2D). We found that the <italic>acvr1b-b</italic> splice-blocking morpholino indeed disrupts the splicing of the zygotic transcript but does not affect the already spliced maternal transcript. Additionally, we show that the phenotype observed upon combinatorial zygotic knockout of <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> recapitulates the zygotic knockout of <italic>oep</italic> (new Figure 3A,C), further supporting the idea that maternally deposited receptor mRNAs contribute to Nodal signaling.</p><disp-quote content-type="editor-comment"><p>Suggestions for authors:</p><p>Although example images were presented for phenotype classification, it is important to show an example image of the nodal loss of function phenotype generated specifically from the acvr1b-a and acvr1b-b dual loss of function embryos (perhaps in a supplemental figure).</p></disp-quote><p>We have included additional more detailed example images for the individual conditions in our revised manuscript for clarification (new Figure 3A).</p><disp-quote content-type="editor-comment"><p>The authors conclude that the maternal transcripts of acvr1b-a and acvr1b-b are critical for nodal signaling based on the strong nodal loss of function phenotype using the acvr1b-b translation blocking MO, and lack of phenotype from the acvr1b-b splice blocking MO. In order to make this conclusion though the authors need to show that the splice blocking MO is actually disrupting the acvr1b-b transcript, as opposed to the lack of phenotype being due to the MO not effectively inhibiting splicing (or causing an in-frame cryptic splice site usage).</p></disp-quote><p>Thank you for the suggestion. We have performed the suggested analysis and included the results in our revised manuscript (new Figure 3 —figure supplement 2D). We found that the <italic>acvr1b-b</italic> splice-blocking morpholino indeed disrupts the splicing of the zygotic transcript but does not affect the already spliced maternal transcript. However, even with 2 ng of injected morpholino, spliced transcripts are detected at shield stage (new Figure 3 —figure supplement 2D). This suggests either a long persistence of the maternal transcripts or incomplete knockdown.</p><p>To further test whether maternally deposited receptor mRNA contributes to Nodal signaling, we have complemented our analysis with zygotic combinatorial receptor mutants (new Figure 3A,C). We show that the phenotypes observed upon zygotic knockout of both <italic>acvr1b-a</italic> and <italic>acvr1b-b</italic> resemble the zygotic <italic>oep</italic> knockout phenotype<italic>,</italic> indicating a partial rescue of the Nodal loss-of-function phenotype by maternal transcripts.</p><disp-quote content-type="editor-comment"><p>Regarding the previous point, something that seems to suggest that the splice blocking acvr1b-b MO is not inhibiting acvr1b-b function is that there is no zygotic nodal loss of function phenotype in the splice-blocking acvr1b-b MO injected acvr1b-a MZ mutants (figure 3C).</p></disp-quote><p>We fully agree with this interpretation. As outlined above, we did observe a disruption of transcript splicing upon injection of the morpholino, but we also observed remaining spliced transcript at shield stage indicative of persistent maternal transcripts or incomplete knockdown. This might explain the absence of a zygotic loss-of-function phenotype. However, together with the results obtained from the combinatorial zygotic receptor mutants (see above), this suggests a contribution of maternal receptor mRNA. We have adjusted our interpretations in the text accordingly.</p><disp-quote content-type="editor-comment"><p>It is not clear to me why the quantification of nodal signaling in acvr1b-a and acvr1b-b loss of function and rescue experiments is measured as the number of tiers of cells (distance from ligand source) of pSmad2/3? The ligand distribution should either not be changed or perhaps increased based on receptor loss. Instead, for a more accurate measure of signaling level, the amount of pSmad2/3 (fluorescence intensity) should be measured in discreet regions of the embryo. In the images shown, it appears that the acvr1b-a mutant alone has weaker staining compared to wild-type, which may indicate lower signaling activity even in the absence of a morphological phenotype.</p></disp-quote><p>This was also suggested by Reviewer #1 and Reviewer #2 (see above), and we have included additional quantifications in dorsal and lateral domains in the revised manuscript (new Figure 4 —figure supplement 1).</p><disp-quote content-type="editor-comment"><p>In the FRAP experiment in figure 6B, the example image of acvr1b-a and acvr1b-b loss of function seems to have worse fluorescence recovery than the wild-type embryos, which is opposite of the general trend in the graph of all of the data. When I went to look at the source data to clarify, I just see the final diffusion coefficient numbers that were used to generate the plot. It would be helpful to have the raw fluorescence intensity measurements in this data set.</p></disp-quote><p>As suggested, we have included representative fits and raw fluorescence intensity measurements in the revised manuscript (Figure 6 —figure supplement 1A, Figure 6 —figure supplement 1 – source data).</p></body></sub-article></article>